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Organophosphorus (OP) pesticide toxicity is a global health problem. Respiratory failure due 
to neuromuscular transmission dysfunction accounts for about 300,000 deaths annually in 
rural Asia.  However, the clinical manifestation is complex, and described in terms of acute, 
intermediate, and chronic syndromes. The underlying mechanism of toxicity is still unclear. 
OP pesticides contain inhibitors of acetylcholinesterase (AChE), for example dimethoate, 
emulsified in an organic solvent, typically cyclohexanone. A hypothesized mechanism is 
initial excitotoxicity through inhibition of acetylcholinesterase followed by failure of 
neuromuscular synaptic transmission. I tested this electrophysiologically in vitro by 
measuring properties of spontaneous miniature endplate potentials (MEPPs) and evoked 
endplate potentials (EPPs) in isolated sciatic nerve/flexor digitorum brevis muscles from 
mice, bathed in HEPES-buffered mammalian physiological saline (MPS). Muscle action 
potentials were abolished with µ-conotoxin (2µM). First, we tested the effects of plasma 
taken from Göttingen minipigs instilled orally (isofluorane anaesthesia) with a formulated 
pesticide (2.5ml/kg) whose active ingredient is dimethoate dissolved in cyclohexanone. This 
plasma abolished evoked synaptic transmission and increased spontaneous MEPP frequency 
within 60-180 minutes of bath application. However plasma from minipigs instilled with 
dimethoate alone produced no failure of transmission. Plasma contained either pesticide or 
dimethoate significantly increased the half decay time of EPPs. However, pesticide-plasma 
also contained the metabolites omethoate (100µM) and cyclohexanol (5 mM).  We found 
that bath application of omethoate alone caused a potent dose-dependent increase in EPP 
decay time. Cyclohexanol (5 mM) also increased EPP decay time but it also decreased both 
the excitability of axons and MEPP amplitude. In combination, omethoate and cyclohexanol 
produced greater disruption of neuromuscular transmission than either dimethoate or 
cyclohexanone, alone or in combination and this was particularly evident in isometric 
tension recordings, in which prolonged after-contraction and slow relaxation were observed 
during and immediately following tetanic stiumuation in the presence of omethoate and 
cyclohexanol. Voltage-clamp recordings of endplate currents (EPC) partially supported the 
EPP observations. Surprisingly, cyclohexanol-treated preparations showed no significant 
increase in EPC and MEPC decay time. However, there was some evidence of activity-
dependent decline in MEPC amplitude in cyclohexanol while quantal content in these 
preparations showed evidence of an increase suggesting a homeostatic response in evoked 





cyclohexanol treated preparations also revealed preliminary evidence of sensitivity to 
cyclohexanol compared to control preparations. Finally, I tested the effects NMJ 
transmission of 24hr exposure to OP pesticide and its metabolites using a novel organ culture 
system, utilising a mouse mutant (WldS) with a slow nerve degeneration phenotype. After 
incubation of 24 hrs with MPS + pesticides and metabolites, these muscles showed 
significant reduction in function (response to nerve stimuli with EPP/action potential ± 
MEPPs) compared to control cultures. Together, the data indicate that failure of 
neuromuscular transmission by pesticide-plasma cannot be explained solely by dimethoate-
mediated inhibition of acetylcholinesterase. Rather, a combination of metabolic breakdown 
products exerts potent, harmful presynaptic and postsynaptic effects. Either blocking the 
metabolic conversion of the constituents of OP pesticides, or transiently blocking their 
effects on receptors may therefore be an effective strategy for treatment of OP pesticide 
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Respiratory failure in organophosphorus (OP) pesticide toxicity accounts for thousands of 
deaths annually across the globe. There are two types of respiratory failure that occur during 
the course of OP toxicity: a) acute respiratory failure (during the early stage of pesticide 
poisoning) mostly due to central respiratory depression, respiratory muscle weakness and / or 
direct pulmonary effects such as bronchospasms and bronchorrhoes, b) delayed 
neuromuscular weakness and respiratory failure (24 – 72hrs after pesticide poisoning). Even 
though the acute respiratory failure is well characterized, the mechanisms of delayed 
respiratory failure are yet to be established even after several decades since its initial 
identification. The understanding of delayed neuromuscular weakness and respiratory failure 
will benefit the search for novel therapeutic treatments and thereby potentially saving tens of 
thousands of human lives in the future.  
1.1 Pesticide toxicity 
1.1.1 Importance of the problem 
Pesticide toxicity can result from accidental inhalation, ingestion or though skin 
contamination with the product. However, deliberate, self-inflicted poisoning (e.g. attempted 
suicides) contributes to most of the reported cases worldwide. For instance pesticide self-
poisoning leads to 250,000 – 370,000 mortalities every year, and is responsible for about one 
third of global suicides (Gunnell et al., 2007). Among all the pesticide-induced cases, 
organophosphorus (OP) poisoning is the most common in rural Asia (Gunnell et al., 2007), 
accounting for two thirds of the total cases (Eddleston, 2000). For example, in Sri Lanka, 
there were about 17,000 admissions annually in mid 1990’s due to pesticide poisoning, 
which results in occupancy of 35% of the intensive care unit beds in the rural hospitals 
(Eddleston et al., 1998). In 2006, the World Health Organization (WHO) declared, that 
“Pesticide poisoning is the single most important means of suicide worldwide” (Bertolote et 
al., 2006).  
1.1.2 Types of Pesticides 
Many types of pesticides are widely in use world wide. These include organophosphates (for 
example dimethoate, chlorpyrifos), carbamates (carbofuran, propoxur), organochlorines 






OP pesticides are widely used in agriculture and in household applications. Commercially 
available OP pesticides are manufactured as many formulation types including dry spray-
able (e.g. wettable powders, water dispersible granule), liquid spray-able (e.g. soluble 
concentrate, suspension concentrate, emulsifiable concentrate, ect) and dry spreadable 
granules (e.g. soil applied granule on inert or fertilizer carrier) (Gouge, 2000). Emulsifiable 
concentrate (EC), which is a mixer of active ingredient (OP), solvent and a surfactant. 
Formulation improves the properties of a chemical for handling, storage, application and 
may substantially influence effectiveness and safety (Gouge, 2000).  
According to their toxicity (active ingredient compound and its formulations) pesticides are 
classified into five different groups (WHO, 2005), Ia, Ib, II, III and U graded from extremely 
hazardous to unlikely to present acute hazard.   
However, these compounds show major differences in human toxicity and fatalities within 
same pesticide class and with the similar agricultural indication (Dawson et al., 2010). A 
prospective cohort study carried out in Sri Lanka from 2002 until 2008 indicated that 
anticholinesterase (dimethoate, fenthion) and herbicide paraquat pesticides belonging to 
toxicity class II were responsible for most of the hospital administration and the mortalities.  
1.1.3 Clinical manifestation (Signs and symptoms: acute, intermediate syndrome, 
polyneuropathy) 
OP toxicity is mainly categorized as either acute or chronic, according to the onset, clinical 
manifestation and postulated mechanism of action. Acute toxicity is further subcategorized 
into acute cholinergic syndrome and “intermediate syndrome” (IMS). The onset of clinical 
symptoms varies depending on the route of exposure, degree of exposure and the type of OP 
compounds, e.g. ingestion of a large amount of oxon OP (e.g. monochrotophos) can cause 
symptoms within 5 minutes. By contrast, ingestion of the same amount of thiophosphate OP 
(fenthion) may take hours to produce clinical symptoms and signs.  
Since OP pesticides inhibit the enzyme acetylcholinesterase (AChE), the effects of OP 
ingestion are thought to increase levels of acetylcholine (ACh) neurotransmitter in the 
synaptic cleft, thereby causing repeated activation of the ACh receptors. So, acute toxicity 
most likely arises from the overstimulation of ACh receptors present in the central and 





The most common clinical signs of acute cholinergic syndrome include pinpoint pupils, 
muscle fasciculation, diaphoresis, emesis, diarrhoea, salivation, lacrimation and urinary 
incontinence connected with autonomic effect of anticholinesterase. Most deaths occur 
within hours of pesticide ingestion during this “cholinergic crisis” (Lotti, 2001), as a 
consequence of acute respiratory failure due to central respiratory depression, respiratory 
muscle weakness, and/or direct pulmonary effect (bronchospasm and bronchorrhoea). Other 
signs of excessive activity of ACh in the autonomic nervous system include muscarinic 
(salivation, lacrimation, urination and defecation) and nicotinic effects (fasciculation or 
weakness in skeletal muscle or sometimes paralysis). Restlessness, anxiety and 
unconsciousness are some of the findings related to effects of OP on the central nervous 
system (CNS). Hypoxia, hypovolemia and hypotension are some of the cardiovascular 
clinical manifestations. Excessive cholinergic stimulation at skeletal muscles results in 
fasciculation or weakness.  
Intermediate syndrome is characterized by delayed muscle weakness resulting in respiratory 
failure without cholinergic features or fasciculation. Development of proximal muscle 
weakness, cranial nerve palsies, and respiratory failure lasting up to several weeks are the 
common clinical features of IMS. Patients need long term artificial ventilation until they 
regain capability of self-breathing. As a result of long term artificial ventilation during  IMS, 
pesticide poisoning became responsible for half of the intensive care unit bed occupancy in 
rural Asian hospitals, leaving less opportunity to treat more debilitating diseases such as 
myocardial infarction, encephalitis, etc. (Eddleston et al., 1998).  
IMS was first described as a syndrome of muscular paralysis occurring in conscious patients 
24-96 hours following ingestion of OP pesticides, after the acute cholinergic syndrome has 
been treated with atropine (Senanayake and Karalliedde, 1987) .  
Early studies described the involvement of central respiratory failure, bronchoconstriction 
and neuromuscular block in respiratory failure with anticholinesterases (De Candole et al., 
1953). Wadia et al (1974) described neurological manifestation in two distinct categories: 
type I (present on admission and respond to atropine therapy), and type II (appearing after 
the commencement of treatment and not influenced by atropine). Despite the two distinct 
and non-overlapping syndromes of OP-induced respiratory failure suggested in the literature, 
many clinical cases do not directly fall in two categories (Eddleston et al., 2006). It appears 





(central and peripheral); however, further research is required to identify the underlying 
mechanism of action.   
Dysfunction in NMJ transmission affects the diaphragm and intercostal muscle, which 
ultimately leads to respiratory failure. Clinical and experimental studies of IMS have 
basically focused on structural (OP induced myopathy) and functional (electrophysiological) 
aspects of the NMJ. Surprisingly, however, even though this syndrome has been well 
documented for decades, the underlying mechanism of the neuromuscular dysfunction is still 
unknown. The hypothesized mechanisms of action for IMS include: overstimulation of 
nicotinic acetylcholine receptors (nAChRs); down regulation of post synaptic nAChRs; and 
nAChR conformational changes with prolonged depolarization (Senanayake and 
Karalliedde, 1987; De Bleecker, 1995) . Factors affecting the onset of IMS include rapidity 
and quantity of AChE inhibition and insufficient oxime (antidote for activating AChE 
enzyme)) therapy. The occurrence of IMS is also more common with certain OP pesticides, 
eg: parathion, methylparathion, and fenthion. Understanding distinctive electrophysiological 
abnormalities with nerve conduction studies (Besser et al., 1989b)  facilitates predicting the 
development of IMS (Jayawardane et al., 2008). 
Further consequences of organophosphorus toxicity include organophosphorus induced 
polyneuropathy (OPIDP) resulting from inhibition of neuropathy target esterase 
(lysophospholipase) present in nervous tissue. This occurs as a consequence of chronic OP 
exposure over days or weeks following acute exposure. Transient loss of neuropathic target 
esterase activity, putative disruption of membrane phospholipid homeostasis, axonal 
transport, and glial-axonal interactions are some of the mechanisms involved with OPIDP 
(Glynn, 2006). Indistinct distal muscle weakness, pain and progressive paralysis are the 
common clinical signs present in the OPIDP. There are also reports of a chronic clinical 
syndrome which differs from both acute toxicity and OPIDP. This involves neural 
degeneration and subsequent neurological, neurobehavioral and neuropsychological 
consequences. This syndrome is referred to as organophosphorus induced chronic 
neurotoxicity (OPICN) (Abou-Donia, 2003). It is thought to occur from exposure to a single, 
large toxic dose or to small subclinical doses of OP compounds, which later then develop as 
long term neurological deficit, lasting for years after exposure (Abou-Donia, 2003). One 
hypothesised mechanism for OPICN is either via necrotic death of brain neuronal cells or 






1.1.4 Clinical management of organophosphorus pesticide toxicity 
Acute cholinergic syndrome occurs after exposure to a high dose of OP compounds. The 
effect of this is consistent with excessive stimulation of muscarinic and nicotinic cholinergic 
receptors due to persistent levels of acetylcholine (ACh) in the central, autonomic and 
peripheral nervous system (see above). 
Diagnosis with history of acute exposure to OP is mainly from the clinical signs of 
cholinergic crisis. The main laboratory tests that aid diagnosis of OP poisoning are those that 
measure the level of specific OPs and metabolites in biological tissues and 
acetylcholinesterase activity in plasma or blood. Electromyography is also used as a 
diagnostic test for AChE inhibition at the NMJ (Jayawardane et al., 2008).  
Preliminary clinical management for patients with OP toxicity are to ensure an adequate 
airway and ventilation (endotracheal intubation and positive pressure ventilation) and 
stabilization of cardiorespiratory function by reversing excessive muscarinic effects (anti-
muscarinic therapy; atropine) along with the supportive care (Eddleston et al., 2004; 
Eddleston et al., 2008). The oximes such as pralidoxime chloride (2-PAM) or obidoxime are 
used as antidotes which enhances the hydrolytic regeneration of the AChE (Eyer, 2003). In 
some instances, evacuation of stomach content is performed by gastric lavage especially 
patients who have not experienced emesis after ingestion of OP (Eddleston and Clark, 2010). 
1.1.5 Pesticide pharmacodynamics and clearance 
The chemical nature of OP compounds is highly variable: e.g. the octanol-water partitioning 
value (log Kow) ranges from -0.2 (monocrotophos) to 6 (bromophos ethyl) and water 
solubility (log sol) ranges from -1.1 (prothiofos) to 6 (dicrotophos).  The variable nature of 
these chemicals is reflected in the differing toxicity, kinetics, clinical syndrome and response 
to antidote.  
OP pesticides are either direct (oxon) or indirect (thion) inhibitors of carboxylic ester 
hydrolases (e.g: acetylcholinesterase [AChE]), and butyrylcholinesterase (Kwong, 2002; 
Eddleston and Clark, 2010). 
Formulation of pesticides uses solvents including organic and partially chlorinated 
compounds (Petrelli et al., 1993). The most common solvents used in organophosphorus 





The majority of the OP compounds are lipophilic and not ionised, therefore absorbed rapidly 
following ingestion. Absorption is also facilitated by the presence of solvent and emulsifier 
used in the technical formulation of pesticides (Vale, 1998; Kwong, 2002). Following 
ingestion and uptake from the gut, OP compounds accumulate rapidly in fat, liver, kidney 
and salivary glands (Vale, 1998; Kwong, 2002). Phosphorothioate (P=S) compounds are 
more lipophilic compared to phosphates (P=O), therefore stored extensively in the fat. These 
lipophilic compounds also cross the blood brain barrier in most cases (Vale, 1998). Inactive 
thiophosphorus OPs (eg: dimethoate, parathion) undergo bioactivation (desulfation) via liver 
cytochrome P450, producing active, oxon metabolites (eg: omethoate, paraoxon) (Foxenberg 
et al., 2007). Some studies have reported involvement of other enzyme complexes in the 
process of desulfation such as flavine-containing mono-oxygenase enzyme (Hodgson and 
Levi, 1992) and of n-oxidation and s-oxidation (Mileson et al., 1998). Furthermore 
cytochrome P450 is also involved in detoxification of both parent compound and disulphide 
compound through a dearylation reaction (Mutch et al., 2003; Poet et al., 2003). The main 
elimination pathway of these OP metabolites is via urine, while lesser amounts excrete 
through faeces and expired air (Vale, 1998) (Fig 1.1). 
Solvents also undergo metabolism inside the body. For example, cyclohexanone undergoes 
reduction to cyclohexanol, a process mediated by reverse activation of alcohol 
dehydrogenase, which is strongly expressed in the liver and stomach lining in most humans. 
However, some studies indicate that apart from formation of cyclohexanol, there is a 
significant production of cyclohexanediol (Mraz et al., 1994). Xylene, another commonly 
used solvent in pesticide formulation, also undergoes metabolic transformation before 
excretion via urine.  Xylene is mostly excreted as a conjugated form “toluric acid”. A lesser 
amount is excreted as xylenol (Sedivec and Flek, 1976; Miller and Edwards, 1999). During 
the course of metabolism, xylene also utilizes both alcohol dehydrogenase and aldehyde 
dehydrogenase enzyme similar to cyclohexanone metabolism (Fig 1.1). 4-Methylpyrazole 
(Fomepizole) is a competitive inhibitor of alcohol dehydrogenase, which is commonly used 









Fig1.1: Schematic diagram of pesticide metabolism. A: Three main components present in 
commercially available pesticide, B; metabolism of commercial pesticide Dimethoate EC 
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1.1.6 Animal models for studying pesticide toxicity 
OP pesticide toxicity has been studied using several animal models, including rodents, 
primates and zebra fish (Yen et al., 2011). However, the confounding factor behind pesticide 
toxicity in most previous studies is lack of evidence on effects of commercial pesticides 
rather than their purified ingredients. Almost all previous studies have used only the 
presumed active ingredient (anticholinesterase) to determine the effects. There are only very 
few studies that have examined the effects of commercial product (Casida and Sanderson, 
1961; Eddleston et al., 2012). It has been shown that the LD50 for pesticide is less than 50% 
of that of the active ingredient alone (Casida and Sanderson, 1961). The use of rodent animal 
models to understand pesticide toxicity is still a debatable question as they have greater 
capacity for metabolic detoxification of OPs compared to humans (Wrighton and Stevens, 
1992).  Due to similarities to human detoxification and excretion of drugs, use of minipigs in 
toxicology studies have become more important (Svendsen, 2006; Forster et al., 2010b; 
Forster et al., 2010a). Considering the relevance of the animal model for toxicological 
studies (minipigs show similar detoxification and excretion of drugs with humans) and the 
use of matterials (commercial pesticide which contains both active ingredient and solvent), 
Eddleston et al (2012) intensive minipig model of OP toxicity has an important bearing on 
understanding mechanisms of OP pesticide toxicity in human.  
1.1.7 Effects of dimethoate EC40 ingestion in a minipigs model 
Dimethoate EC belongs to the class of moderately toxic pesticides (WHO class II), while 
producing higher fatalities compared to other class II pesticides (20.6%) in humans (Dawson 
et al., 2010). Eddleston et al (2012) have shown that poisoning of minipigs with commercial 
pesticide dimethoate EC40 demonstrated a similar clinical picture to that of human patients, 
including severe cardiovascular shock, neuromuscular transmission dysfunction and 
insensitivity to pralidoxime (antidote for AChE inhibition) therapy. Most importantly, they 
have shown that severe toxicity arose from the combination of the OP active ingredient and 
solvent rather than the OP alone. Absence of solvent (dimethoate alone) did not produce 
NMJ dysfunction, along with substantial reduction in cardio-toxicity.  
In Eddleston’s model Göttingen minipigs were first anaesthetised and cardiorespiratory 
functions were maintained at an optimal level. The animals then received either formulated 
(commercial product) or unformulated (active ingredient only) pesticides, or saline control, 





pharmacological interventions as required: for example noradrenaline to overcome 
hypotensive shock. Mechanomyography was used to monitor in-vivo neuromuscular 
function. Trains-of-four (TOF) stimuli were applied at 2 Hz, at intervals greater than 10 s. 
The use of TOF to monitor neuromuscular blockade is common medical practice among 
surgeons (Fuchs-Buder et al., 2009). In the minipig model, complete loss of NMJ 
transmission was apparent about 12 hours from post treatment with pesticide dimethoate 
EC40 (commercial product). However, there was no indication of neuromuscular block 






















Fig. 1.2: Data from minipig model of OP toxicity A; Mechanomyography traces showing 
relative (uncaliberated) force from a minipig model of organophosphorus toxicity. 
Dimethoate EC40 treated minipigs showed apparent loss of neuromuscular function after 12 
hours post treatment, while saline or dimethoate only treatments did not cause any functional 
loss. This observation suggests that both dimethoate (anticholinesterase) and cyclohexanone 
(solvent) is required to produce neuromuscular transmission block B: Plasma concentration 
levels of pesticide ingredients and their metabolic breakdown producs after oral treatment of 
Dimethoate EC40. Note that concentrations of dimethoate, omethoate, cyclohexanone and 
cyclohexanol stabilized after about 8hrs at 1mM, 100µM, 1mM and 5mM respectively. 













1.1.8 Metabolism of dimethoate and cyclohexanone 
As stated above, dimethoate and cyclohexanone undergo metabolic conversion to omethoate 
and cyclohexanol, respectively (Fig. 1.1). 
Dimethoate is converted into its oxygen analogue omethoate through a desulfuration 
pathway in the liver that utilises cytochrome P450 enzyme. Due to a higher level of 
accumulation in the body and increased appearance in urine it is thought that omethoate has 
more stability to enzymatic hydrolysis than dimethoate (Lucier and Menzer, 1970). Both 
dimethoate and omethoate formulate a hydroxyalkyl compound, which then undergoes 
further dealkylation by liberation of aldehyde group then excretion via urine (Lucier and 
Menzer, 1970).  
Cyclohexanone undergoes metabolic reduction to form cyclohexanol via the alcohol 
dehydrogenase enzyme. Glucuronide-conjugated cyclohexanol is the major urinary excreted 
form in humans and other animals (Sakata et al., 1989; Mraz et al., 1994).  However, the 
presence of 1,2-cyclohexanediol and 1,4- cyclohexanediol in urine after acute exposure to 
cyclohexanone has been identified in humans (Mraz et al., 1994).  
1.1.9 Preliminary hypothesis 
Based on the findings reported by Eddleston et al (2012), my preliminary hypothesis was 
that failure of synaptic transmission at NMJ with OP pesticide poisoning is not entirely due 
to anti-acetylcholinesterase activity but, rather, due to the combinatorial actions of both the 
anticholinesterase active ingredient and the solvent present in the pesticide.  
I have examined my primary hypothesis in this thesis using commercial pesticide 
Dimethoate EC40, similar to Eddleston et al (2012). Before itemising the detailed objectives, 
I consider first the relevant physiological and pharmacological properties of mammalian 
NMJs.  
1.2 Structure and function of the neuromuscular junction (NMJ) 
NMJs are one of the most highly examined synaptic sites in vertebrates due to their apparent 
simplicity and accessibility. They had been studied using many techniques such as 
electrophysiology and physiological imaging (Del Castillo and Katz, 1954; Takeuchi and 
Takeuchi, 1959; Wood and Slater, 1997; Gillingwater et al., 2002; Ribchester et al., 2004; 





1981; Nagwaney et al., 2009) and immunofluorescence labelling (Court et al., 2008) in order 
to understand synaptic formation, function and plasticity (Costanzo et al., 2000; Ribchester, 
2009).  
1.2.1 Muscle contraction and its regulation (motor unit, twitch, tetanus) 
A motor unit consists of a motor neuron and the skeletal muscle fibres innervated by its 
axonal terminals. This is the basic functional unit of co-ordinatation of muscle contraction. 
The force of the muscle contraction can be increased by recruiting more motor units and by 
increasing the frequencies of the action potentials that drive them. Experimental paradigms 
yield two types of contraction: isometric (constant length) and isotonic (constant force or 
load) contractions (Berne, 1992).  
When a single stimulus is applied to the nerve, a single action potential will be elicited in the 
muscle fibres it innervates and, after an activation delay, the muscle will contract. This single 
contraction is called a twitch contraction (Brown and Matthews, 1960). The twitch tension 
rises to a maximum within 10 – 50 ms and then more slowly returns to resting tension, with a 
time course that depends upon the particular muscle. Fast twitch muscles has faster rise time, 
while slow twitch muscles take longer time to reach maximum twitch tension (Buller et al., 
1960). 
A second stimulus, applied before the muscle has completely relaxed, induces another 
contraction that adds to the first, the sum of the tensions becoming greater than that of a 
single twitch. This is called summation. When muscle is stimulated at a higher frequency, 
the tension rises to a more-or-less steady value, much greater than the twitch tension, and 
this is referred to as a tetanus, or tetanic contraction. When the individual twitch 
contributions to the tetanus can still be seen in the record, this tetanus is called unfused or 
incomplete. However, at higher stimulation frequency, the maximum tension the muscle can 
sustain is obtained and individual twitches are no longer discernible, and this is called a 
fused or complete tetanus.  Slow twitch muscles produce fused tetanus at low frequencies 
(e.g. 15Hz) while fast twitch muscles produce fused tetanus at higher frequencies (e.g. 
60Hz).  
1.2.2 History of research on the NMJ: a model chemical synapse 
As defined classically by C.S. Sherrington, the point of functional contact between a neuron 





over whether transfer of signals from neurons to their targets occurs mainly through either 
direct electrical interaction or via chemical interaction (neurotransmitter), it is now 
universally accepted that most synapses in the mammalian nervous system, including NMJ, 
are chemical synapses which involves release of neurotransmitter (ACh in the case of NMJs) 
from the presynaptic portion (motor nerve terminal).  
The first idea of a chemical synapse was generated by Elliot in 1904, while Loewi in 1921 
demonstrated the chemical nature of transmission in the autonomic nervous system via a 
simple experiment utilising the effect of perfusate collected from an isolated frog heart 
produced by stimulation of the vagus nerve (Nicholls, 2012). The ACh action in 
neuromuscular transmission was establishment by Dale and his colleagues (Dale et al., 
1936). The use of NMJ as a model chemical synapse was pioneered by Fatt and Katz (1951) 
with their intracellular recording of MEPP at frog NMJs. This was then taken further to 
establish the quantal hypothesis, which is the modern day understanding of transmitter 
release from chemical synapses (Katz, 1996). 
1.2.3 Structure and ultrastructure of NMJ 
NMJs comprise three main compartments: presynaptic/motor nerve terminal, post 
synaptic/folded skeletal muscle surface, and synaptic cleft  and four cell types: motor 
neurons, muscle fibres, terminal Schwan cells and kranocytes (Court et al., 2008) (fig. 1.3, 
1.4). 
Muscle fibres originate from mesodermal cells to produce myotubes, which then mature to 
produce peripherally nucleated muscle fibres. Motor neurons are derived from the 
ventricular germinal zone in the neural tube. Their axons progress through peripheral 
nervous to muscles where they branch and innervate muscle fibres (Douglas and Ribchester, 
1986). Schwan cells have a neural crest cell origin and follows motor axons until they reach 
their final targets (Grinnell, 1995; Sanes and Lichtman, 1999). Initially, muscle fibre 
innervation is polyneuronal (muscles fibres are innervated by two or more motor inputs). 
The post natal maturation leads to removal of the convergence by the process referred to as 
synapse elimination, resulting in mononeuronal innervation of muscle fibres (Brown et al., 
1976; Betz et al., 1979). This synapse elimination is influenced by competition - a process 
which utilises activity-dependent and -independent process (Ribchester and Barry, 1994; 






Fig 1.3: Schematic diagram of NMJ demonstrating different types of cells associated. 




















































Fig 1.4: Cellular architecture of NMJ. A: Electron micrograph showing four cell types of 
NMJ a)motor nerve terminal, b) motor endplate, c) Schwan cell, d) kranocyte. B: enlarged 
synaptic bouton, e) junctional folds, f) synaptic vesicles, g) mitochondria. C: enlarged NMJ, 
h) post synaptic densities, i) active zones, j) synaptic cleft.  Electro micrographs from Court 











The primary function of the motor nerve terminal is neurotransmitter release. The ultra-
structural hallmark of nerve terminals are the synaptic vesicles: 30nm spheres that contain 
the neurotransmitter acetylcholine (ACh), which cluster in the distal half of the terminal that 
faces the muscle fibre. Most of the mitochondria present in the motor nerve terminal are 
gathered in the proximal half of the terminal. The other important structural hallmark of 
nerve terminals are the active zones (dense patches on terminal membrane, associated with 
voltage gated K+ and Ca2+ ion channels, and many proteins including syntaxin, SNAP 25), 
where synaptic vesicles bind and release their contents into the synaptic cleft (Ruiz et al., 
2011; Sudhof, 2012, 2013). Other significant protiens in the nerve terminal include choline 
acetyltransferase (ACh synthetic enzyme) and a vesicular ACh transporter (which transport 
ACh in to the synaptic vesicles) and multiple presynaptic membrance channels and receptors 
(see below).  
The main post synaptic features are proteins associated with detection of neurotransmitter 
ACh such as ACh receptors, ion channels and associated binding proteins.The skeletal 
muscle surface has many structures that optimize synaptic transmission, including a high 
density of ACh receptors in junctional folds (~ 1µm deep) (Sanes and Lichtman, 1999) 
(>10,000 / µm2) (Salpeter & Loring, 1985) that open directly opposite active zones. In 
addition voltage-sensitive sodium ion channels are concentrated in the crypts of the 
junctional folds (Slater, 2009). The arrangement enhances efficacy of synaptic transmission 
(Wood and Slater, 1997). There is also presence of neural cell adhesion molecules 
concentrated along with the sodium ion channels (Covault and Sanes, 1986). The 
heterogeneous composition of the cytoskeleton of the junctional folds involves generating 
and maintaining the different domains within them (Sanes and Lichtman, 1999).  
The synaptic cleft is the space (50nm) between the pre and post synaptic surface. It is 
infiltrated with extracellular matrix: the basal lamina. Acetylcholinesterase (AChE) enzyme 
is contained within the synaptic basal lamina and projected into junctional folds (McMahan 
et al., 1978). Along with the AChE, there are many other molecules present such as collagen 
IV, laminin, glycoconjugates and signalling molecules (agrin and neuregulin) (Sanes and 
Lichtman, 1999). The basal lamina determines and coordinates the pre-synaptic 
differentiation of the active zones and the post-synaptic accumulation of AChRs, as well as 






1.2.4 Axonal action potential and presynaptic voltage-gated ion channels 
Axonal action potential propagation to the NMJ is via “saltatory conduction”. This is a mode 
of conduction which action potential leaps from one node of Ranvier (active region on the 
axon, containing voltage-gated sodium channels) to the next (Slater, 2009). Upon reaching 
the nerve terminal, the action potential influences many different types of ion channels in 
order to trigger the exocytosis of the synaptic vesicles.  
There are many types of ion channels present in the presynaptic nerve terminal. Among 
these, voltage gated ion channels are important in process of neurotransmitter release, 
namely Ca2+, K+, Na+, Cl-, and non-selective ion channels. Among the various sub types of 
Ca2+ channels present (L, N, NTP, Nt, P, P and /or Q and Q) (Meir et al., 1999) mammalian 
motor nerve terminal contain “N” type voltage gated Ca2+ channels (Hamilton and Smith, 
1992) and P/Q type (Plomp et al., 1992; Uchitel et al., 1992). Mammalian motor nerve 
terminal also contain three sub-types of K+ channels; namely delayed rectifier K+ channels, 
Ca2+-gated K+ channels and ATP-sensitive K+ channels (Tabti et al., 1989).  
1.2.5 Neuromuscular transmission: EPP/EPC; quantal analysis; and non-linear 
summation (NLS) 
Transmitter release from nerve terminal occurs in following series of steps (Meir et al., 
1999).  
The propagation of an action potential into the nerve terminal is the first step of evoked 
transmission. This will lead to presynaptic activation of different molecules causing the 
depolarization of the presynaptic membrane. This membrane depolarization influences large 
numbers of voltage-gated ion channels such as Na+, Ca2+, K+, Cl- and some nonselective 
channels. The opening of Ca2+ channels allow entry of Ca2+ ions into the nerve terminal, 
which then binds to intracellular Ca2+ sensors (e.g. synaptotagmin) (Bommert et al., 1993). 
Ca sensor activation leads to activation of vesicular and terminal SNARE protieins in the 
nerve terminal.  This activation of fusion machinery leads to fusion of synaptic vesicles with 
the surface membrane at active zones and induces rapid release by exocytosis of multi-
molecular “quanta” of ACh, from synaptic vesicles into the synaptic cleft (Katz and Miledi, 
1969). This fusion machinery involved is mediated by SNARE proteins, which includes 





Spontaneous release of vesicles occurs normally at low frequency (1/sec) producing small 
(1mV) depolarization at postsynaptic membrane (MEPPs) (Fatt and Katz, 1951; Liley, 
1956).There is also a low leakage of ACh from nerve terminal, referred to as non-quantal 
release, but this does not normally cause a substantial endplate depolarization either at rest or 
following nerve excitation (Vyskocil et al., 2009).  
The ACh molecules released from the nerve terminal diffuse through the synaptic cleft and 
then bind to ligand-gated ACh receptor ion channels. This will initiate conformational 
change in the AChR and opening of the ion channel, leading to changes in the ion 
permeability either side of membrane, thus initiating a net inward ionic current (endplate 
current, EPC) due to influx of Na+ ions into the post synaptic cell and K+ ionic efflux into the 
synaptic cleft. The resulting depolarization, the EPP, causes opening of voltage-gated 
sodium ion channels, which then initiate a muscle action potential, and finally contraction of 
the muscle cell via excitation-contraction coupling (Slater, 2009). The EPCs have a rapid rise 
and slower exponential decay which is determined by the rates at which the AChR switches 
among resting, intermediate and open states (Magleby and Stevens, 1972). EPPs have longer 
time course as the endplate current must discharge through the passive membrane resistance 
and capacitance of the muscle fibre. Most of the ACh released from the presynaptic terminal 
is hydrolysed to acetate and choline by the action of AChE either before reaching the post-
synaptic membrane or after interacting with receptors, thereby terminating synaptic 
transmission. Choline is taken up in to motor nerve terminal by choline-transporter and 
utilized in the re-synthesis of ACh. Synaptic vesicles are recycled by endocytosis and the 
recycled vesicles refilled with ACh for subsequent re-utilization (Betz and Wu, 1995; Betz 
and Angleson, 1998). 
The idea that multi-molecular “quanta” of transmitter were released from presynaptic 
terminals was first suggested by B. Katz and his colleagues in middle of the 20th century 
(Fatt and Katz, 1951; Del Castillo and Katz, 1954, 1956; Katz and Miledi, 1969). They 
established a statistical model, which could describe the fluctuation of “quantal content” of 
the EPP in different situations by relating it to the amplitude of the unitary quantal 
component: that is, miniature EPPs (MEPPS) (Fatt and Katz, 1951; Del Castillo and Katz, 
1954, 1956; Katz and Miledi, 1969).  According to this model, the quantal content of an EPP 
can be estimated by dividing the amplitude of the EPP by the “quantal size”, equivalent to 







𝑚𝑒𝑎𝑛 𝐸𝑃𝑃 (𝑜𝑟 𝐸𝑃𝐶)𝑎𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒
𝑚𝑒𝑎𝑛 𝑀𝐸𝑃𝑃 (𝑜𝑟 𝑀𝐸𝑃𝐶)𝑎𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒
 
The Direct Method suffers from the effects of non-linear summation (see below) but accurate 
estimates of quantal content may be obtained from EPCs and MEPCs instead, since non-
linear summation does not occur when ionic currents are measured at a fixed membrane 
potential, for instance under voltage clamp. 
According to the “quantal hypothesis”, the mean quantal content (m) is a product of the 
number of quanta / vesicles available for release (n) and the probability of their release (p).  
𝑚 = 𝑛. 𝑝 
Further consideration of this binomial relationship, leads to the general prediction that 
probability of release of x quanta (P(x)) is given by: 
𝑃(𝑥) =  
𝑛!
(𝑛 − 𝑥)! 𝑥!
 . 𝑝𝑥 . 𝑞(𝑛−𝑥) 
The quantities n and p cannot easily be determined independently. However, simpiifying 
assumptions can be made that the number of quanta released by any given stimulus is very 
much less than the number available (x<<n) and the probability of release of each vesicle is 
very much less than unity (p<<1). Under these mathematical conditions, the relationship 
between P(x) and m simplifies to a Poisson distribution:  
𝑃(𝑥) =  
𝑚𝑥
𝑥!
 . exp(−𝑚) 
In normal physiological synaptic transmission, evoked EPPs produced by nerve stimulation 
reach the threshold level and trigger a muscle action potential. However, transmission can be 
depressed by blocking ACh receptors (using a nicotinic receptor antagonist such as d-
tubocurarine) or by reducing the probability of quantal release through increasing the Mg2+ 
ion concentration and reducing the Ca2+ ion concentration in the medium (Del Castillo and 
Katz, 1954; Dodge and Rahamimoff, 1967).   
Two alternative methods for estimating quantal content arise from the analysis that led to the 
Poisson equation. These methods are commonly referred to as the Method of Failures and 





When the mean quantal content is low, some of the nerve stimulation does not produce an 
evoked response. This low quantal content is achieved in experimental conditions by 
reducing the Ca2+ and or increasing the Mg2+ ion concentration in the bathing medium 
(Dodge and Rahamimoff, 1967). This bathing medium leads to reduction in probability of 
release (p), thereby reduced mean quantal content.  Under these conditions, quantal content 
can be estimated using the “Failures method”.  From the Poisson distribution: 
𝑃 (0) = exp(− 𝑚) 
The probability of failures, P (0), is determined experimentally by counting the number of 
failures divided by the number of stimuli. Taking natural logarithms and rearranging the 
above equation gives:  




Another property of the Poisson distribution is that its variance equal its mean (Hubbard et 
al., 1969).  
It can be shown that:               𝑉𝑎𝑟𝑖𝑎𝑛𝑐𝑒 (
𝑣1
𝑞
) = 𝑉/𝑞 
Where v1 is individual EPPs amplitude, q is mean MEPP size and V is mean EPPs 
amplitude. It can be shown that  
𝑞 = 𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 (𝑣1)/𝑉 
Thus, an alternative method of estimating quantal content is the “Variance method”, which 
employs the mean and variance of EPP amplitudes: 
𝑚 = 
(𝑚𝑒𝑎𝑛 𝐸𝑃𝑃 𝑎𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒)2
(𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 𝑜𝑓 𝐸𝑃𝑃 𝑎𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒)
 
This is also referred in terms of the coefficient of variation (C.V= standard deviation / 
mean): 
𝑚 = 𝐶. 𝑉.−2 
The reliance on EPP in estimating quantal content can produce errors in estimated m due to 





higher m. Non-linear summation arises because as the amount of transmitter released onto 
the post synaptic membrane increases, the depolarization produced by each quantum 
decreases. In another words, as the driving force decreases (difference between the resting 
membrane potential and the reversal potential for the action of ACh at its receptor), the EPP 
amplitude reduces. The Direct method of quantal analysis is based on EPP: MEPP ratios, can 
therefore lead to underestimates of m, while Variance method can produces overestimates 
(Martin, 1955; Wilson, 1977). The non-linear summation of the EPP amplitude can be 
corrected mathematically using following equation (Martin, 1955; McLachlan and Martin, 
1981). 
𝑉′ =  𝑉 ⁄ ((1 − 𝑓. 𝑉 ⁄ 𝐸) 
Where V’ is the corrected EPP amplitude, V is the observed EPP amplitude. E is the driving 
force (difference between the resting membrane potential and the reversal potential). The 
correction factor f is an arbitrary value which varies from the muscle fibre to muscle fibre 
depending on its length, diameter and membrane resistance (McLachlan and Martin, 1981).  
Use of EPC (and MEPC) to estimate quantal content is a more reliable method as EPC 
amplitudes do not need to be corrected for non-linear summation since the driving force 
remains constant at a voltage-clamped neuromuscular junction. EPCs therefore sum linearly 
at a constant membrane potential (McLachlan and Martin, 1981; Wood and Slater, 2001).  
1.2.6 Mechanisms of exocytosis and vesicle recycling: 
Exocytosis of the synaptic vesicles is associated with interaction of two set of proteins 
present in synaptic vesicles (V-SNARES – synaptotagmin and synaptobrevin) and nerve 
terminal membranes (T-SNARE – syntaxin and SNAP-25). Following “docking” of the 
synaptic vesicles at the active zones, vesicles are then turn in to “primed” state assisted by 
ATP-dependent step, before release from the terminal (Slater, 2009). Further increase in 
cytoplasmic Ca2+ level converts “primed” vesicles in to full fusion (Stanley, 1997). This 
triggers the conformational changes in the synaptic terminal and causes fusion, thereby 
releasing transmitter into the synaptic cleft (Slater, 2009; Sudhof, 2012, 2013).  
Following exocytosis, recovery of the nerve terminal membrane normally occurs through 
endocytosis. Recycled vesicles are then taken in to the nerve terminal and transferred to 





then transported in to the recycled vesicles by the vesicular cholinergic transporter (VAChT) 
thereby preparing for the subsequent transmitter release (Erickson and Varoqui, 2000).  
1.2.7 Drugs affecting transmitter release, action and breakdown 
Synthesis, storage, release, action and inactivation of the neurotransmitters are the major 
target mechanisms affected by drugs.  
Ethylcholine mustard aziridinium ion inhibits choline acetyltransferase (ChAT)) while 
hemicholinium-3 blocks the membrane transporter responsible for uptake of choline. These 
compounds therefore inhibit the synthesis of neurotransmitter ACh (Rang, 2003).  
Filling of the synaptic vesicles by ACh is prevented via inhibition of the ACh membrane 
transporter by vesamicol (Parsons et al., 1993).  
Drugs affecting release mechanisms mainly act as either inhibitors or enhancers. A high 
concentration of Mg2+ ions competes with Ca2+ ions and depresses exocytosis, while ω –
agatoxin inhibits the voltage gated Ca2+ ion channels (“P/Q” sub type), thereby blocking 
transmission. Botulinum toxins block transmitter release by binding to and enzymically 
cleaving the SNARE proteins involved in transmitter release (Simpson, 2004). Drugs that 
enhance transmitter release include 4–aminopyridine, which blocks presynaptic potassium 
channels, and α-latrotoxin which tonically permeabilises presynaptic membranes to Ca2+ and 
causes substantial asynchronous release and depletion of synaptic vesicles from nerve 
terminals (Henkel and Sankaranarayanan, 1999).  
Transmitter action is also affected by drugs by that act either as inhibitors (antagonists) or 
enhancers (agonists). Antagonists bind to ACh receptors and thereby prevent formation of 
ACh-receptor complexes. Nicotinic antagonists include d-tubocurarine and α- bungarotoxin. 
There is another set of anatgonists that act on ACh receptors by inducing allosteric changes 
in ACh receptors, or steric hindrance to ACh binding, thereby reducing the affinity of 
receptors for ACh molecules. These include phencyclidine and methyl violet-10B. Drugs 
that act as agonists of ACh neurotransmitter action include carbachol, decamethonium 
(which prolongs the open state of the ligand-gated channels) and suxamethonium, which act 
as a depolarizing blocker through initial sustained activation of ACh receptors, then 





The group of drugs and compounds acting on inactivation of the neurotransmitter by AChE 
include carbomates (e.g. neostigmine, pyridostigmine, physostigmine) and OPs (e.g. 
echothiopate, sarin, malathion, dimethoate,). These drugs and compounds act as reversible or 
irreversible inhibitors of acetylcholinesterase molecule.  
1.2.8 Determinants of safety factor for neuromuscular transmission 
The high safety factor of the neuromuscular transmission is also one of the important 
elements of reliable transmission at NMJ. Safety factor is referred to as “ability of 
neuromuscular transmission to remain effective under various physiological conditions and 
stresses” (Wood and Slater, 2001). The safety factor at NMJ is a consequence of the amount 
of transmitter released per nerve impulse exceeding that required to trigger an action 
potential in the muscle fibre by a factor of 2 – 5 (Wood and Slater, 2001). There are many 
elements that contribute to safety factor including quantal release, AChE activity, ACh 
receptor numbers, density of post synaptic Na+ channels, and architecture of postsynaptic 
folds (Wood and Slater, 2001).   
The reliability or effectiveness of neuromuscular transmission depends on the size and 
molecular organization of the NMJ and how the molecules that mediate transmission are 
distributed in it (Slater, 2009). These ensure the reliability of NMJ transmission, without 
failures, even after intense voluntary exertion (Bigland-Ritchie et al., 1978). Reduction in 
reliability cause severe impairment in overall neuromuscular transmission. Inherited or 
acquired reduction in reliability of transmission leads to fatigue, weakness and paralysis of 
the muscle (Slater, 2009).  
1.2.9 Passive electrical properties and action potentials in muscle fibres 
Passive membrane properties of the muscle affect several features: a) the size and magnitude 
of the endplate potential, b) the time course of the membrane potential after current injection, 
c) the distance that depolarization will travel, and d) the speed of the potential propagation. 
These membrane properties include membrane resistance (Rm), membrane capacitance (Cm) 
and intracellular axial resistance (Ra). The membrane and axial resistances can be lumped 
together in a quantity referred to as the “input resistance” (Rin), which is principally 
determined by the diameter or cross-sectional area of the muscle fibre and membrane 
permeability at a given membrane potential. Empirically (ie experimentally), Rin is 





constant step current (Rin=ΔV/ΔI). The property of membrane capacitance also confers a 
delay in the voltage response to a step current. The time delay is indicated by the membrane 
time constant (τ). 
The commonly used experimental technique determining these passive properties include 
applying a step current pulse through a membrane (first electrode) and to measure the time 
required for the membrane potential to reach a steady level using a second electrode inserted 
in to the same fibre with minimum distance (typically less than 100 µm) from the first one.  
Input resistance determines the EPP amplitude, and this depends on the density of the open 
channels at rest (how leaky the muscle membrane is) (Rm), axial resistance (Ra) and diameter 
of the muscle fibre (d). Input resistance is related to Rm and Ra by the following equation 
(Jack et al., 1983): 







Therefore, smaller diameter and less leaky muscle fibres will have larger input resistance. 
The lipid bi-layer of the cell membrane also acts as capacitance. Membrane capacitance (Cm) 
also affects the time course the EPP. Membrane capacitance depends on the specific 
capacitance (Cm) and muscle fibre diameter. Cin is also defined by the following equation. 
𝐶𝑖𝑛 = 𝐶𝑚(4𝜋𝑑
2) 
Cm is a constant due to the uniform thickness of the membrane; therefore larger fibres will 
have higher membrane capacitance. Current flow will first charge the capacitance and then 
flow through the resistance. Therefore, as the capacitance charge, the amount of current 
flowing through the resistance increases until it reaches a steady stage voltage. The rate of 
change in this voltage is called membrane time constant (τ).  
𝜏 =  𝐶𝑚𝑅𝑚 
The larger the τ is, the longer it takes to reach max voltage and slower the decay from the 
maximum voltage.  
For the approximation of spherical cell, the time course of the response to a step current 









Where Im is membrane current. In this model, membrane time constant is determined by the 
time taken for the voltage to reach (1/e) or 63% of the steady-state voltage. However, the 
relationship between voltage and time constant is different in non-spherical cells. 
The voltage and current relationship across the membrane in a “cable model” of the muscle 
fibre can be determined by combining Ohms law for the resistance with the time dependence 

















. Which approximately grouping to a Gaussian curve 
(Equation 13.73 and 13.74 in Jack et al (1983)).  
Since erf(1) = 0.84, V rises to 84% of its steady state value in one time constant (Jack et al., 
1983). Therefore, time constant is measured from the 84% time to maximum for long cables 
(like TS muscle fibres) but about 63% for short cables (like FDB muscle fibres).   
Axial resistance determines how far an impulse will travel. Current flow through the muscle 
fibre will face the axial resistance. The length constant, λ, describes the change in Vm at 
distance X, and this voltage change can be modelled using following equation. 
∆𝑉𝑚(𝑋) = 𝑉𝑜𝑒
−𝑥/𝜆 
The length constant, λ, can be determined by using following equation. 
 λ = √𝑅𝑚/𝑅𝑎 
Therefore, λ depends on the specific membrane resistance and axial resistance and 
membrane voltage will drop more steeply with distance the larger the diameter of the muscle 
fibre. 
Similar to neurons, generation of action potential in muscle also requires depolarization of 
the membrane potential to the threshold level. Sub-threshold currents produced by the 





channels (Nav 1.4, sub type present in the skeletal muscle), which accumulate in the crypts of 
the postsynaptic folds. This activation causes regenerative entry of positive charge into the 
cells. This depolarization reaches the threshold level, leading to firing of an action potential 
in the muscle. During this time, positive charge entering at the NMJ is greater than that 
leaving in the surrounding region (Slater, 2009). Therefore, the excess charge depolarizes the 
adjacent membrane to threshold, setting in train the regenerative process that underlies the 
action potential.  
In experimental conditions, Nav 1.4 channels can be blocked using toxins such as conotoxin 
(µ-CTX) in order to abolish the muscle action potential, thereby facilitating the examination 
of EPP and underlying EPC (Braga et al., 1992; McIntosh and Jones, 2001; Ribchester et al., 
2004).  
 
1.2.10 Molecular mechanisms of excitation-contraction coupling and myofilament force 
generation 
The process that links the action potential to cross-bridge cycling and contraction is called 
excitation-contraction coupling. This involves mainly three mechanisms; a) neuromuscular 
transmission and depolarization of the endplate membrane, sarcolemma, and t-tubules, b) the 
mobilization of Ca2+, c) the action of Ca2+ on myofibrillar regulatory mechanisms that 
control cross-bridge cycling (Huxley, 1974).  
Once an action potential is fired, the resulting surface depolarisation of the skeletal muscle is 
then carried into the cell via t-tubules (invagination of surface membrane). These t-tubules 
are connected to the sarcoplasmic reticulum (SR) (a specialized form of endoplasmic 
reticulum) at sites called “triads”. At triads, dihydropyridine receptors (voltage-dependent 
Ca2+ channels in t-tubules) interact with ryanodine receptors (Ca2+ release protein in the SR), 
thereby triggering Ca2+ release in to the cytoplasm, thus leading to a muscle contraction.  
Muscle contraction is a result of an interaction between myofibrils. These myofibrils are 
organized to form array of distinct thick (myosin) and thin (actin, troponin, and tropomyosin) 
filaments. These filament arrays overlap to form sarcomeres. The heads of the myosin 
molecules project out from the thick filaments towards the thin filaments and these 





The level of free Ca2+ in the cytoplasm regulates the muscle contraction. Maintenance of the 
free Ca2+ at a low level occurs via the sarcoplasmic reticulum, which contains energy 
dependent Ca2+ transporters.  
Relaxation occurs when Ca2+ is pumped back into the sarcoplasmic reticulum. Subsequently, 
crossbridges are detached from the thin filaments and the troponin-tropomyosin regulated 
inhibition of actin and myosin interaction is restored. Finally, active tension disappears and 
the rest length is restored. This completes the contraction-relaxation cycle. 
1.3 Acetylcholine (ACh), ACh Receptors (AChR) and ACh esterases (AChE) 
Acetylcholine is an ester of acetic acid and choline which is synthesised in the presynaptic 
nerve terminal. The acetyl group from the acetyl-coenzyme A is transferred to choline by the 
enzyme choline acetyltransferase (ChAT) (Nachmansohn and Machado, 1943; Byrne and 
Roberts, 2004).  
1.3.1 Molecular characterization of the postsynaptic AChR: activation and 
desensitization 
The endplate AChRs are heteropentamers, comprising α, β, and δ subunits, along with either 
the fetal γ subunit or the adult ε subunit (Takai et al., 1985).    
The mechanism of ACh binding to AChRs and forming agonist-receptor complex was first 
described by del Castillo & Katz (1957). However, the mechanism proposed, one agonist 
binding site per receptor, was quickly modified with evidence showing more than one 
binding site (Katz and Thesleff, 1957b). 















    𝐴2𝑂   
In the case of identical binding sites, where A is the agonist, R is the resting receptor with 
the channel closed, AR and A2R are the inactive complexes with the channel closed and A2O 
is the active complex with the channel open. K+1 and K+2 are the agonist association rate 
constants, K-1 and K-2 are the agonist dissociation rate constants, β2 is the channel opening 
rate constant and α2 is the channel closing rate constant. 
The desensitisation of motor endplate (Katz and Thesleff, 1957b) is a process that inactivates 





long time. First, it was described that to a large extent desensitization develops following 
steady-state exposure to agonist, suggesting that in the desensitized state an AChR binds 
agonist more tightly than in its resting state. Later it was shown that agonist affinity 
increases in a time dependent manner and onset of the affinity increase occurs in parallel to 
the onset of functional desensitization (Weiland et al., 1976; Weiland et al., 1977; Sine and 
Taylor, 1980). Manod et al (1965) constructed a model (the MWC model) that incorporated 
the concept of interconvered active and inactive stats of the receptors with different affinity 
for their agonist (ACh in the cleft). The MWC model was subsequently modified on the 
basis of single channel analysis and can be represented as follows.  
       AO           A2O 
    β1     α1          β2     α2 
   A + R                  AR + A                     A2R   
 
Where A is the agonist, R is the resting state, O is the open channel state. K+1 and K+2 are the 
agonist association rate constants, K-1 and K-2 are the agonist dissociation rate constants, β1 
and β2 are the channel opening rate constants and α1 and α2 are the channel closing rate 
constants. 
More complex models have been proposed and these (see Sine, 2012) and the modified 
MWC model above is still widly regarded as the foundation for receptor desensitization and 
its kinetics.  
1.3.2 Molecular pharmacology of nicotinic AChR: agonist, antagonists 
Agonists are the molecules that bind to receptors and initiating biological response while 
antagonists bind to receptors and block the agonist mediated response (Rang, 2003) 
Some of the agonists mediating biological response at nAChRs include ACh, nicotine, 
epibatidine, cytisine and anatoxin A (Meir et al., 1999).  
d-Tubocurarine is one of the important prototypical competitive antagonists of the nAChRs. 
It is a non-depolarizing, competitive antagonist (Jenkinson, 1960). α-Neurotoxins (including 









nAChRs. However, they bind to nAChRs with exceptionally high affinity and therefore 
effectively irreversibly. Molecular mechanisms include multiple points of attachment, 
conformational changes at the binding site, conformational changes in the toxin, or a 
combination of all (Meir et al., 1999).  
1.3.3 Presynaptic cholinergic receptors 
The presence of neuronal nicotinic AChRs in peripheral nervous system has been identified 
in many species including mammals (Wessler et al., 1992). Similar to post synaptic nAChRs 
neuronal nicotinic AChRs also comprise five subunits, mainly α and β (Cooper et al., 1991). 
Unlike post-synaptic nAChRs, neuronal nAChRs are modulators of neurotransmitters 
(Bowman et al., 1990; Meir et al., 1999). It is appear to be that these receptors likely to be 
involved in the positive-feedback regulation of ACh release, hence acting as autoreceptors 
(Meir et al., 1999). There is also some evidence on avaialblility of neuronal muscarinic 
AChRs at NMJ (Caulfield, 1993; Santafe et al., 2003), which appear to have similar role as 
neuronal nicotinic AChRs, indicating possible modulating of ACh release (Slutsky et al., 
1999; Santafe et al., 2003).  
1.3.4 Localisation and biochemistry of AChE 
AChE is one of the fastest enzymes known (Nair et al., 1994): one AChE molecule degrades 
about 25,000 ACh molecules per second, (Quinn, 1987; Taylor and Radic, 1994). The 
enzyme is composed of homotetramers of globular catalytic subunits attached to a collagen 
tail (ColQ-AChE) (Massoulie and Millard, 2009) (Fig 1.5). Vertebrate AChE has many 
molecular forms, including AChEH (hydrophobic form) and AChET (Tailed form), in which 
AChET is present in adult muscle and brain (Massoulie, 2002). The deposition of the ColQ-
AChE in the basal lamina depends on nerve-derived components, as well as muscle activity 
(Massoulie and Millard, 2009). The active site of the AChE molecule consists of 2 subunits, 
a peripheral anionic site and an esteratic sub site (Taylor and Radic, 1994); the esteratic sub-
site is responsible for the hydrolysis of the ACh molecules. The anionic site interacts with 
the ACh quaternary ammonium atom and is responsible for its correct orientation (Taylor 
and Radic, 1994; Pohanka, 2011). This active site consists of a catalytic triad which include 
serine, histidine and glutamate protein molecules. The active site lies close to the bottom of a 
deep and narrow “gorge” (Sussman et al., 1991; Sussman et al., 1993; Taylor and Radic, 
1994). The globular structure is lined with 14 hydrophobic residues (Sussman et al., 1991). 





complex undergo acylation followed by de-acylation reactions in order to liberate acetic 
acid and regenerate the free enzyme (Taylor and Radic, 1994).  
Mutations which produce an absence of the collagen tail result in muscle weakness 
(Massoulie and Millard, 2009). The anionic site of AChE enzyme also plays an important 
role in the development of Alzheimer’s disease at CNS, as amyloid β peptide interacts with 
the peripheral anionic site. This may contribute to the formation of amyloid plaques and 





















Fig 1.5: Schematic diagram illustrating content of the synaptic cleft. A: Interactions 
among basal lamina, presynaptic and post synaptic molecules, B; Scheme of AChE 
molecules (catalytic domain subunits are in blue colour and collagen tail subunits are in red 

































1.3.5 History and mechanism of action of classic anticholinesterases 
The use of anticholinesterase by humans can be dated back to centuries. The people of old 
Calabar (a city of south-eastern Nigeria) used to administer a Calabar bean mixture as an 
ordeal to persons accused of witchcraft or other crimes, as a punishment of their guilt. Many 
years later, it was identified that calabar beans contain physostigmine, a reversible 
cholinesterase inhibitor alkaloid (Fraser, 1867).  
The inhibition of AChE by non-OP anticholinesterases (carbamates) occurs similar to OP 
induced AChE inhibition. In the presence of carbamates, AChE enzyme undergoes 
carbamylation, thereby inhibiting the activation of AChE (Wilson et al., 1960). However, 
carbamates bound to AChE hydrolyse spontaneously, thus reactivating the enzyme.   
1.3.6 Therapeutic uses of anti-AChE 
Therapeutic use of anticholinesterase can be traced to the 1870s’ as physostigmine was used 
to treat glaucoma. Synthetic cholinesterase inhibitors were started to use as a therapy for 
skeletal muscle and autonomic disorders in 1930s’. Both pyridostigmine and physostigmine 
have been used for many years for the treatment of myasthenia gravis. Although the short-
duration anticholinesterases are generally safe, reports of their misuse are associated with a 
clinical syndrome similar to pesticide intoxication. The first cholinesterase inhibitor to be 
tried for Alzheimer disease was tacrine, which was released for clinical use in 1993. 
However, it is no longer in clinical practice due to its adverse effects. Anticholinesterases 
drugs such as rivastigmine are now widely used for treating dementia in humans. Similarly, 
anticholinesterases metrifonate has been used to treat schistosomiasis and is undergoing 
trials for the treatment of primary degenerative dementia.  
1.4 Organophosphorus toxicity 
Organophosphate compounds are a diverse group of chemicals used in both domestic and 
industrial settings, which include insecticides (malathion, parathion, diazinon, fenthion, 
dichlorvos, chlorpyrifos, ethion), nerve gases (soman, sarin, tabun, VX), ophthalmic agents 
(echothiophate, isoflurophate), and antihelmintics (trichlorfon). Herbicides (tribufos [DEF], 






1.4.1 History of OP: from nerve agents to pesticide 
The first synthetic OP was made in 1854 by Philip de Clermount, who described the 
synthesis of tetraethyl pyrophosphate at a meeting of the French Academy of Sciences 
(Bajgar, 2004). Almost a century later, Lange and Schrader (1930) investigated the use of 
organophosphates as insecticides. Six years later, the first of the nerve agent intended for 
military use, known as “tabun” was synthesised by Schrader and he then synthesised second 
nerve agent “sarin” two years later (Sidell and Borak, 1992). Parathion was one of the first 
OP pesticide commercialized, which was invented by the Schrader in 1940s’ following his 
discovery of nerve agents. 
Massive organophosphate intoxication arose from suicidal, chemical warfare and accidental 
events. For example, the Jamaican gingerpalsy incident in 1930 affecting 30,000 – 50,000 
people and accidental ingestion of ethion-contaminated food in a social ceremony in 
Magrawa, India in 2005, leading to 15 victims of OP toxicity. More importantly, chemical 
weapons (nerve gases) still pose a very real concern in this age of terrorist activity, including 
notable events such as in the battle fields of Iraq (1980s), sarin poison on a Tokyo subway 
(1995) and recent incident of sarin attack on the Ghouta agricultural belt around Damascus, 
Syria on the morning of 21 August (2014). However, the most substantial number of deaths 
occurs through the pesticide self-poisoning across the rural Asia (see Section 1.1) (Gunnell 
et al., 2007).  
1.4.2 Mechanisms of inhibition of AChE by OP; antidotes and their mechanism 
In the presence of the active OP compound, a serine hydroxyl group of the AChE molecule 
(the active site of AChE responsible for catalysis of ACh) is phosphorylated, inactivating the 
enzyme (Eddleston 2010). The inactive enzyme then undergoes one of two subsequent 
changes in state namely a) reactivation, either spontaneously or in response to drugs (oximes 
– see below) or b) “aging”, which is loss of one alkyl group from the inactive enzyme, 
rendering the molecule permanently inactive (Fig 1.5). The rate of spontaneous reactivation 
of phosphorylated AChE enzyme depends on the chemical structure of OP compounds 
(Moretto, 1998; Vale, 1998). Ester groups attached to the phosphorus atom in OP 
compounds are mainly either two methyl (dichlorvos, dimethoate, malathion) or two ethyl 
groups (chlopyrifos, parathion). Dimethyl phosphorylated AChE enzymes have a rapid 
spontaneous reactivation; thereby patients should improve even without employing oxime 





Phophorothioate compounds (P=S) need bio-activation to their phosphate analogues (P=O) 
in order to become biologically active (Sidell and Borak, 1992; Vale, 1998; Lotti, 2001). 
Biologically active phosphate (P=O) compounds show variability of action depending on the 
specific subunits occurring as R1, R2 and X (subgroups) (Sidell and Borak, 1992) (Fig 1.6). 
In the reaction step of phosphorylation and inactivation of the AChE molecule, the X moiety 
is displaced from the phosphorus atom (OP compound) by a serine hydroxyl group (AChE 
molecule). The kinetics of this reaction is determined by the X moiety (leaving group) 
(Sidell and Borak, 1992). 
Reactivation of the inhibited AChE enzyme can be enhanced by oxime antidotes, such a 
pralidoxime or obidoxime. The OP molecule binds to the esteric site of the AChE enzyme.  
Oximes, first bind to the anionic site of the enzyme, followed by binding to the OP molecule. 
This pralidoxime-OP binding results in conformational changes to the OP molecule, thus 
leading to unbinding of the OP-AChE. This frees the enzyme esteric site, allowing the 
capacity to hydrolyse ACh molecules to recover.   
 As a consequence of AChE enzyme inhibition, ACh is accumulated in the synaptic cleft. 
This results in persistent activation of acetylcholine receptors (AChRs) in the post synaptic 
membrane. Furthermore, cholinesterases inhibition increases the concentration of ACh left to 















Fig 1.6: Pharmacology of OP action. A: General structure of organophosphate compounds 
comprising of R1-2 groups (hydrogen, alkyl, aryl and others, alkoxy and amino) and X which 
is a dissociable (leaving) group (halogens, cynos, alkylthio group, rest of inorganic or 
organic acid), B; steps of inhibition, regeneration and aging of AChE enzyme by 















1.4.3 Consequential effects of OP and non-OP inhibition at NMJ 
Acute and chronic effects of competitive and non-competitive inhibition of AChE have been 
studied widely in both clinical and experimental studies.  
Electrophysiological examination is one of the most important parameters of clinical 
examination in diagnosing effects of toxicity on the peripheral nervous system (NMJ) in 
pesticide-poisoned patients. Normally repetitive stimulation produces no change in 
amplitude of compound muscle action potentials (CMAP) during a train of stimuli up to 
30Hz (van Dijk et al., 2000). However at higher frequencies (>30Hz) an incremented pattern 
in the amplitude of CMAPs (pseudofacilitation) is observed (van Dijk et al., 2000; 
Jayawardane et al., 2009). Irregular patterns of CMAPs occur with repetitive stimulation 
following cutaneous exposure to OP compound. These include a decrement-increment 
response (CMAPs produced a reduction in amplitude followed by increase with in the train 
of stimuli), which is exacerbated by the administration of edrophonium (a reversible 
anticholinesterase inhibitor) (Maselli et al., 1986). Several other abnormal patterns of 
electromyographical recordings have been observed in different clinical studies with 
pesticide poisoned patients (Maselli et al., 1986; Besser et al., 1989a; De Bleecker, 1995; 
Jayawardane et al., 2008). These include: 1) decrement-increment, 2) combination of 
decrement-increment and repetitive fade, 3) severe decrement, and 4) progressive decrement. 
The severity of the abnormalities in CMAPs is increased with higher frequency stimulation 
(Jayawardane et al., 2008). It has also been reported that a decremented response in EMG 
with anticholinesterases can be attributed to desensitization of the post synaptic nAChRs.  
Besides clinical studies, many experimental studies have examined the effects of AChE 
inhibition using OP and non-OP agents at NMJ, both in-vivo and in-vitro.    
Primary post synaptic effects include changes in characteristics (rise time, amplitude and 
decay time) of both, MEPPs / MEPC and EPPs / EPCs.  
Previous studies have shown an increase in MEPP amplitude with neostigmine (Boyd and 
Martin, 1956; Blaber and Christ, 1967), but subsequently decline to control value possibly 
due to desensitization or weak antagonism of AChR by the neurotransmitter (Eccles and 
Mac, 1949; Fatt, 1954). However, there is also evidence of unchanged MEPP amplitude with 
AChE inhibition in paraoxon (Laskowski and Dettbarn, 1979). On the other hand, lower 
concentrations such as 10-9 - 10-7M neostigmine, ambenonium and edrophonium increase 





neostigmine, physostigmine and edrophonium (>10µM) depress the increment of EPC 
amplitude (Albuquerque et al., 1988). 
Some studies observed 0.9 fold increment in MEPP rise time with neostigmine and 
ambinonium (1-10 µM) (Blaber and Christ, 1967; Tiedt et al., 1978); however the same 
concentration of pyridostigmine shows no significant change in MEPC rise time (Pascuzzo 
et al., 1984). 
The most prominent effect of anticholinesterase treatment (carbamates and 
organophosphates) is a significant increase in the half decay time of the MEPP (Blaber and 
Christ, 1967; Laskowski and Dettbarn, 1979; Bois et al., 1980) and MEPC (Miledi et al., 
1984) and EPP (Eccles et al., 1942; Eccles and Mac, 1949; Blaber and Christ, 1967; Katz 
and Miledi, 1975). Not only prolongation of the time course of EPP but also it’s underlying 
EPC increased decay time with anticholinesterase treatment (Kordas, 1977). Treatment with 
anticholinesterase dramatically prolongs the time course of synaptic current decay due to 
lateral spread by diffusion of non-hydrolysed ACh which then repetitively binds to AChRs 
before removal from the synaptic cleft by diffusion (Katz and Miledi, 1973; Hartzell et al., 
1975; Morrison, 1977).  
There have been several reports on anticholinesterases binding to molecules at NMJ other 
than AChE. These molecules mainly include AChRs resulting in changed gating kinetics of 
the receptors (Kuba et al., 1974; Maleque et al., 1982; Akaike et al., 1984; Albuquerque et 
al., 1984; Pascuzzo et al., 1984; Albuquerque et al., 1985).  
The occurrence of receptor desensitization with acetylcholinesterase inhibition had been 
frequently reported (Katz and Miledi, 1977; Wray, 1981; Akaike et al., 1984; Albuquerque et 
al., 1984; Shaw et al., 1985; Sherby et al., 1985) including evidence of NMJ transmission 
failure via desensitization of the post synaptic nicotinic receptors (Katz and Thesleff, 1957b; 
Thesleff, 1959; Katz and Miledi, 1973; Akasu and Karczmar, 1980; Magleby and Pallotta, 
1981; Giniatullin et al., 1997; Giniatullin and Magazanik, 1998). 
Anticholinesterase effects on presynaptic nerve terminal can be detected mainly with 
changes in spontaneous transmitter release (MEPP/MEPC frequency) and evoked transmitter 
release (quantal content).  
There are limited reports providing evidence of changes in spontaneous transmitter release 





rat diaphragm (Liley, 1956) showed no change in spontaneous transmitter release. On the 
other hand some studies have reported that smaller concentrations (µM) of anticholinesterase 
stimulate spontaneous release (Boyd and Martin, 1956; Blaber and Christ, 1967; Laskowski 
and Dettbarn, 1975; Bois et al., 1980), while reduction of rate the spontaneous release could 
be obtained at higher concentrations of prostigmine (Boyd and Martin, 1956; Duncan and 
Publicover, 1979) perhaps due to its curarizing action (blockage of postsynaptic nAChRs) 
(Eccles and Mac, 1949; Fatt, 1954).  
It has also been shown that this increment of MEPP frequency that occurs via AChE 
inhibition is unlikely to be direct action of the drug on presynaptic terminals, as the MEPP 
frequency increment was reversed using an AChE reactivator pralidoxime chloride 
(Laskowski and Dettbarn, 1979). Moreover increased MEPP frequency also reversed with 
reduced Ca2+ and increased Mg2+ (Laskowski and Dettbarn, 1975) suggesting 
anticholinesterases lead to indirect effects on exocytosis, for example via the excess ACh 
activity presynaptic receptors, or as a consequence of depolarization of the terminal in 
response to additional efflux of K+ via postsynaptic AChR when AChE is inhibited.  
Alterations in presynaptic ion currents with anticholinesterases were also observed in several 
studies. It has been shown that neostigmine depresses the amplitude of K+ currents in the 
perineural waveforms. This might account for the ability of neostigmine to increase the 
quantal content of the endplate potential (Braga et al., 1993). These authors also reported that 
anticholinesterase has a direct action on motor nerve terminals to block the delayed rectifier 
K+ channels and enhance transmitter release. However, some reports shown that ACh itself 
suppresses delayed rectifier K+ channels (Hevron et al., 1986; Shakiryanova et al., 1994). It 
was suggested that this modulation may be significant in cases of acetylcholinesterase 
inhibition, accounting for nerve terminal membrane hypersensitivity (Meir et al., 1999).  
There is also evidence on dose dependent changes in presynaptic ultrastructure with AChE 
inhibition (Hudson et al., 1978). The authors reported the presence of vesicles which were 
two or more times the average diameter of synaptic vesicles, as were occasional vesicles 
with denser than normal content along with an irregularities present in the membrane 
recycling / vesicle formation system in acute and sub-acute anticholinesterase treated (in-
vivo) preparations. Subsequent reports also further demonstrated alterations in the synaptic 
vesicles including increased number of coated vesicles with in vivo administration of 





Spontaneous and stimulus induced repetitive firing in both nerve and muscle is another 
frequently reported feature of anticholinesterase activity, thought to be due to repeated action 
of ACh on its receptors (Morrison, 1977). Single stimuli induced repetitive muscle action 
potentials (RMAP) in anticholinesterase treated preparations were observed in many studies 
(Clark et al., 1983, 1984; Maselli and Soliven, 1991). These RMAPs are also responsible for 
repeated twitch potentiation triggered by single stimulus. It has been suggested that possible 
mechanisms of RMAP include persistent depolarization due to prolonged or repetitive EPP 
or both (Clark et al., 1984). In addition to repetitive firing, occurrences of spontaneous and 
evoked antidromic activity with anticholinesterases were also observed (Werner, 1960a, b; 
Laskowski and Dettbarn, 1975). The spontaneous muscle fasciculation and twitch 
potentiation produced by paraoxon (Barnes and Duff, 1953) and DFP (Van Der Meer and 
Meeter, 1956) in rat diaphragm preparations are thought to be due to antidromic action 
potentials being initiated at one nerve terminal and transmitted to other terminals of the same 
motor unit, thus giving rise to repetitive action potentials in its muscle fibres (Webb and 
Bowman, 1974). It is also suggested that these stimuli induced antidromic back firing with 
anticholinesterases, which impairs neuromuscular transmission of subsequent stimuli (Besser 
et al., 1992). These previous reports may explain the fasciculation and impaired 
neuromuscular transmission following pesticide poisoning.  
Some of the studies have also examined the denervation or paralysis response with 
anticholinesterase treated preparations. Reported observations included physiological 
(decreased membrane potential with increase half decay time, slow rise time, low frequency 
in MEPP) (Meshul et al., 1985; Kawabuchi et al., 1991) and morphological (disruption of 
organelles in the axonal terminal and regional or total withdrawal of the nerve from the post 
synaptic folds) alterations in both acute and sub-acute exposure of anticholinesterases 
(Hudson et al., 1986). These studies suggest that mitochondrial and vesicular abnormalities 
were due to unusual level of mitochondrial activity and or an irregularity in the membrane 
recycling / vesicular formation system. Further reports shows sub lethal doses of sarin 
induced non Wallerian type (localized) axonal degenerative changes in the neuromuscular 
junction followed by subsequent sprouting with time (Kawabuchi et al., 1991). These authors 
showed that presence of MEPP at 800-2500µm away from endplate 5 days post toxicity 
compared to no MEPP at control samples (>600µm). This MEPP recording further indicated 
that slow rise time with longer half decay time and irregularity in shape. Degenerative ultra-
structural changes with paraoxon included mitochondrial disruption, alterations in synaptic 





neuromuscular junction (Laskowski et al., 1975, 1977). These effects were visible as early as 
30 minutes after injection of the drug in-vivo.  
These previous observations suggested that anticholinesterases have multiple effects on 
synaptic transmission at the NMJ, both conventionally (inhibition of AChE, thus repeated 
binding of ACh on AChRs) and non-conventionally (direct action of ACh on AChRs and 
presynaptic terminal due to increase concentration of ACh in the synaptic cleft). However, 
the contribution of anticholinesterase activity towards neuromuscular transmission failure 
reported in pesticide poisoned human patients is still debatable, because none of the reports 
show direct evidence of delayed muscle weakness (delayed synaptic transmission failure), as 
occurs in IMS.  
1.4.4 Relationship of OP AChE toxicity to OP pesticide toxicity and IMS 
Some studies have looked at the possibility of NMJ synaptic transmission block being due to 
AChE inhibition.  
Acetylcholine can also act as a weak antagonist for ACh receptors due to its prolonged 
activation which cause desensitization or depolarizing neuromuscular block. Earlier it was 
noted a depression in EPPs amplitudes occurs with a wide range of anticholinesterases 
(Eccles and Mac, 1949). These were then identified as depolarizing effects (Nastuk and 
Alexander, 1954; Katz and Thesleff, 1957a; Blaber and Christ, 1967). It was reported that 
occurrence of cumulative depolarization of the endplate with repetitive nerve stimulation in 
the presence of anticholinesterase is partially due to accumulated residue of ACh which 
continued to act during the slow depolarization (Katz and Miledi, 1975) and stabilization of 
open ionic channels in the endplate membrane persisting after the transmitter has diffused 
away (Kuba et al., 1974). Evidence of depolarizing block with ambenonium and 
methoxyambenonium has been also reported (Blaber, 1960). Irreversible neuromuscular 
block was also detected with millimolar concentrations of paraoxon (Laskowski and 
Dettbarn, 1979).  
It has also been observed that anticholinesterases induce an accumulative depolarization with 
high frequency trains of stimuli (Chang et al., 1986). It was hypothesised that this could be 
due to regenerative Ca2+-spike which results in explosive release of ACh. Further evidence 
was provided on mechanisms for evoking regenerative release involving ACh receptors and 
Ca2+ channels which are different from these involved in the normal quantal release of ACh 





Some reports demonstrated that only a fraction of all AChE sites at a cholinergic junction are 
involved in the hydrolysis of ACh released from the nerve terminal (Koelle and Steiner, 
1956; Mc and Koelle, 1959).  
Tetanic fade (decrease in amplitude of the tension response or inability to sustained fused 
tetanic responce) in high frequency repetitive stimulation produced in the presence of OP 
and non-OP anticholinesterases has been reported frequently (Berry and Evans, 1951; Barnes 
and Duff, 1953; Van Der Meer and Meeter, 1956; Fleisher et al., 1960; Heffron and 
Hobbiger, 1979). It was shown that the tetanic fade caused by the anticholinesterase drugs 
are a consequence of depolarizing block through accumulating ACh (Blaber and Bowman, 
1963). 
The comparison of AChE activity and high frequency indirect stimulation has revealed that 
considerable reduction in functional AChE activity is required before the diaphragm loses its 
ability to respond with a sustained tetanus (Heffron and Hobbiger, 1979). These authors also 
stated that minimum (critical) level of functional AChE activity required for a normal tetanic 
response is directly related to the frequency of stimulation and once the functional AChE has 
been reduced to the critical level a very small further reduction leads to complete tetanic 
fade. In contrast, some reports demonstrate that fade of tetanic contraction caused by 
anticholinesterase is explained by the inactivation of sodium channels in the area 
surrounding the endplate, but that sustained fade is due to a decrease in transmitter release 
(Chang et al., 1986). There has also been speculation on a pre-junctional mechanism which 
causes endplate current train rundown and tetanic fade (Gibb and Marshall, 1987). In 
conjunction to the above assumption, it is observed that choline, hexamethonium and 
tubocurarine reduced both tetanic fade and endplate potential run-down caused by 
neostigmine, despite the fact that they themselves also induced these two effects. The mutual 
reversal by neostigmine and AChR antagonist of endplate potential run-down may implicate 
the presence of a positive (physiological increase of ACh to overcome high demand) and a 
negative (pharmacological decrease exert by the accumulated ACh) feedback regulation for 
evoked transmitter release via nicotinic AChR in the mammalian motor nerve, depending on 
the concentration of ACh within the synaptic cleft (Chang et al., 1988).    
1.4.5 Efficacy, potency and mechanism of dimethoate/omethoate action 
As the toxicity of dimethoate in animal depends on its conversion to oxon analogue, 





dimethoate (Lucier and Menzer, 1970). Phenobarbital is an inducer of hepatic microsomal 
enzyme (Which convert dimethoate to omethoate) (Vardanis, 1966); pre-treatment of mice 
with phenobarbital leads to a significant increase in dimethoate toxicity (Menzer and Best, 
1968). On the other hand, pre-treatment with sesamex (inhibitor of hepatic microsomal 
oxidation) did not reduce the dimethoate toxicity; as sesamex inhibit the detoxification 
pathways of both dimethoate and omethoate (Lucier and Menzer, 1970).  
1.5 Organic solvent toxicity 
Use of organic solvents has become increasingly prevalent due to their importance in the 
industrial use. There are many types of organic solvents available. Toxicity of these organic 
solvents arise depending on the mechanism of action (which is usually related to their 
structure) and the amount or dose of exposure of particular solvent.  
1.5.1 Clinical syndromes 
Among the many clinical symptoms caused by organic solvent toxicity in humans, 
neurotoxicity is most prevalent (White and Proctor, 1997). Depending on the exposure (large 
acute exposure or small chronic exposure) these compounds cause either temporary or 
permenent damage to CNS and PNS. CNS depression and psychomotor or attentional 
deficits along with the symptoms of fatigue, irritability, confusion, or depression, and 
memory difficulties may present when CNS is affected, while PNS symptoms include 
gradual onset intermittent tingling and numbness, with progression to an inability to perceive 
sensation and muscle weakness (White and Proctor, 1997). Diagnostic test indicate 
neurophysiological and neuropsychological functions used to diagnose clinical syndrome in 
these patients (White and Proctor, 1997). 
1.5.2 Effects of organic solvents on NMJ 
The effects of cyclohexanone and cyclohexanol on synaptic transmission are unknown and 
neither of them have been studied at the NMJ. However, it is noteworthy that the 
cyclohexanol analogue, 2-(4-benzylpiperidino) cyclohexanol (vesamicol), inhibits the 
vesicular loading of ACh molecules at the nerve terminal (Prior et al., 1992) causing a 
reduction in the quantum size. The effects of aliphatic alcohols on neuromuscular 
transmission have been studied. For instance, it was shown that ethanol reduces direct and 
indirect twitch and tetanic contractions by depressing NMJ transmission (Wali and Hayter, 





ethanol enhances synaptic transmission through post synaptic mechanisms, i.e. increasing the 
ACh channel open time. There have been some studies of the effects of ketones on 
neuromuscular transmission. For instance, Okada (1967) described effects of acetone on 
NMJ, showing a dose dependence of MEPP frequency and EPP decay; while Larsen et al 
(1996) shows that acetone has blocking effects on muscle Na+ currents. Other studies of 
organic solvents include effects of dimethyl sulfoxide (DMSO) which also produces dose 
dependent effects on the NMJ including AChE inhibition (McLarnon et al., 1986). It was 
shown that irreversible uncoupling of the mechanical activity of the muscle produced by the 
glycerol treated nerve muscle preparations is through the alterations in the EPP amplitude 
(Sosa and Zengel, 1993).   
Sumarry; 
Pesticide poisoning leads to about 250,000 – 370,000 mortalities every year, and is 
responsible for about one third of global suicides. Understanding this is important in view of 
the major significance of pesticides, including Dimethoate EC, on human health, particulary 
in developing Asia, where their use remains widespread; and where suicides, or severe and 
debilitating life-threatening illness, including IMS, are a major health problem and a burden 
to hospital services.  IMS, in particular, is poorly understood and there is no effective 
treatment except artificial ventilation, Understanding the mechanisms of action of the 
constituents of pesticides like Demothoate EC and their role in causing the paralysis that is 
characteristic of IMS could lead to the discovery and development of effective 
pharmacological treatment; relieving the burden of health care in rural communities in Asia 
and potentially saving thousands of lives annually. Understanding the mechansisms could 
also lead to deeper biological insight into the function of several components of the 
neuromuscular system and perhaps to other paralysing disease in which neuromuscular 
function is compromised. 
1.6 Aims and objectives 
1.6.1 Overall Aim 
In order to understand the mechanisms triggering the respiratory failure due to 
neuromuscular transmission block during the intermediate syndrome of OP poisoned 
patients, we must first address the effects of these pesticide and their metabolites, either 
alone or in combination, on neuromuscular transmission. As I have discussed above 





synaptic transmission. However, the causes of delayed muscle weakness and paralysis due to 
this anticholinesterase are still unknown. Furthermore, direct evidence of effects of the 
solvent used in industrial pesticides and their metabolites on NMJ synaptic transmission is 
missing.  
1.6.2 Detailed hypotheses 
My overall aim in this thesis was to test the hypothesis that the delayed respiratory failure 
after ingestion of pesticide is due to failure of neuromuscular transmission; and that this is a 
consequence of initial excitotoxicity, resulting from inhibition of acetylcholinesterase. To 
test this overall hypothesis, I have investigated the effects of components of one particular 
commercial pesticide: dimethoate EC.  
As I have mentioned earlier, Dimethoate EC is a moderately toxic pesticide according to the 
WHO classifications. Moreover, due to high toxicity in class 1 OP pesticides, the Food and 
Agriculture Organization (FAO) has advised withdrawal of more class I pesticides from 
agricultural practice (FAO, 2002). Therefore, it is highly likely there will be an increase in 
use of Dimethoate Ec40 in agricultural practice world wide. Furthermore, Dimethoate 
toxicity in humans is responsible for higher mortality rates with increased cardiotoxicity and 
development of IMS (Dawson et al., 2010). Thus, use of dimethoate in my experiments is 
appropriate in order to understand the mechanism of IMS and development of new 
therapeutic regimes.  
My detailed hypotheses were that:  
1. The initial, acute syndrome is caused by the anticholinesterase effects of dimethoate 
at the neuromuscular junction (NMJ). 
2. Metabolic conversion of dimethoate and cyclohexanone to omethoate and 
cyclohexanol, respectively, contribute to acute pesticide toxicity at the NMJ. 
3. Transmission failure in IMS is due to the persistent combined effects of dimethoate, 








1.6.3 Three objectives 
The objectives in the three Results chapters were therefore to examine the main predictions 
from the above hypotheses, as follows: 
i. First I investigated how the pesticide, its ingredients dimethoate and cyclohexanone, 
and their metabolites omethoate and cyclohexanol (Fig 1.7), respectively, affected 
synaptic transmission at the NMJ. This was done by examining cellular (intracellular 
recordings) and functional (isometric tension) characteristics of neuromuscular 
synaptic transmission with pesticide components, either alone or in combination 
(Chapter 3). The results show that omethoate and cyclohexanol have potent, additive 
effects in prolonging synaptic potentials and isometric contractile responses that 
exceed those of dimethoate or cyclohexanone.  
ii. Next, I investigated further the mechanisms by which omethoate and cyclohexanol 
interfered with neuromuscular transmission, by measuring passive membrane 
properties and synaptic currents under voltage clamp (Chapter 4). I found evidence 
for complex presynaptic and postsynaptic mechanisms in addition to effects 
attributable to inhibition of AChE. 
iii. Finally, I attempted to model the neuromuscular transmission failure in IMS and to 
verify whether it is due to the persistent combined effects of omethoate and 
cyclohexanol on neuromuscular transmission. This was accomplished using a novel 
ex vivo assay. I found that a cocktail of dimethoate, omethoate, cyclohexanone and 
cyclohexanol impaired synaptic transmission and enhanced synaptic degeneration ex 
vivo. I extended these findings by demonstrating additional, use-dependent 
deterioration of transmission following additional, acute stimulation in the presence 










Fig 1.7: Structural formulae of the compounds used in this thesis. The P=S in dimethoate 
(red circle) is oxygenated in the liver to P=O in omethoate (red circle), by the enzyme 
complex cytochrome P450. Cyclohexanone is converted in to cyclohexanol in the stomach 
and small intestine by reverse activation of alcohol dehydrogenase. The normal substrate for 
this enzyme is ethanol, which is reduced to acetone. Neostigmine is a quaternary nitrogen 




















1.6.4 Preview of conclusions 
Taking all the data from my studies together, I conclude that failure of neuromuscular 
transmission induced by pesticide ingestion cannot be explained solely by inhibition of 
acetylcholinesterase by either dimethoate or omethoate. Rather, the metabolic breakdown 
products (both omethoate and cyclohexanol) exert an additive or synergistic, harmful 
combination of presynaptic and postsynaptic effects. Interestingly, in addition to its 
postsynaptic effects, cyclohexanol appears to show similar presynaptic effects to vesamicol 
on neuromuscular transmission, and also to affect presynaptic membrane currents. Finally, 
the results of my study utilising an isolated ex-vivo assay suggest that prolonged exposure to 
both the ingredients and their metabolites may be required to produce IMS. This novel assay 
may also constitute a fruitful method for evaluating pesticide toxicity from longer duration 
exposures and its modifiers. 
These findings, and further understanding of the mechanisms of synaptic toxicity that they 
may lead to, could facilitate the development of better therapeutics and more effective 







































Methods outlined below are common to some of the experiments reported Chapters 3-5. 
Methods specific to experiments reported in those Chapters are described in their Methods 
sections.  
2.1. Animals 
2.1.1 Animal care and housing 
Mice were maintained in the facilities at the University of Edinburgh in accordance with UK 
Home Office regulations (United Kingdom Animals (Scientific Procedures) Act, 1986). All 
mice used were housed in standard light (12h light 12h darkness) and temperature conditions 
and in cages of 6 or fewer. Mice had access to food and water ad libitum. 
Age matched male and female C57/Bl6 (6 – 12 weeks) mice were used in most experiments. 
In some experiments I utilized C57 Wlds and thy1.2-YFP16 Wlds (6 – 8 weeks) (6 – 8 weeks) 
mice (Wong et al., 2009).    
 2.1.2 Animal sacrifice 
All the mice were killed by cervical dislocation, according to the UK Home Office 
regulations, Schedule 1.  
2.2 Composition of the salines 
Hepes-buffered mammalian physiological Saline (MPS: 137mM NaCl, 5mM KCl, 2mM 
CaCl2, 1mM MgCl2, 5mM Hepes, 5.6mM Glucose, equilibrated by bubbling with air, 
supplied by a domestic aquarium pump) was prepared at room temperature (20 – 25 0 C) in 
advance of the animal sacrifice. The pH of the solution was measured using a standard pH 
meter (Sartorius pH meter PB-11) and adjusted to pH 7.2 - 7.4 using 1M NaOH or 1M HCl. 
2.3 Muscle disections 
2.3.1 Flexor digitorum brevis (FDB) muscle preparation 
Directly after sacrifice, hind limbs were amputated and skin was stripped. Then limbs were 
placed in fresh MPS for dissection. Each of the legs was pinned (minutien pins) in a Sylgard-
lined Petri dish. The FDB muscle along with the tibial nerve was dissected and nerve-muscle 
preparation then transferred back to MPS until commencement of the physiological 





According to Bekoff and Betz (1977b; Bekoff and Betz, 1977a), the short length of FDB 
muscle fibres in rats suggested that membrane electrical parameters are equivalent to a short 
cable model with open circuit ends. The most important practical consequence of this is that 
FDB muscle fibres (which are even shorter in mice, see (Gillespie and Ribchester, 1988) are 
isopotential. Thus, endplate depolarization spreads rapidly without decrement throughout the 
muscle fibre.  
It was shown that rat FDB muscle fibres are isopotential along their length: thus, current 
generated from a source located at any point along the fibre (including the NMJ) can be 
faithfully recorded by a microelectrode located anywhere else in the fibre (Bekoff and Betz, 
1977b; Bekoff and Betz, 1977a). Mouse FDB muscle fibres are also short (<500µM) 
(Gillespie and Ribchester, 1988; Ribchester et al., 1995; Gillingwater et al., 2002; Ribchester 
et al., 2004) and therefore could be expected to behave in a similar manner to that of rat 
muscle fibres. These properties demonstrate that FDB is a particularly suitable muscle for 
routine electrophysiological examinations of neuromuscular transmission.  
2.3.2 Trangularis sterni (TS) muscle preparation 
Directly after sacrifice, the mouse was pinned on a cork board. Thoracic skin was removed 
and the ribcage was carefully dissected out, and then transferred to Hepes MPS at room 
temperature. 
 The ribcage was then halved symmetrically along the sternum and one half was pinned on 
Sylgard lined Petri dish which contained Hepes MPS for dissection. The trangularis sterni 
muscle (single layer thin muscle) along with the corresponding intercostal nerves (McArdle 
et al., 1981) was exposed after careful removal of second to fifth ribs. Nerve-muscle 
preparations were then transferred back to MPS until commencement of the 
electrophysiological recording. 
2.3.3 Lumbrical muscle dissection and staining 
Lumbrical muscle dissection was carried along with the dissection of FDB nerve muscle 
preparations for ex-vivo culture assay (see above). After 24 hours of culture, the combined 
FDB and lumbrical nerve muscle preparation was then returned to a Petri dish containing 
MPS ± drug treatment. The lumbrical muscle was then carefully separated from the FDB 
muscle and the FDB was then used for physiological analysis. The lumbrical muscles were 





tetramethylrhodamine-isothiocyanate (TRITC) α-bungarotoxin (Molecular Probes, USA) 
which labelled post synaptic acetylcholine receptors (AChRs). The preparation was then 
placed on a rocking platform (Stuart Scientific, UK) for 10 minutes covered in tin foil. The 
sample was washed three times with MPS for 10 minutes each, and then fixed by immersion 
in 4% paraformaldehyde (Electrone microscopy science, USA) for 15 minutes followed by 
two cycles of washing with MPS as previously. Fixed muscles were then mounted on glass 
slides in Vectashield (Vector laboratories, UK) and covered with a coverslip ready for 
fluorescence microscopy.  
2.4 Drug and toxins  
The following were used: µ-conotoxin (µ-CTX ) (GIIIIB µ-CTX; Bachem AG, Switzerland), 
tetramethylrhodamine-isothiocyanate (TRITC) α-bungarotoxin (Molecular Probes, USA), d-
tubocurarine (15mg/1.5ml, Evans medical LTD, England), neostigmine (2.5mg/ml, Phoenix 
Pharma LTD, Gloucester), dimethoate (Cheminova, Denmark), omethoate (Sigma aldridge, 
United kingdom), cyclohexanone (Sigma Aldridge, United kingdom), cyclohexanol (Sigma 
Aldridge, United kingdom). 
2.5 Electrophysiological apparatus and intracellular recordings of MEPP/EPP 
All experiments were done at room temperature (20 - 25°C).  
2.5.1 EPP recording (Indirect stimulation) 
Preparations were pre-treated with MPS containing 2.5 µM µ-CTX for 20 minutes or until 
twitch contractions had disappeared. µ-conotoxin is contained in the venom of the 
piscivorous marine snail, Conus geographus L (Cruz et al., 1985). This toxin blocks voltage 
gated muscle sodium channels (Nav 1.4) (Li and Tomaselli, 2004), thereby abolishing muscle 
action potentials, while having no discernible effect on nerve sodium channels (Braga et al., 
1992; McIntosh and Jones, 2001; Gillingwater et al., 2002; Ribchester et al., 2004). 
After incubation with µ-conotoxin, the preparation was pinned in a Sylgard-lined chamber, 
approximate volume 10 ml, filled with MPS. The nerve was positioned in glass suction 
electrode and stimulated via a Digitimer DS2 isolated constant voltage stimulator driven by a 
Digitimer D4030 programmer. Microelectrodes (Harvard apparatus / glass capillary tube, 
GC150F-15, 1.5 O.D. * 0.86 I.D.) for intracellular recordings were pulled using a Flaming / 
Brown micropipette puller (P87 Sutter instrument. USA). Electrodes were back filled with 4 





potentials were recorded using an HS-2A (*0.1LU) head stage mounted on Leica 
micromanipulator and connected to Axoclamp 2B amplifier (Axon instrument, USA). The 
reference electrode was a silver wire connected to an Ag/AgCl pellet immersed in the 
bathing medium and connected to the signal ground of the head-stage. Signals were 
amplified using Neurolog AC/DC amplifier (neurology NL 106), low pass filtered at 3 KHz 
(neurology NL 92) and then passed through a Humbug filter (Quest scientific, Canada) to 
eliminate 50 Hz main interference. Signals were digitized (50KHz) in to a personal computer 
(DELL., USA) via Micro 1401 mk II (Cambridge Electronic Design Limited., England) 
interface. EPP recordings were analysed using WinWCP software (Dr John Dempster, 
Strathclyde Electrophysiological Software, University of Strathclyde, UK) for several 
characteristics (Fig 2:1). These measurements include latency, peak amplitude, rise time, half 
decay time and quantal content.  
Before each drug treatment, 6 -12 EPP recordings were obtained from randomly selected 
fibres. The preparation was stimulated with a trains-of-four nerve stimuli, delivered at 33Hz 
(interval 30ms) with an interval of 5s between each stimulus train. The trains were repeated 
up to 30 times. The preparation was then incubated for 20 minutes with respective drug 
treatment before commencing further recording.  
2.5.2 Recording & analysis of MEPPs 
Spontaneous activity was recorded using direct couple (DC) condition for 60 – 100s at each 
fibre with a steady membrane potential at -60 to -70mV. Recordings were discarded if the 
resting membrane potential had drifted more than 20mV difference from the original value. 
MEPPs were recorded via a CED 1401 Micro mk II using Spike– 2 software (Cambridge 
Electronic Design, UK) digitized at 50KHz (20µsec/cycle). Analysis of the recordings was 
carried out with Mininalysis software (Synaptosoft, USA). The specific data files were first 
converted to Axon binary files (ABF) and an amplitude correction factor of 0.2 was applied 
to correctly calibrate the data recordings. Then the data were processed to detect 
characteristic MEPP parameters such as rise time, amplitude, decay time and inter event-
interval-frequency.  
2.6 General statistical method for data analysis and composition of group data 
All the data represented as mean ± SEM, unless otherwise stated. “N” numbers refer to as 
number of muscles tested. “P” values were represented as conventional stat (P < 0.05 = *). 





(GraphPad Software Inc, USA). Multiple groups were compared using analysis of variance 
(ANOVA) ± post-test (Bonferoni). Unpaired t-tests were used where applicable to 


























Fig 2.1: Analysis of the endplate potential parameters. End plate potential properties were 
measured using WinWCP software. Time of the stimulation was displayed by the stimulus 
artefact appears at the beginning of the trace. The measured parameters include; peak 
amplitude of the EPP, latency (time between the stimulus and the beginning of the response) 
and rise time of the peak. Decay time was analysed as T50, i.e. using WinWCP the time for 







































Chapter 03: Effects of Dimethoate EC pesticide, its constituents and metabolites on 



















Effects of anticholinesterases on neuromuscular synaptic transmission have been studied 
extensively since the early 20th century. For instance, Brown et al (Brown et al., 1936; Bacq 
and Brown, 1937; Brown, 1937) made myogenic recordings from anaesthetized cat muscles 
and reported repetitive contraction, resembling tetani, in response to single nerve stimuli 
following intravenous injections of eserine (presently known as physostigmine), an extract 
from the calabar bean. Eccles et al (1942) used extracellular field potential recordings to 
measure EPPs and reported that the principle effect of eserine on cat and frog muscles was 
“lengthening of the action of the neuromuscular transmitter, thus leading to prolonged 
junctional negativity with consequent catelectrotonic effects”. Fatt and Katz (1951) and Del 
Castillo & Katz (1954) extended these studies using intracellular microelectrode recording to 
demonstrate the prolongation of spontaneous MEPPs and evoked EPPs by physostigmine at 
neuromuscular junctions in frog muscle. Further widening the use of anticholinesterases, 
Katz and Thesleff (1957a) used edrophonium and neostigmine to examine neuromuscular 
transmission in frog muscles, showing edrophonium potentiated the depolarizing effects of 
ACh. However potentiation of depolarizing effects was weak when preparations were pre-
treated with neostigmine. Since these pioneering studies, there have been many reports 
describing effects of anticholinesterases on neuromuscular transmission, using intracellular 
microelectrode recording.  
The use of OP compounds, such as sarin, in chemical warfare can be traced back to the 
1930’s. However, studies of their anticholinesterase effects on neuromuscular transmission 
became available only in the early 1950’s (Berry and Evans, 1951; De Candole et al., 1953). 
OP also became increasingly used as pesticides from the middle of the 20th century: 
parathion was among the first marketed. However, detailed in-vitro electrophysiological 
analysis of the effects of the active ingredient of OP pesticides, such as paraoxon, only 
became available in the 1970’s (Kuba et al., 1974; Laskowski and Dettbarn, 1975).  
Interestingly, OP compounds such as octamethyl pyrophosphoramide (OMPA) were also 
initially used as an anticholinesterse treatment for myasthenia gravis, as an alternative to 
neostigmine (Silvestri and Wolfe, 2012), but with adverse consequences of a “cholinergic 
crisis” that exacerbated the original condition in some cases.  
Most of the available evidence concerning the effects of formulated pesticide (ie the 
commercial agricultural products) on NMJ synaptic transmission had been reported in the 





analysis of toxicity of pesticide containing the OP dimethoate initially focused on the 
anticholinesterase activity of intraperitoneally-injected pure compound (Dongren et al., 
1999). Until recently, little consideration was given to the possible toxicity of the organic 
solvent in which the dimethoate is normally dissolved in the commercial pesticide, after it is 
ingested (Eddleston et al., 2012). This deficiency demonstrates a lack of knowledge and 
understanding of potential combinatorial actions of the components of pesticides on 
neuromuscular transmission, at molecular, cellular and overall functional levels.  
As I introduced in Chapter 1, the pesticide known as dimethoate EC 40 comprises three main 
components; dimethoate (the “active ingredient”), cyclohexanone (an organic solvent), and 
an emulsifying agent that acts as a surfactant (unknown molecular identity, apparently a 
trade secret). When ingested, the known pesticide ingredients undergo metabolism in the 
intestine and liver. I have summarized in Chapter 1, the breakdown and excretion of 
dimethoate EC40 and its metabolites but the principle metabolic conversions I have focused 
on in this chapter are those from dimethoate to omethoate, and from cyclohexanone to 
cyclohexanol. The blood plasma of human patients poisoned with dimethoate EC contains all 
four compounds (Eddleston et al 2008) and this was emulated and reproduced in a pig model 
(Fig 1.2) (Eddleston el at 2012).  
For the research described in the present Chapter, I set out to measure the effects on 
neuromuscular transmission of formulated pesticide and its OP and solvent components, 
singly and in combination. I used NMJ in isolated flexor digitorum brevis (FDB) muscles 
from mice as my experimental paradigm because FDB muscle fibres are short, isopotential 
and therefore readily accessible to intracellular recording and electrophysiological analysis 
of synaptic transmission, for instance in models of synaptic degeneration (Bekoff and Betz, 
1977b; Ribchester et al., 1995; Gillingwater et al., 2002; Ribchester et al., 2004) (Brown et al 
2014, in press). 
First, I studied the effects of plasma obtained from minipigs poisoned with the formulated 
dimethoate EC pesticide, or with dimethoate alone, on spontaneous MEPPs and evoked 
EPPs, measured with intracellular microelectrodes. Second, I measured the effects of 
dimethoate, omethoate, cyclohexanone or cyclohexanol, (collectively referred to as DOCC) 
singly and in various combinations when added to Hepes-buffered mammalian physiological 
saline (HEPES-MPS) bathing the isolated nerve-muscle preparations. I constructed dose-
response curves for the two most potent of these compounds: omethoate and cyclohexanol. 





to repetitive, patterned nereve stimulation, in order to emulate respiratory activity, since the 
clinical signs and symptoms following pesticide ingestion suggest that both the acute 
cholinergic crisis and subsequent paralysis of muscle in IMS appear to be activity-dependent. 
Lastly, I determined the effects of omethoate and cyclohexanol on overall functional 
responses, measured from twitch and tetanic muscle contractions. 
The data suggest that the metabolites of Dimethoate EC, specifically omethoate and 
cyclohexanol, potently interact to prolong EPPs but by different mechanisms. In 
combination, they produce profound adverse and synergistic effects on neuromuscular 






















The following methods are specific to this chapter. For general methods and chemicals, 
please refer to Chapter 2.  
Base line recordings for all the experiments were carried out in Hepes MPS at room 
temperature. 
3.2.1 Minipig plasma samples and intracellular recording (EPP/MEPP)  
Plasma samples (arterial blood) were obtained from treated minipigs 10 – 12 hrs after 
administration of pesticide (2.5ml/kg), dimethoate (1g/kg) or saline (2.5ml/kg) by oral 
gavage. These plasma samples (2ml) were centrifuged at 1200 RPM for 2 minutes and 
supernatant was retained. First, baseline EPP / TOF and MEPP measurements from 10 fibres 
were obtained from µ-CTX pre-treated (as described in general methods) FDB nerve-muscle 
preparations. Further EPP or MEPP recordings of 20 - 30 fibres were made with treatment (≈ 
2ml of respective plasma or volume of neostigmine / positive control to obtain 10µM final 
bath concentration) added to the recording chamber followed by a 20 minutes equilibration 
period, leaving a 10 minutes interval after every sixth fibre.  
3.2.2 Intracellular recordings (EPP / MEPP) with purified pesticide ingredients and 
their metabolites  
Baseline recording of EPPs and MEPPs were made from in 6 – 10 muscle fibres (µ-CTX 
pre-treated preparations) according to the stimulation protocol stated below (step 1 – step 10) 
(Fig 3.1). Each of the impaled muscle fibres was stimulated with the patterns described 
below. Test compounds were then added to the recording chamber to the final concentration 
required. After 20 minutes equilibration, intracellular recordings were made from further 6 – 
10 muscle fibres with 10 minutes interval at each fibre recording. This was in order to 
mitigate presynaptic vesicular depletion and/or desensitized post synaptic receptors as a 
consequence of high frequency repetitive stimulation. Treatments included pure compounds 
of formulated pesticide dimethoate EC (i.e. dimethoate and cyclohexanone), either alone or 
in combinations with their metabolites (omethoate and cyclohexanol). Treatment 
concentrations for this experiment were adopted from Eddleston el al 2012, based on plasma 








The stimulation protocols for individual recordings were included in the table below. 
Stimulation protocol (step 1 – 10) was repeated for every sampled muscle fibre. 
Initial characterization  
 Step 1 Step 2 Step 3 Step 4 Step 5 
No of cycles per 
recording 
5 5 5 5 5 
Stimulation frequency 1Hz 2Hz 5Hz 10Hz 20Hz 
Single cycle length 7s 7s 7s 7s 7s 
No of stimuli per cycle 4 4 10 10 10 
 
Rhythmic pattern stimulation 
 Step  6 Step 7 Step 8 Step 9 Step  10 
No of cycles per 
recording 
5 5 5 5 5 
Stimulation frequency 50Hz 50Hz 50Hz 50Hz 50Hz 
Single cycle length 5s 5s 5s 2.5s 2.5s 










Fig 3.1: Schematic illustration of rhythmic patterned stimulation protocol. Note that 
number of stimuli per cycle changes from 10 to 100 and single cycle length was varied 













































Sampling protocol:  
Intracellular recordings of MEPP and EPP were carried out as follows. First, 20s – 30s of 
MEPPs were recorded. Then from the same fibre, EPPs were recorded. Stimulation protocols 
were designed with sufficient interval between each cycle, to avoid fatiguing the muscle. 
This protocol was then followed by further 20s – 30s of MEPP recording. I then continued 
with the rhythmic patterned high frequency stimulation steps. Finally another 20s – 30s of 
MEPPs recorded on the same fibre, to observe whether there was any evidence for 
presynaptic modifications (e.g. synaptic vesicle depletion) following high frequency burst 
stimuli, in the presence of pesticide and their metabolites.  
3.2.3 Sampling protocol for drug concentration curves 
Cumulative drug dose-response data were acquired as follows. First, baseline EPP / TOF or 
MEPP measurements were obtained from 10 muscle fibres in µ-CTX pre-treated FDB nerve-
muscle preparations (see above). Then the respective drugs were added to the bath to achieve 
the targeted drug concentration. After a 20 minutes equilibration, further EPP or MEPP 
recordings were made from 20 fibres, placing a 5 minutes interval after every fifth fibre. The 
protocol continued until data from all the accumulated drug concentrations had been 
obtained from the same muscle.  
3.2.4 Measurements of AChE activity  
The following procedure was carried out in New Jersey Medical School-Rutgers University, 
Newark, United States of America by Dr. V. Patel and Dr. L.G. Sultatos. 
Hemidiaphragms were dissected, weighed, and homogenized in 9 volumes of 100 mM 
sodium phosphate buffer (pH 7.4). Production of thiocholine in the Ellman reaction was used 
to measure AChE activity. Briefly, a total of 1 ml of reaction volume containing 0.44 mM 
acetylthiocholine and 0.1 mM 5,5′-dithio-bis(2-nitrobenzoic acid) was placed in a cuvette. 
The reaction was initiated by addition of 50 µl of muscle homogenate, and the increase in 
optical density at 412 nm (due to thiocholine production) was followed for 10 min in a 
Shimadzu UV2550 spectrophotometer (Kyoto, Japan). The slopes of optical density curves 






3.2.5 Isometric tension measurement recordings 
Tension recordings were carried out using tibial nerve - FDB muscle preparations. Following 
dissection, the proximal tendon of the FDB muscle was attached to black braided 7.0 silk 
sutures less than 2cm in length, (Fine Science Tools, Germany) tied in a loop at the free end. 
The preparation was then pinned using its three distal tendons in a Sylgard-lined recording 
chamber filled with MPS. The threaded end was then attached to an Akers / Sensonor AE875 
force transducer rigidly mounted on micromanipulator. 
The force transducer was connected to a Neurolog NL106AC/DC amplifier via a Wheatstone 
bridge circuit powered by a rechargeable 6V battery, built in house. The muscle and the 
force transducer were aligned orthogonally. Resting length was adjusted to give a maximum 
evoked twitch response. Amplified signals were then fed into a personal computer (DELL., 
USA) via a CED Micro 1401 mk II interface (Cambridge Electronic Designs, UK). Both 
isometric twitch and tetanic tension were recorded using Spike–2 software (Cambridge 
Electronic Design, UK) digitized at 1 KHz (1ms/point). The preparation was then incubated 
for 20 minutes with respective drug treatments and the above stimulus protocol repeated to 
obtain the measurements of their effects. 
For indirect tension measurements, the nerve was positioned in glass suction electrode and 
stimulated via a Digitimer DS2 isolated constant voltage stimulator connected to a Digitimer 
D4030 programmer. For direct stimulation two silver wires were positioned alongside the 
muscle. These electrodes were connected to the DS2 stimulator.  
3.2.6 Sampling protocol for twitch / tension measurements 
The following steps are the sampling protocol. First motor unit recruitment was measured in 
response to graded indirect stimulation. Base line recording of twitch and tetanic tension 
measurements in Hepes MPS were then obtained in response to 40 stimuli delivered at 
frequencies of 0.5Hz, 1Hz, 2Hz, 10Hz, 20Hz and 50Hz, with an interval of 2 minutes 
between each stimulus frequency. Drug treatment was then added to the recording chamber 
followed by a 20 minutes incubation period. During incubation, the muscle was continuously 
stimulated indirectly at 0.1 Hz and resulting twitch tensions were monitored and recorded. 
Further recordings of twitch and tetanic tension at different stimulation frequencies similar to 
base line recordings, were then obtained. Direct stimulation was carried out in Hepes MPS, 
containing d-tubocurarine (5µM) to abolish neuromuscular transmission, with pulses of 20 – 





cyclohexanone and cyclohexanol) for these experiments were adopted from Eddleston el al 
(2012) as for EPP recordings.  
 
3.3 Results 
In accordance with the overall hypothesis and predictions indicated in the General 
Introduction, my primary objective in these experiments was to establish how dimethoate EC 
pesticide, its dimethoate and cyclohexanone solvent ingredients, and their metabolites 
omethoate and cyclohexanol, respectively, affect neuromuscular transmission. 
3.3.1 Pesticide plasma prolongs neuromuscular transmission 
Electrophysiological analysis of trains-of-four EPP showed that control plasma (plasma from 
minipigs treated with saline) added to FDB muscles bathed in Hepes MPS did not alter EPP 
characteristics. In other words, there was no discernible effect of plasma alone on 
neuromuscular transmission (Fig 3.2).  
Pesticide plasma samples appeared to prolong EPP time course demonstrating statistically 
significantly difference from control MPS (half decay time: Hepes MPS; 3.02±0.6ms, 
control plasma; 3.24±0.28ms, pesticide plasma; 5.04±0.8. mean ± SEM, (P < 0.05, 
Bonferroni’s, “F = 8.08”) (Fig 3.2, 3.3, 3.4). Interestingly, prolongation of the synaptic 
potentials was evident 2 – 4 hrs post treatment with pesticide plasma preparations, whereas 
neostigmine took less than 10mins to act and dimethoate plasma took about 30mins to act 
(Fig 3.5). However, neither half-decay time nor peak amplitude of MEPPs indicated any 
statistically significant alteration from the control MPS values (half decay time: Hepes MPS; 
2.63±0.81ms, pesticide plasma; 2.87±0.65ms. mean ± SEM, P > 0.05, ANOVA) (Fig 3.8, fig 
3.9). However, there was a significant increase in MEPP frequency with pesticide plasma 
treated samples compared to the Hepes MPS, suggesting a stimulation of spontaneous 
transmitter release from presynaptic motor nerve terminals (Hepes MPS; 0.68±0.34s-1, 
dimethoate plasma; 0.53±0.2734s-1, pesticide plasma; 1.27±1.2034s-1, neostigmine; 
0.66±0.4434s-1 mean ± SEM, P < 0.05, Bonferroni's, “F = 9.84”) (Fig 3.9 C). These data 
suggests that other ingredients present in the pesticide plasma have additional effects on 
NMJ transmission. Based on the findings reported in pigs (Eddleston et al., 2012), I 





Dimethoate plasma prolonged EPP decay similar to the effect of neostigmine (see below), 
consistent with the anticholinesterase activity of dimethoate (and / or its metabolites, see 
below), 30 – 60 minutes after adding plasma to the recording chamber (Fig 3.2, 3.3, 3.4, 3.5).  
The half decay time of MEPPs and EPPs were increased compared to its control Hepes MPS 
samples (EPP half decay time: Hepes MPS; 3.02±0.6ms, control plasma; 3.24±0.2ms, 
dimethoate plasma; 5.4 ±1.05ms. mean ± SEM, P < 0.05, Bonferroni's, “F = 8.08”) (MEPPs 
half decay time: Hepes MPS; 2.63±0.81ms, dimethoate plasma; 3.35±0.97ms. mean ± SEM, 
P < 0.05, Bonferroni's, “F = 13.30”) (Fig 3.8, 3.9).  
Neostigmine (which I employed as a positive control for anti-AChE activity), as expected, 
prolonged synaptic transmission, producing a significant increase in half decay time of both 
MEPPs (Hepes MPS; 2.63±0.81ms, neostigmine; 3.66±0.81ms. mean + SEM, P < 0.05, 
Bonferroni's, “F = 13.30”) and EPPs (MPS; 3.21±0.75ms, control plasma; 3.24±0.28ms, 
neostigmine; 5.41±1.23ms, mean ± SEM, P < 0.05, Bonferroni's, “F = 8.08”) (Fig 3.2, 3.3, 
3.4, 3.5) within 10 minutes of adding it to the recording chamber. The peak amplitude of 
MEPPs also showed a significant increase (Fig 3.8, 3.9), while EPP amplitude showed a 
slight decrease (Fig 3.6). Interestingly, resting membrane potential depolarised significantly 
in the presence of neostigmine (Hepes MPS; -64.07±1.2mV, control plasma; -58.34±1.5mV, 
dimethoate plasma; -63.19±1.4mV, pesticide plasma; -61.88±1.1mV, neostigmine; -
54.73±1.5mV, mean ± SEM, P < 0.05, Bonferroni's, “F = 5.89”) (Fig 3.7). This might have 
been responsible for the observed decline in EPP peak amplitude, either as a result of 
reduced driving force on EPP depolarization or the effects of non-quantal ACh release 
(Vyskocil et al., 1983; Vyskocil et al., 2009), receptor desensitization (Krnjevic and Miledi, 
1958; Magleby and Pallotta, 1981; Giniatullin and Magazanik, 1998) or all these together.  
In summary, dimethoate plasma (containing dimethoate and its metabolite omethoate) 
prolonged EPPs in a manner consistent with anticholinesterase activity reported previously 
in the literature. On the other hand combination of dimethoate, cyclohexanone and their 
metabolites (pesticide plasma) have some noticeable additive effects on synaptic 
transmission at the NMJ along with anticholinesterase activity. Therefore I hypothesised that 
effects of pesticide plasma (anticholinesterase activity along with the additive effects) may 
have adverse effects on synaptic transmission; hence I set out to look any for evidence for 
NMJ transmission failure with the pesticide plasma-treated nerve muscle preparations in the 





Fig. 3.2: Intracellular endplate potential (EPP) recordings with different treatments. A: 
Neostigmine (positive control) Showing substantial prolongation of synaptic potential decay, 
B; Control plasma (plasma from minipigs treated with saline) had no effects on EPP time 
course compared to Hepes MPS (trace E), C: Pesticide plasma (plasma from minipigs treated 
with commercially available pesticide, Dimethoate EC), D; Dimethoate plasma (plasma from 
minipigs treated with unformulated pesticide, i.e. pure dimethoate). Pesticide plasma (C) and 
dimethoate plasma (D) traces show smaller increases in EPP decay time, but not to the same 















Fig 3.3: Half decay times (T50%) of EPPs in trains of four with different treatments. A: 
Half decay time of EPPs (WinWCP settings: time to decay from 90% to 50% of peak 
response) with different treatments. B: B-a: Hepes MPS Vs Neostigmine, B-b; Hepes MPS 
Vs Control plasma, B-c; Hepes MPS Vs Pesticide plasma, B-d; Hepes MPS Vs Dimethoate 
plasma. E 1 – 4 represent each subsequent EPP in T-O-F traces.  Each bar represents mean ± 
SEM [n  (No of muscles): Hepes = 14, neostigmine = 3,  control plasma = 3, pesticide 
plasma = 5, dimethoate plasma = 3] (p < 0.05, ANOVA, Bonferroni post test – 




















































































































Fig 3.4: Half decay times facilitation of EPPs in trains of four with different treatments. 
A: Example train of four (E 1 – 4 represent each subsequent EPP in T-O-F traces), B: Decay 
time facilitation during T-O-F stimuli as per following equestion; 
𝐷𝑒𝑐𝑎𝑦 𝑡𝑖𝑚𝑒 𝑓𝑎𝑐𝑖𝑐𝑖𝑡𝑎𝑡𝑖𝑜𝑛 (𝑇50%) =  
𝑇50% 𝑜𝑓 𝐸4−𝑇50% 𝑜𝑓 𝐸1
𝑇50% 𝑜𝑓 𝐸1
∗ 100%.  
The percentage increases in half-decay time of the fourth EPP in relation to the first in 
subsequent (Increment of time course of fourth response compared to first response were 
standarzed as a percentage from the initial time course). Each bar represents mean ± SEM [n  
(No of muscles): Hepes = 14, neostigmine = 3,  control plasma = 3, pesticide plasma = 5, 
dimethoate plasma = 3] (p < 0.05, ANOVA, Bonferroni post test – treatements were 


















Fig 3.5: Time course of half decay time increase in different treatments. Half decay time 
of the baseline recordings were approximately 2 – 3 ms. Note that neostigmine produced 
prolonged decay time (≈ 6 – 7 ms) soon after treatment while dimethoate and pesticide 
plasma had a slow onset producing the similar effects. Data were shown from single 
experiment for each of the treatment (n=1). Line was fitted with linear regression to 


































































Fig. 3.6: Comparison of synaptic potential rise time and peak amplitude. A; rise time of 
EPP-TOF responses, B; peak amplitude, of EPPs (E1) with different treatment. Note that the 
significant reduction in peak amplitude of EPPs in neostigmine and pesticide plasma treated 
samples. E 1 – 4 represent each subsequent EPP in TOF traces. Data obtained from 20min – 
4hrs post treatment. Each bar represents mean  ± SEM [n  (No of muscles): Hepes = 14, 
neostigmine = 3,  control plasma = 3, pesticide plasma = 5, dimethoate plasma = 3] (p < 











Fig 3.7: Comparison of change in resting membrane potential in response to drug 
treatments. Data was obtained during the period of 20min – 4hrs post treatment. Only 
neostigmine treatment produced a significant depolarization of the resting membrane 
potential. Other treatments produced no significent change, in comparison to Hepes MPS.  
Data reprecent a cumulative value from all the experiments. Each bar represents mean value 
± SEM (fibres) [n  (No of muscles): Hepes = 14, neostigmine = 3,  control plasma = 3, 
pesticide plasma = 5, dimethoate plasma = 3] (p < 0.05, ANOVA, Bonferroni post test - 





































Fig 3.8: Intracellular MEPPs recordings with different treatments. A-a: Hepes MPS, B-
b: neostigmine, C-c: pesticide plasma, D-d: dimethoate plasma. Note the pesticide plasma 
treated samples displayed an increase MEPP frequency (C). A – D traces represent a slower 
time base and show the distribution of MEPP, while a – d traces represent a fast time base 






























Fig 3.9: Comparison of MEPPs parameters with different plasma treatment: A; Peak 
amplitude, B; Half decay time, C; MEPP frequency. Dimethoate plasma MEPPs showed a 
significant increase in both peak amplitude and half decay time comapared to Hepes MPS, 
while pesticide plasma MEPPs showed significant increment in MEPPs frequency compared 
to Hepes MPS. Neostigmine treated samples MEPPs also showed a significant increase in 
half decay time compared to Hepes MPS. Data obtained from 20min – 4hrs from treatment, 
each  represent mean frequency ± SEM [n  (No of muscles): Hepes = 14, neostigmine = 3,  
pesticide plasma = 5, dimethoate plasma = 3] (p < 0.05, ANOVA, Bonferroni post test - 

















3.3.2. Prolonged exposure to pesticide plasma produces neuromuscular block  
The hallmark of IMS is muscle paralysis. Therefore, I asked next whether minipig plasma 
would cause a neuromuscular transmission block. Plausible evidence for NMJ transmission 
block was observed with pesticide plasma treated preparations, as there were no detected 
EPP responses upon stimulation after 2- 4hrs. The incidence of evoked transmission failure 
emerged shortly after EPPs began to show prolongation of their decay time, which was also 
2 – 4 hrs post treatment. Interestingly, these effects were reversible, as EPPs recovered after 
the 3 – 4 cycles of washing with Hepes MPS (Fig 3.10). Even though EPPs could not be 
evoked in these muscle fibres, they still produced MEPPs, suggesting that spontaneous 
transmission was unaffected. Nevertheless, this obstruction of evoked transmission was only 
observed with formulated pesticide plasma treated samples, while other treatments produced 
no such effects (Table 3.1). 
In summary, the data suggested the complex nature of the effects of pesticide plasma on 
neuromuscular transmission consistent with data from pig studies in vivo. My preliminary 
findings are consistent with the pig data suggest perhaps that the anticholinesterases activity 
of dimethoate alone is not sufficient to explain IMS. Data from the pig study (Eddleston et 
al., 2012) implicated roles for pesticide solvent (cyclohexanone) and the metabolites of both 
dimethoate and cyclohexanone, namely omethoate and cyclohexanol. I therefore turned my 
attention next the in-vitro effects of these components.  













Fig 3.10: Traces showing evoked synaptic transmission failure following addition of 
pesticide plasma to the bathing medium. Traces:  A; Hepes MPS, B; pesticide plasma 
showing prolonged EPP decay, C; pesticide plasma showing complete block of 
neuromuscular transmission, (Note that there is only stimulus artefact along with MEPPs are 
present) D; Hepes MPS (after pesticide plasma was washed off, showing evidence of 





















Table 3.1: Summary data of electrophysiological evaluation of synaptic transmission at 
NMJ in minipig plasma treated preparations. Note that EPPS remained in only one 




























Mean membrane potential 
(Em) during the course of 
experiment 
Frequency of MEPPs  
throughout the 
experiment 
No of experiments in with 
EPPs were evoked by nerve 
stimulation at the beginning 
of procedure 
No of experiments with 
EPPs at the end of 
procedure 
Neostigmine -54.73±1.5mV 0.66±0.4434s-1 4/4 4/4 
Control Plasma -58.34±1.5mV 0.68±0.34s-1 3/3 3/3 
Dimethoate Plasma -63.19±1.4mV 0.53±0.2734s-1 3/3 3/3 





3.3.3 Omethoate and cyclohexanol in combination synergistically prolong synaptic 
transmission 
If the hypothesis that the ingredients of pesticide and/or their metabolites required for the 
effects of pesticide plasma is correct then we would predict that the parent compounds in 
pesticide and their metabolic breakdown products would have additive or synergistic effects 
on NMJ synaptic transmission.  
I therefore test the effects of dimethoate, omethoate, cyclohexanone and cyclohexanol 
together referred to as (DOCC) singly and in various combinations. 
First, it was necessary to examine how individual components of the pesticide and their 
metabolites affect synaptic transmission. I measured rise time, amplitude and decay time of 
synaptic potentials in this experiment. Secondly, I sought to test the treatment potency of 
each individual compound on neuromuscular transmission. I used prolongation of EPP decay 
time as an index of anticholinesterase activity. Thirdly, I tested whether it was possible to 
reproduce neuromuscular transmission block using combinations of the DOCC components. 
The objective of this set of experiments was to identify whether combinations of these 
molecules might be responsible for the failure of neuromuscular transmission observed in 
human pesticide-poisoned patients with IMS and the decline of mechanomyographic 
responses observed in the intensive care minipig model of OP toxicity (Eddleston et al., 
2012).   
Fig 3.11 shows sample traces of EPPs recorded using different drug treatments. Traces were 
further analysed for their post synaptic characteristics: that is, their rise time, peak amplitude 
and half decay time.  
Inspection of single EPPs in different treatments suggested prolongation of synaptic 
potentials with dimethoate, omethoate, cyclohexanol and their combinations but not with 
cyclohexanone (fig 3.11). Quantitative analysis of EPPs at 1Hz confirmed the significant 
increment of half decay time with omethoate compared to Hepes MPS (fig 3.12A, table 3.2). 
I also found that cyclohexanol prolonged synaptic transmission, showing a significant 
increase in decay time (fig 3.12A, table 3.2). Interestingly, an additive effect on half decay 
time was observed in preparations when omethoate and cyclohexanol were added to the 
bathing medium (fig 3.11, 3.12A, table 3.2). Surprisingly, peak amplitudes of EPPs (fig 
3.12B, table 3.2) showed a reduction, in neostigmine, dimethoate, cyclohexanol and 





The effect of omethoate on cholinesterase activity was measured in a biochemical assay and 
the results are shown in Figure 3.13. (These measurements were carried out by Dr. V. Patel 
and Dr. L.G. Sultatos at New Jersey Medical School-Rutgers University, Newark, USA). It 
is evident that 100µM omethoate completely inhibits AChE activity. Cyclohexanol (5mM) 
also inhibits AChE activity but only by about 25 – 30% Thus, when considering the 
mechanisms for additive effects of omethoate and cyclohexanol on half decay time of EPPs, 
these data together suggest that the effects of cyclohexanol in combination with omethoate 
cannot be explained simply by additional inhibition of AChE, since this enzyme is 
completely inhibited by omethoate alone at the concentrations present in poisoned plasma 
and in my in vitro experiments. Cyclohexanol must therefore prolong EPPs by some other 
mechanism in addition to its mild anti-AChE effects. 
More pronounced effects on EPP decay were observed with low concentrations of omethoate 
(EC 50; 2.75µM), compared with dimethoate (EC 50: 1.4mM) (fig 3.14). Both 
cyclohexanone and cyclohexanol were also tested for prolongation of synaptic potentials 
using the same criteria of increase half-decay time as a measure. Ethanol was tested for 
comparison with since it is also a substrate for alcohol dehydrogenase and it is already 
known to affect the NMJ transmission (Searl and Silinsky, 2010b, a). The data show that 
both cyclohexanol and ethanol potentiate EPP decay at higher concentration of the drug 
(mM), while cyclohexanone has no discernible effects on EPP decay time even at higher 
concentrations (mM) (fig 3.15).  
Together therefore, these results indicate that the metabolic breakdown products omethoate 
and cyclohexanol have more potent effects on decay kinetics of neuromuscular transmission 











Fig 3.11: Comparison of EPPs with different combination of pesticide components. A; 
Hepes MPS, B; neostigmine (10µM), C; dimethoate (1mM), D; omethoate (100µM), E; 
cyclohexanone (1mM), F; cyclohexanol (5mM), G; Omethoate and cyclohexanol, H; 
dimethoate, omethoate, cyclohexanone, cyclohexanol (DOCC). Note that decay time of EPP 
is longest when all four components of pesticide are combined together. Treatment 
concentrations for were adopted from Eddleston el al 2012, based on plasma concentrations 















Table 3.2: Summary of statistical analysis of post synaptic parameters with pesticide 
ingredients. Statistical test; oneway analysis of variance. Post test; Bonferroni multiple 
comparison test. (CH-one, CH-ol and DOCC represent, cyclohexanone cyclohexanol and 
dimethoate, omethoate, cyclohexanone and cyclohexanol respectively). N = 3 muscles per 























Half Decay time (mS) 
Bonferroni's Multiple Comparison Test Mean Diff. t 
Significant? 
 P < 0.05? Summary 95% CI of diff 
  Hepes MPS vs 1mM Dimethoate  -3.573 2.379 No ns -7.848 to 0.7024 
  Hepes MPS vs  100µM Omethoate -8.634 5.116 Yes *** -13.44 to -3.829 
  Hepes MPS vs 1mM CH-one  -0.2901 0.1719 No ns -5.095 to 4.515 
  Hepes MPS vs 5mM CH-ol  -8.333 4.937 Yes *** -13.14 to -3.528 
  Hepes MPS vs Ometho + CH-ol -22.63 13.41 Yes *** -27.44 to -17.83 
  Hepes MPS vs DOCC -32.8 19.43 Yes *** -37.61 to -28.00 
  
Peak Amplitude (mV) 
Bonferroni's Multiple Comparison Test Mean Diff. t 
Significant? 
 P < 0.05? Summary 95% CI of diff 
  Hepes MPS vs 1mM Dimethoate  8.791 4.599 Yes *** 3.349 to 14.23 
  Hepes MPS vs  100mM Omethoate 4.426 2.06 No ns -1.691 to 10.54 
  Hepes MPS vs 1mM CH-one  0.7922 0.3687 No ns -5.324 to 6.909 
  Hepes MPS vs 5mM CH-ol  11.8 5.492 Yes *** 5.683 to 17.92 
  Hepes MPS vs Ometho + CH-ol 14.27 6.643 Yes *** 8.155 to 20.39 







Fig 3.12: Comparison of EPP parameters with different combinations of the pesticide 
components. A: half decay time B; peak amplitude. Prolongation of decay time is largest 
when either two metabolites or all four ingredients of pesticides are combined together. Note 
the additive effects of omethoate and cyclohexanol on decay time when combined together. 
Each bar represent mean  ± SEM (n = 3 muscles per each treatment group) (p < 0.05, 
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Fig 3.13: AChE activity after 30 minutes incubation of the treatment at room 
temperature. Each data point represent mean ± SEM (n = 6 muscles per each treatment 
group) (p < 0.05, ANOVA, Dunnett’s post test). Experiments of AChE activity was carried 
out by Dr. V. Patel and Dr. L.G. Sultatos at New Jersey Medical School-Rutgers University, 
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Fig 3.14: Change of half decay time with drug concentration. Effective concentration 
(Ec) 50 value for dimethoate and omethoate are 1.4mM and 2.75µM respectively. Note that 
the low Ec 50 value of omethoate compared to dimethoate. Each data point represent the 

















































































Fig. 3.15: Change of half decay time with drug concentration. Cyclohexanol had a 
threshold (maximum) effect of 3mM and at 5mM produced about 60% increase in half decay 
time of EPP; where as the effects of cyclohexanone was barely detectable at 5mM (see also 
fig 3.12A). Cyclohexanol have had detectable effects on decay time of the synaptic potential, 
while cyclohexanone produce no effects. Each bar represent the mean half decay time ± 



















































































3.3.4 Patterned repetitive stimulation at high frequencies produce short term synaptic 
depression with different combinations of pesticide ingredients and metabolites 
I next examined for evidence of synaptic depression on NMJ transmission failure using high 
frequency (10Hz -50Hz) trains of stimulation with varying intervals between trains (fig 
3.16). Example traces of trains (10) of stimuli (50Hz) from Hepes MPS recording are shown 
in figure 3.17. Qualitative evaluation was carried out for responsiveness of the muscle fibre 
for stimulation and run down of EPP trains during high frequency stimulation. µ-CTX 
pretreated preparations in MPS do not produce muscle action potentials or mechanical twitch 
upon stimulation. However, some responses with omethoate and its combinations were more 
complex, indirectly producing counteraction of µ-CTX effects, resulting in a muscle action 
potentials and mechanical twitch upon nerve stimulation. In baseline Hepes MPS, the 
threshold nerve stimulation intensity required to reliably produce a train EPPs was about 1 – 
2 V (pulse width 0.1ms). Under these conditions, trains of stimuli delivered at frequencies up 
to 100Hz produced EPPs in response to every stimulus in the train (Figure 3.16, 3.17). 
However, in the presence of cyclohexanol, a higher stimulus intensity was required (> 10V) 
to robustly produce trains of EPPs. I frequently observed intermittent or complete absence of 
EPPs during trains of stimuli at 10 - 50Hz at stimulus intensities that were sufficient to 
generate EPP trains at high frequency in normal MPS (Fig 3.18). The effect in cyclohexanol 
was overcome by increasing the stimulus intensity. I did not investigate this further (but see 
Chapter 4) and for the remaining experiments I simply ensured that stimulus intensity was 
adequate to evoke consistent response in preparations treated with cyclohexanol.  
Sample traces of 50Hz trains of stimuli with treatment are summarised in figure 3.19. 
Cumulative depolarization leading to facilitation of the EPP responses, along with a base line 
shift were observed in both omethoate and cyclohexanol treated preparations. Sustained 
depolarization upon which EPPs of decreasing amplitude were superimposed along with the 
prolonged decay time of the EPP are likely to be responsible for the observed summation of 
the responses. The baseline shift was also probably a consequence of accumulation of ACh 
in the synaptic cleft.  However, the apparent initial temporal summation along with the slight 
rundown of the subsequent EPP (amplitude) responses was more noticeable in combinations 
of either metabolic breakdown products (omethoate and cyclohexanol) or in preparations 
treated with all four compounds tested. The synergestic effects of omethoate and 
cyclohexanol combination was observed with analysis of half decay time of the last EPP 





I also observed possible evidence for ACh receptor desensitization during high frequency 
trains of stimuli in combinations of omethoate and cyclohexanol, and in DOCC-treated 
preparations, as EPP amplitudes appeared to become disproportionately reduced in 
amplitude with the prolongation of the train (Fig 3.20). 
Most remarkably, profound effects of omethoate and cyclohexanol were observed in trains of 
qualitative analysis of response in repetitive stimulation (50Hz) (fig 3.21). In Hepes MPS, 
multiple cycles of high frequency bursts of stimuli produced short term synaptic depression 
within each cycle.  However, there was no apparent fatigue, since the first EPP in each 
subsequent cycle produced similar responses, demonstrating fairly quick recovery of 
synaptic transmission. Possible evidence for desensitisation was also minimal as; a) the peak 
amplitude of the EPPs was comparatively stable after initial short term depression in 
subsequent stimulus trains, b) decay time of the EPPs were also relatively constant in 
subsequent stimulus trains. However when DOCC was added to the recording chamber, it 
showed a baseline shift along with the temporal summation and prolonged decay time of the 
first EPPs response. Interestingly, subsequent cycles showed reduction in temporal 
summation along with the decline in prolonged decay compared to first response. These 
observations suggest depression of synaptic transmission with DOCC with repetitive 
stimulation at higher stimulation frequencies. Reduction in prolonged decay with subsequent 
cycles also suggests possible desensitization of the junctional ACh receptors. Omethoate in 
combination with cyclohexanol also produced similar effects, but the magnitude of the 
response reduction with subsequent cycles was largest when DOCC was present.  
Collectively, these data suggest that the parent components of pesticide ingredients have 
smaller effects on synaptic transmission at the neuromuscular junction than their metabolites. 
However, the effects were more pronounced when all four components were combined. 
Therefore, next I set out to examine, what are the consequences of these alterations on 











Fig 3.16: Sample traces of EPPs recorded in different frequencies of stimulation. Traces 
obtained in Hepes MPS. A; 1Hz, B; 10Hz, C; 20Hz. The EPPs in B show synaptic 
depression with repetitive stimulation. It is also evident that short term synaptic depression 
becomes quicker with higher stimulating frequencies, as it took 1s to produce similar amount 
of depression at 10HZ (Trace B) while at 20Hz (trace C) it only required 500ms. Trace C 
















Fig 3.17: Sample traces from 50Hz trains of stimuli with different intervals between 
subsequent trains. Traces obtained in Hepes MPS. A: three successive trains of stimuli (10 
stimuli per train) with an interval of 5 s between each train, B; three successive trains of 
stimuli (10 stimuli per train) with an interval of 2.5 s between each train. In both A and B, 
EPP traces shows no evidence of fatigue (reduction in EPP amplitude) in successive cycles, 





































Fig 3.18: Comparison of different responses observed with cyclohexanol (5mM) at 
stimulating frequency of 20Hz. A; Responsive fibre producing EPP at each stimuli. Note 
the summation and prolonged decay time of EPPs B; Intermittent failures during a train of 



























Fig 3.19: Traces from 50Hz trains (25 stimuli) and half decay time of last EPP response 
with different combination of pesticide components. A; Hepes MPS, B; dimethoate 
(1mM), C; omethoate (100µM), D; cyclohexanone (1mM), E; cyclohexanol (5mM), F; 
Omethoate and cyclohexanol, G; dimethoate, omethoate, cyclohexanone and cyclohexanol 
(DOCC), H; Half decay time (T50%) of the last EPP reponse in 50Hz trains of stimuli. 
Prolongation of last EPP decay was maximum at all four components together (trace G). 
Each bar represent mean  ± SEM (n = 3 muscles muscles per each treatment group) (p < 
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Fig 3.20: Traces from 50Hz trains (25 stimuli) demonstrating possible desensitisation of 
the AChRs. A: traces from a preparation treated with omethoate and cyclohexanol, B; traces 




























Fig 3.21: Multiple cycles of repetitive stimulation (50Hz) EPPs response trains (5s 
interval between each cycle) with different treatments. A: Hepes MPS, horizontal arrows 
indicate the subsequent cycles. There is no indication of fatigue or desensitization of EPP 
responses. B: DOCC, horizontal arrows indicate the subsequent cycles. There is dramatic 
fatigue along with desensitization with successive cycles. C – G: First and fifth responses of 
respective treatment. Vertical arrows indicate the response after 5 consecetive cycles C: 
Dimethoate, D: Cyclohexanone, E: Omethoate, F: Cyclohexanol, G: Omethoate and 
cyclohexanol. Dimethoate and cyclohexanone shows no fatigue or desensitization of EPP 
responses in subsequent repetitive stimulation while omethoate, and omethoate and 
cyclohexanol show clear fatigue or desensitization of EPP responses. Cyclohexanol alone 










3.3.5. Metabolic breakdown products of dimethoate EC prolong muscle contractions  
Finally, I asked what the functional effects of prolongation of the EPPs by individual 
components of pesticide might have on muscle contractions (twitches or tetani).  
There was no evidence of selective loss of motor units with any of the treatments as delivery 
of graded stimulation before and after treatment produced no change in number of motor 
units per sample (Data not shown).  
Analysis of the data revealed that dimethoate, cyclohexanone or cyclohexanol does not 
produce any modifications of twitch or tetanic tension compared to recordings in Hepes MPS 
(Fig 3.22, 3.23). There was slight twitch potentiation with omethoate and DOCC treated 
preparations (Fig 3.22, 3.23). In 2/3 experiments the twitch amplitude increased by more 
than 40% (with omethoate or cyclohexanol alone produced smaller increase: all three 
repeats, the maximal increase were about 10%). However, ANOVA indicated that the 
difference did not produce a statistical difference. The potential of type II statistical error in 
this experimemnts could perhaps be address in further experimets. However, since twitch 
amplitude was of less interest than the underlying synaptic physiology, no further twitch 
tension measurements were undertaken. Twitch amplitude percentages (twitch amplitude as 
a percentage of control twitch amplitude) with different treatments were observed at 0.1Hz 
frequency with reference to control MPS as follows: dimethoate 100.87±4.760, 
cyclohexanone: 91.48±1.40%; omethoate: 113.33±4.68%; cyclohexanol: 96.51±5.053%; 
omethoate and cyclohexanol: 148.21±34.16%; DOCC: 113.17±0.77% (mean ± SEM, P > 
0.05, ANOVA, “F = 2.05”) (These measurements presented as a percentages in order to 
standardize the data).  
Summation of twitch responses was observed at frequencies as low as 1 – 2 Hz in 
preparations treated with combination of omethoate and cyclohexanol compared to other 
treatments (fig 3.24). The combination of omethoate and cyclohexanol also caused a smooth 
tetanic fusion at lower frequency (10Hz) than the individual components (Fig 3.25). 
However, incomplete tetanic frequency fusion was also evident with omethoate, 
cyclohexanol and DOCC preparations (fig 3.25).  
Interestingly in preparations treated with cyclohexanol alone, 50Hz tetanic tension responses 
showed no increment in amplitude or the relaxation phase of the muscle contraction 
compared to that of Hepes MPS (Fig 3.26). However, omethoate-treated preparations 





Remarkably, but consistent with EPP data (in section 3.3.4) combination of omethoate and 
cyclohexanol produced an even greater prolongation of both after-contraction and the 
relaxation phase, lasting for several seconds (Fig 3.26).   
Surprisingly, DOCC produced shorter and weaker after-contractions and a shorter relaxation 
phase compared to combination of omethoate and cyclohexanol together (Fig 3.26, 3.27). 
This was consistently observed with all three muscles tested with DOCC. Thus it appears 
that dimethoate and cyclohexanone partially counteract the response to omethoate and 
cyclohexanol. Besides the more rapid relaxation of the tetanic tension produced by of all four 
components together, these response amplitudes were also reduced compared to those in 
control MPS (fig 3.26). There are several possible explanations for this effect of DOCC, 
including desensitisation of the AChRs by accumulated ACh in the synaptic cleft due to 
anticholinesterase activity, thus curtailing the NMJ transmission. Alternatively 
depolarization block might have caused inactivation of the muscle voltage gated Na+ 
channels leading prevention of AP propagation. Another possibility is the direct action of 
these components on the muscle fibre itself, hence minimising the ability to produce 
sustained prolonged contraction of the muscle. A third possibility is that dimethoate 
competes with omethoate reducing the inhibitory effects of the latter on AChE activity. 
However, this last explanation is not supported by the EPP data shown in Fig 3.12. 
Direct stimulation of the muscle was used to test whether the effects of omethoate in 
prolonging muscle contraction were due to direct effects on muscle, rather than dependent on 
neuromuscular transmission. Direct stimulation bypasses the post synaptic ACh receptors 
and directly excites the muscle to produces an action potential and muscle contraction. 
However, direct stimulation also excites motor axons. Therefore to rule out a direct effect of 
omethoate on muscle contraction itself, I blocked AChR with d- tubocurarine. Direct 
stimulation of the muscle in the presence of 5µM d-tubocurarine (d-Tc) and omethoate 
(100µM) displayed no prolongation of the tetanic contraction compared to the effects of 
nerve stimulation at 50Hz stimuli (Fig 3.28). Thus, the prolonged tetanic contraction 
observed in the indirect stimulation is not consequence of the OP components affecting 
muscle contraction. The prolonged contraction observed in omethoate is therefore due to an 
effect on neuromuscular transmission.  
In summary, the results in this Chapter suggest that omethoate and cyclohexanol, the 
metabolic breakdown products of dimethoate Ec, produce potent inhibition of AChE activity 





muscle physiological function, including, prolonged after-contractions and slow relaxation in 
response to repetitive stimulation (table 3.3). However, I made a number of puzzling and 
confounding observations: for instance, high frequency repetitive stimulation with DOCC 
produced longest decay time in EPP responses; however the mechanical response to high 
frequency stimulation in DOCC is less affected than in a solution containing added 
























Fig 3.22: Example traces comparing potentiation of twitch amplitude with different 
treatments compared to control MPS. Paired traces of tension represent control Hepes 
MPS trace (1st trace) and after 20 minutes incubation of respective treatment (2nd trace). 
Preparations were continuously stimulated at 0.1Hz stimulation frequency during 20 minutes 
incubation period. A: dimethoate (1mM), B; cyclohexanone (1mM), C; omethoate (100µM), 
D; cyclohexanol (5mM), E; Omethoate and cyclohexanol, F; dimethoate, omethoate, 
cyclohexanone and cyclohexanol (DOCC).   Note that the twitch tension amplitude 
facilitation is relatively increased in combination of omethoate and cyclohexanol treated 












Fig 3.23: Comparison of twitch potentiation with different combinations of the 
pesticide components. A: Change in twitch amplitude over 20 minute (incubation period) 
after treatment at 0.1Hz stimulation frequency. Each point represent mean (n = 3 muscles  in 
each treatment). B; Twitch amplitude % change after 20 minutes incubation with treatment.  
(Twitch amplitude% was calculated as a percentage of subsequent twitch amplitude from the 
first twitch amplitude (Control MPS)). Note that the combination of omethoate and 
cyclohexanol produces considerable increases in twitch amplitude compared to other 
treatments.  Each bar represents mean  ± SEM (n = 3 muscles  in each treatment group) (p > 























































Fig 3.24: Traces of twitch tension at low stimulation frequency (1Hz & 2Hz) with 
different combination of pesticide components. A; Hepes MPS, B; dimethoate (1mM), C; 
omethoate (100µM), D; cyclohexanone (1mM), E; cyclohexanol (5mM), F; omethoate and 
cyclohexanol, G; dimethoate, omethoate, cyclohexanone and cyclohexanol (DOCC). Note 
that the summation of repetitive stimulation response along with the base line shift is evident 












Fig 3.25: Temporal summation and tetani (10Hz) with different treatments. A; Hepes 
MPS, B; dimethoate (1mM), C; omethoate (100µM), D; cyclohexanone (1mM), E; 
cyclohexanol (5mM), F; omethoate and cyclohexanol, G; dimethoate, omethoate, 
cyclohexanone and cyclohexanol (DOCC). Note incomplete fusion at this frequency in all 
(C, E, F and G) but B and D compared to Hepes MPS (A). The most complete fusion at this 
frequency was observed with omethoate + cyclohexanol (trace F) and not DOCC (trace G), 













Fig 3.26: Tetanic tension responses to repetitive stimulation 40 stimuli at 50Hz with 
different combinations of pesticide / metabolites components. The resonses to each 
treatment (red line) is shown for comparison with a control trace (Hepes MPS, 50Hz 40 
stimuli - black line) obtained before adding the compound indicated. A: dimethoate (1mM), 
B; cyclohexanone (1mM), C; omethoate (100µM), D; cyclohexanol (5mM), E; omethoate 
and cyclohexanol, F; dimethoate, omethoate, cyclohexanone and cyclohexanol (DOCC). 
Note the prolonged after contraction that continued after a 50Hz stimuli train compared with 
control traces in panel C, E and F. Interestingly, the prolonged after contraction observed in 
the presence of omethoate and cyclohexanol (panel E) were reduced in duration when all 










Fig 3.27: comparison of 50Hz tetanic tension decay time (relaxation) with omethoate, 
Omethoate and cyclohexanol, and dimethoate, omethoate, cyclohexanone and 
cyclohexanol. A: 10% decay of the tetanic contraction, B; 50% decay of the tetanic 
contraction, C; 90% decay of the tetanic contraction. Note that the maximum decay of the 
tetanic contraction is produced by omethoate and cyclohexanol combination while DOCC 
produced the minimum. Each bar represents mean  ± SEM (n = 3 muscles per each treatment 































































Fig 3.28: Comparison of direct and indirect tetanic tension (50Hz stimulation) in the 
presence of omethoate (100µM). Indirect stimulation produced a prolonged contraction 
with delay in relaxation, while direct stimulation (with d-tubocurarine) produced a rapid 
relaxation. This shows the involvement of ACh and post synaptic receptors in producing 
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Experiment Major Findings 
EPP and MEPP recordings in samples treated 
with minipig plasma and neostigmine 
Neostigmine treatment (positive control) significantly prolonged the decay time course of the EPPs and 
MEPPs (p < 0.05) 
Both pesticide plasma and dimethoate plasma treatments also significantly prolonged the decay time of EPPs 
(p < 0.05) consistent with AChE inhibition 
Neither Hepes MPS nor control plasma prolonged the decay time course of EPPs /MEPPs (p > 0.05) 
Pesticide plasma significantly increase spontaneous transmitter release (MEPP frequency) (p < 0.05) 
In addition pesticide plasma also produced reversible evoked transmission block (5/6 experiments)  
EPP and MEPP recordings in samples treated 
with individual components of pesticide 
(dimethoate Ec) and their metabolites, either 
singly or in combination 
Omethoate and cyclohexanol produced significant prolongation of EPP decay either singly or in combination 
(p < 0.05). However, combination of all four components and their metabolites (dimethoate, omethoate, 
cyclohexanone and cyclohexanol) yielded the longest EPP decay time  
Cumulative dose response curves indicated that low concentrations (µM) of omethoate have greater effects on 
EPP decay time, while dimethoate required higher concentrations (mM) for similar effects  
High frequency 50Hz stimulation produced tonic prolonged depolarization in omethoate, omethoate 
+cyclohexanol and DOCC treated preparations (p < 0.05)  
AChE activity in muscle samples 100µM omethoate completely inhibited the AChE activity in muscle homogenates. Cyclohexanol (5mM) 
produced partial but significant inhibition of AChE (p < 0.05). Thus prolongation of EPP decay in omethoate 
+ cyclohexanol cannot be explained by additive effects on AChE inhibition 
Isometric contraction measurements in samples 
treated with individual components of the 
pesticide and their metabolites 
Pesticide components and their metabolites either singly or in combination did not produce significant 








Intermediate syndrome in OP pesticide poisoned human patients is a progressive muscle 
paralysis most notable in proximal muscles including respiratory and neck muscles.  This 
muscle paralysis has a delayed onset compared to the “cholinergic crisis” observed soon 
after ingestion of OP pesticides. The mechanism underlying this respiratory muscle paralysis 
is hypothesised to be failure of synaptic transmission at the NMJ. Therefore the main 
objective of this chapter was to evaluate this hypothesis and to understand how pesticide 
components and their metabolites act on neuromuscular synaptic transmission, then to 
identify how these individual components either alone or in combination might contribute 
towards the failure of NMJ synaptic transmission. Hence, I hypothesised that neuromuscular 
transmission failure (i.e. respiratory paralysis) present in pesticide poisoned human patients 
is due to the combinatorial effects of both anticholinesterase and solvent. This was tested in 
this Chapter using different approaches including cellular responses (MEPP and EPP) and 
functional responses (twitch and tetanic muscle tension). I obtained substantial evidence to 
demonstrate that not only anticholinesterase compounds (dimethoate and its metabolite 
omethoate), but also the organic solvent (cyclohexanone and its metabolite cyclohexanol) are 
responsible for the observed alterations in NMJ synaptic transmission. I have also shown that 
compared to the parent components of dimethoate Ec (dimethoate and cyclohexanone), its 
metabolites (omethoate and cyclohexanol) produce effects at a substantially lower 
concentration, suggesting a more potent effects on NMJ synaptic transmission.  
3.4.1 Pesticide plasma increases the time course of the synaptic transmission at the 
NMJ, and also produces reversible evoked transmission block 
First, I tested my hypothesis using minipig plasma obtained from pigs treated with either 
dimethoate alone, commercial pesticide or saline. Use of minipig plasma instead of 
commercial pesticide was advantageous as plasma contained not only the parent compounds, 
but also its metabolites, at conceentrations that had been shown to cause NMJ failure 
(Eddleston et al., 2012).  
My results with plasma treated nerve muscle samples show that control plasma has no 
effects on synaptic transmission. Neostigmine, as a positive control confirmed the classic 
anticholinesterase effects showing elongation of the decay phase of synaptic transmission of 
both MEPPs and EPPs (Blaber and Christ, 1967; Katz and Miledi, 1973; Kordas, 1977; 





to neostigmine in terms of increase decay time, suggesting the anticholinesterase effects. 
However the increment of decay time facilitation with treated plasma (dimethoate and 
pesticide) was not as great as with a low dose of neostigmine. This confounding effect could 
be due to; a) anticholinesterase activity is lower than expected in the sample, b) some of the 
molecules of anticholinesterases are bound to other molecules, or c) these samples 
(dimethoate and pesticide plasma) have a slow release mechanism of anticholinesterase 
molecules, i.e. OP; hence it is not available to act on the AChE enzyme (for example, some 
binding protein in plasma produce slow release) (For instance; lipid soluble OPs such as 
parathion tend to dissolved in body fat and release slowly to act upon acetylcholinesterase 
molecules). The possibility of a slow release mechanism is supported by the observation of 
the time taken to develop an increase in EPP decay time with different treatments. 
Neostigmine produced increase decay time within about 2 – 10 minutes of bath application, 
while dimethoate plasma and pesticide plasma took 30- 60 minutes and 2- 4 hrs respectively. 
However, even though pesticide plasma treated preparations had little effects on the time 
course of synaptic transmission, it eventually produced a complete evoked neuromuscular 
block.  
Reduction in peak amplitude of the both MEPP and EPP was noted with neostigmine, while 
dimethoate plasma-treated preparations showed an increase in peak amplitude of both 
MEPPs and EPPs. Some reports showed increase in MEPPs amplitude of 1.5 to 2 fold with 
neostigmine (Boyd and Martin, 1956; Blaber and Christ, 1967), but this subsequently 
declines to control level, suggesting possibly desensitization or weak antagonism such as 
channel block of AChRs by the accumulated neurotransmitter present in the synaptic cleft 
(Eccles and Mac, 1949; Fatt, 1954). Furthermore there is also evidence of unchanged MEPP 
amplitude with AChE inhibition by paraoxon (Laskowski and Dettbarn, 1979). On the other 
hand, lower concentrations such as 10-9 - 10-7M neostigmine, ambenonium and edrophonium 
increase the amplitude of EPPs by 0.5 - 2 fold (Blaber and Christ, 1967)while higher 
concentrations of neostigmine, physostigmine and edrophonium (>10µM) depress the 
increment of EPC amplitude (Albuquerque et al., 1988). I have used 10µM neostigmine in 
my experiments; therefore higher drug concentration might be a possible reason for observed 
amplitude reduction as in some of the previous reports (Albuquerque et al., 1988). 
I also, observed significant depolarization of the resting membrane potential in neostigmine 
treated samples. This may also have contributed to the reduction in EPP amplitude, due to a 
reduction in driving force required produce additive synaptic depolarization. Some research 





treatment (Kuba et al., 1974; Tiedt et al., 1978; Bois et al., 1980; Tattersall, 1990), while 
some showed evidence of dose dependent depolarization by anticholinesterases (Blaber and 
Christ, 1967; Laskowski and Dettbarn, 1979) followed by spontaneous repolarization of the 
membrane potential (Meshul et al., 1985; Kawabuchi et al., 1991).  
In addition, pesticide plasma also produced a significant increase in MEPP frequency 
suggesting increase in spontaneous release activity of neurotransmitter from presynaptic 
terminals. However, there were no discernible effects of any of the other treatments 
(neostigmine, control plasma and dimethoate plasma) suggesting this could be either due to a 
synergistic effect of anticholinesterase and solvent or solvent alone. It has previously been 
shown that frog muscle (Fatt and Katz, 1951) or rat diaphragm (Liley, 1956) treated with 
1µM prostigmine showed no change in spontaneous transmitter release. However subsequent 
studies reports that micromolar concentrations of anticholinesterase stimulate spontaneous 
release (Blaber and Christ, 1967; Laskowski and Dettbarn, 1975; Bois et al., 1980)). It has 
also been suggested that MEPP frequency increases as a result of AChE inhibition and not 
through direct action of the drug on presynaptic terminal (such as action on potassium ion 
channels), as MEPP frequency increment was reversed using an AChE reactivator 2-PAM 
(Laskowski and Dettbarn, 1979). Hubbard et al (1968) showed that changing Ca2+ and Mg2+ 
concentration alters the MEPP frequency in mammalian preparation. However, if any 
compound acts directly on the mechanisms of spontaneous transmitter release at presynaptic 
terminal, it should not be affected by the altered Ca2+ and Mg2+ ion concentration of bathing 
medium. There is also evidence for inhibitory effects of AChE inhibitors on spontaneous 
transmitter release at frog NMJ (Duncan and Publicover, 1979). The authors showed that 
reduced Ca2+ entry into the presynaptic terminal causes a decrease in both spontaneous and 
evoked release. Even though, there is some evidence in the literature for increase MEPP 
frequency with anticholinesterase, I suggest that my results showing an increase MEPP 
frequency with pesticide plasma are more likely to be due to synergistic effects, of 
anticholinesterase and solvent or solvent alone, as dimethoate plasma has no effects on 
MEPP frequency. 
More interestingly, my results suggested an evoked transmission block with pesticide plasma 
treated preparations after 2 – 4hrs post treatment, with failure to produce an EPP upon nerve 
stimulation (with intact MEPP). In previous reports it was noted a curare-like depression 
occurs with anticholinesterase-treated preparations (Eccles and Mac, 1949), and evidence for 
depolarizing effects with treatments were also documented (Nastuk and Alexander, 1954; 





block effects of ambenonium and methoxyambenonium (anticholinesterases used to 
antagonized muscle relaxation) (Blaber 1960). In addition, irreversible neuromuscular block 
was observed with millimolar concentrations of paraoxon (Laskowski and Dettbarn, 1979). 
Surprisingly, however, when I treated FDB nerve-muscle preparations with a combination of 
dimethoate, omethoate, cyclohexanone and cyclohexanol at similar concentrations to known 
present in minipig plasma, I did not see any evoked transmission block. Since control plasma 
did not produce an evoked transmission block, I would suggest that pesticide plasma 
contains components other than dimethoate, omethoate, cyclohexanone and cyclohexanol 
that might have contributed to the observed transmission obstruction. 
In pesticide poisoned patients, progressive respiratory failure, which has later onset (24 – 72 
hrs post poisoning) and lasts up to several weeks, is the primary feature of the intermediate 
syndrome. However, reported transmission block with AChE inhibition, does not provide 
sufficient direct evidence for progressive neuromuscular transmission failure as a cause of 
muscle weakness. Moreover, available evidence on irreversible NMJ transmission failure 
caused by paraoxon (active form of parathion anticholinesterase) occurs at higher 
concentrations of this compound (millimolar). However, in human pesticide poisoned 
patients with respiratory paralysis, the plasma concentration of OP pesticide (active 
component) is around micromolar (5 - 100µM) (Eddleston et al., 2005; Eddleston et al., 
2008; Eddleston et al., 2012). Pesticide absorption from the gut, metabolism in the liver and 
diffusion in-to the neuromuscular junction might have major contributions to this latter onset 
and progressive respiratory paralysis in humans. Furthermore, excretion of the pesticide via 
urine might also influence the final plasma concentration. Moreover, pesticide contains not 
only anticholinesterase, but other components such as solvent and surfactant, the synergistic 
action of these compounds and their metabolites might influence the final outcome of 
respiratory paralysis in human patients. Finally, hyperactivity of respiratory muscles during 
cholinergic syndrome due to hypoxia might also have acted as a user dependent block on 
development of respiratory paralysis.  
Although I did not observe a neuromuscular transmission block with combination of 
dimethoate, omethoate, cyclohexanone and cyclohexanol (DOCC) in-vitro, reversible 
evoked transmission block was noted with the pesticide plasma experiments. This is most 
likely to be due to synergistic action of anticholinesterases, solvent and other components 
present in the minipig plasma. This synergistic action is also supported by the evidence 
shown in the minipig model of OP toxicity, as dimethoate alone did not produce any failure 





transmission block (failure in mechanomyography, 12 hrs post poisoning) (Eddleston et al., 
2012). This study also showed that there is no neuromuscular transmission block observed 
with minipigs treated with solvent alone, suggesting this transmission failure is more likely 
to be due to synergistic action of anticholinesterase and solvent. 
3.4.2 Metabolic breakdown products of dimethoate Ec is more potent than their parent 
constituents 
Next I investigated how the individual components of pesticide alone or in combination 
acted on the synaptic transmission at the NMJ.   
The increased half decay time of EPPs evident at 1Hz with both dimethoate and omethoate is 
quite consistent with their known anticholinesterase activity. However, the observed 
increment in half decay time of EPPs of cyclohexanol treated preparations is most likely to 
be a result of complex mechanism other than inhibition of cholinesterase activity.  The 
rationale behind this speculation comes from the additive effects on half decay time with 
combination of omethoate and cyclohexanol.  The AChE activity in muscle homogenates 
treated with either omethoate or cyclohexanol has shown that 100µM omethoate produced 
99% inactivation of AChE (Fig. 3.13). Although cyclohexanol (5mM) alone produced 25 – 
30% inactivation of AChE enzyme, if cyclohexanol was to increase half decay time through 
anticholinesterase activity, I would not have observed any additive effects when combined 
both together, because by 100µM omethoate would inhibited almost all the AChE enzymes 
in the sample. Therefore this suggests a more complex mechanism of action by cyclohexanol 
on NMJ. For instance, the effects could be similar to those reported for ethanol on mouse 
NMJ, which enhances synaptic transmission at the NMJ via its action on nicotinic ACh 
receptors. Ethanol increases the open channel time of the receptors. In addition ethanol 
potentiates neurotransmitter release, mediated by inhibition of the delayed rectifier 
potassium currents at the presynaptic terminal.  
The observed reduction in peak amplitude with dimethoate (1mM) and omethoate (100µM) 
tallies with the previous literature as it has shown that higher concentrations of neostigmine, 
physostigmine and edrophonium (>10µM) depress the increment of EPC amplitude 
(Albuquerque et al., 1988). Inhibition of AChE results in accumulation of ACh molecules in 
the synaptic cleft, thereby triggering activation of the AChRs repeatedly. This will lead to 
reduction in the probability of post-synaptic membrane mediator (ACh) sensitivity, i.e. 





with acetylcholinesterase inhibition (Katz and Miledi, 1977; Wray, 1981; Akaike et al., 
1984; Shaw et al., 1985; Sherby et al., 1985) including evidence of NMJ transmission failure 
via desensitization of the post synaptic nicotinic receptors is well documented (Katz and 
Thesleff, 1957a; Thesleff, 1959; Katz and Miledi, 1973; Akasu and Karczmar, 1980; 
Giniatullin et al., 1997; Giniatullin and Magazanik, 1998). More surprisingly, cyclohexanol 
treated samples also showed a significant reduction in peak amplitude. Taken together, with 
the increased excitable threshold to produce an EPP from cyclohexanol treated preparations, 
I suggest that the EPP amplitude reduction may be due to a presynaptic mechanism of action, 
in addition to its post synaptic effects (such as desensitization of ACh receptors). Presynaptic 
effects could include, for example, effects on the nerve terminal currents (Ca2+ or K+), 
reducing exocytosis. Possible post synaptic involvement of cyclohexanol include modulation 
of passive membrane properties of muscle fibres such as changes in input resistance, action 
potential threshold etc. 
My cumulative dose response curves show that metabolites of both dimethoate and 
cyclohexanone have more potent effects on NMJ synaptic transmission, confirming previous 
observations of omethoate and cyclohexanol effects on NMJ synaptic transmission.  
In the reaction step of phosphorylation and inactivation of the AChE molecule, the X moiety 
is displaced from the phosphorus atom (OP compound) by a serine hydroxyl group (Fig 1.6). 
According to one view the kinetics of this reaction is determined by the X moiety (leaving 
group) (Sidell and Borak 1992). Both dimethoate and omethoate have the same X subgroup 
(thio-N-methylacetamide group) (Fig 1.7), therefore both of them should show same efficacy 
in inactivating the enzyme. However, phosphorothioate compounds (e.g. dimethoate) require 
bio-activation to their phosphate analogue (i.e.omethoate) in order to produce more efficient 
inactivation of the AChE enzyme. Therefore omethoate produces more potent effects at 
lower concentration on NMJ transmission compared to dimethoate. (See Lucier & Menzer, 
1970) 
On the other hand, the mechanism of increase potency of cyclohexanol compared to 
cyclohexanone on synaptic transmission at the NMJ is yet to be investigated, as there is no 







3.4.3 Omethoate and cyclohexanol produce synergistic effects on neuromuscular 
transmission 
Next I turned to investigating how activity might modulate the synaptic transmission in the 
presence of pesticide components.   
High frequency repetitive stimulation responses showed possible evidence on short term 
synaptic transmission depression (fig 3.21) and desensitization (fig 3.20) with DOCC treated 
preparations. It had also shown that the combination of omethoate and cyclohexanol 
produced more pronounced effects than these components alone. As I have mentioned 
earlier, muscle paralysis is more prominent in respiratory muscles of pesticide poisoned 
patients indicating possible influence of use dependent transmission block at NMJ in the 
presence of pesticide components. Therefore, results from high frequency repetitive 
stimulation could enable us in the future, not only to understand which components of 
pesticide are responsible of failure of synaptic transmission, but also constitute a simple in-
vitro, assay which could be used to test treatment of synaptic transmission failure at NMJ 
following OP pesticide poisoning in humans. 
Finally I have tested the hypothesis that the combination of omethoate and cyclohexanol 
produce synergistic effects on using a more functional aspect of NMJ synaptic transmission, 
namely nerve-evoked muscle contraction. 
Evidence of twitch amplitude observed with anticholinesterases (dimethoate, and omethoate 
and its combinations) treated preparations confirms the results from previous studies (Barnes 
and Duff, 1953) (see page 125 and fig 3.22 & 3.23). However, there are some discrepancies 
over tetanic tension responses with the treatments. Previous reports suggest that low doses of 
OP compounds produce depressed tetani at different frequencies depending on the muscle 
fibre types. Brimblecombe (1970b, a) showed that low doses of sarin applied to slow twitch 
muscle (soleus) caused depression of tetani at 60 Hz frequency, while fast twitch muscle 
(flexor hallucic longus / FHL) sustained the tetani until 150 Hz frequency. However higher 
doses of sarin produced depression of tetani at all frequencies (both FHL and soleus), while 
tetanic response waned rapidly to zero at higher frequencies. Yet, our findings did not show 
a depressed tetani even at higher frequencies. For this we may need to take into account the 
fact that FDB muscle may be a mixed muscle containing both fast and slow twitch muscle 
fibres which are also short in length. Nevertheless, I observed prolonged sustained 
contractions in omethoate (either alone or in combination) treated preparations. It is also 





(Barnes and Duff, 1953). Therefore it might be possible that the amount of AChE inhibition, 
together with the muscle fibre type, has a role to play in the discrepancies of tetanic 
responses I observed with my preparations. Consistent with the EPP data, the most 
significant alteration of muscle contraction was observed with the combination of omethoate 
and cyclohexanol. Surprisingly, DOCC produced less pronounced effects in muscle 
contraction compared to a combination of omethoate and cyclohexanol.  
Even though there are previous reports about the effect of anticholinesterase activity on NMJ 
synaptic transmission and muscle contraction, there is less information on the effects of 
organic solvents. It has been shown that reduced twitch and tetanic tension occurs at fast and 
slow muscles treated with ethanol in in-vitro preparations (Taylor et al., 1992; Pagala et al., 
1995). Similarly, high concentrations of ethanol depress NMJ contraction, while depression 
effects were inhibited faster when prostigmine administrated in to the sample (Etessami, 
1972). It was shown that reduced NMJ contraction is via decreases intracellular calcium-ion 
transients (Cofan et al., 2000).  Furthermore, dimethyl sulfoxide (DMSO) also reduces the 
muscle contraction (both twitch and tetanus) in dose dependent manner (Wali and Hayter, 
1988; Reid and Moody, 1994; Velasco et al., 2003). However, there is no evidence on 
reduced muscle function with cyclohexanone or cyclohexanol in experiments. Therefore it is 
essential to further examine the mechanism of action of both pre synaptic and post synaptic 
alterations produced by pesticide solvent either alone or in combination with 
anticholinesterases.   
Thus, I set to investigate further the synaptic mechanism using these pesticide components in 














Chapter 4: Further analysis of mechanisms of action of Dimethoate EC pesticide and 


















After initial characterization of the EPP properties, from the early 1950’s investigators began 
to explore the underlying current behaviour in neuromuscular preparations in response to 
anticholinesterases.  Voltage clamp recordings of endplate currents (EPC’s) in the presence 
of an anticholinesterase (eserine) were first described by the Takeuchi and Takeuchi (1959), 
who demonstrated a prolongation of both EPC rise time and half decay time. Kordas et al 
(1972; Kordas et al., 1975) showed that at higher concentrations of the anticholinesterases 
(eserine and prostigmine) EPC has complex decay kinetics since they could no longer can 
fitted by a single exponential function, compared to untreated preparations. Later, it was also 
shown that irreversible anticholinesterases such as OP compounds, also showed double-
exponential decay of EPC: as well as significant prolongation of decay (Pascuzzo et al., 
1984). Interestingly, Aguayo and Albuquerque (1986) also demonstrated a double 
exponential decay function when preparation treated with 1-phenyl-4-piperidino-
cyclohexanol. This raises the intriguing question whether cyclohexanol itself, the solvent 
metabolite of Dimethoate Ec, might also have complex effects on the decay time of EPCs.    
Initial evidence of effects on passive membrane properties with anticholinesterase (non OP) 
was first reported by Blaber (1972), who described no discernible effects on input resistance 
or equilibrium potential in edrophonium-treated preparations. However, later reports on the 
effects of the OP compound ecothiopate showed reduction in the input resistance of muscle 
fibres (Kelly and Ferry, 1994). 
The basic physiological mechanism of neurotransmitter release (that is, the quantal nature of 
neuromuscular transmission) was first established by Katz and his colleagues in the 1950s’ 
are who made the first intracellular microelectrode recordings of MEPPs and EPPs (Fatt and 
Katz, 1951; Del Castillo and Katz, 1954, 1956). Since then, effects of anticholinesterase (OP 
and non OP compounds) treatment on both spontaneous and evoked transmitter release from 
presynaptic terminals of neuromuscular junction have been described (Straughan, 1960; 
Laskowski and Dettbarn, 1975). However, the non-linearity of EPP responses (McLachlan 
and Martin, 1981), argues for use of EPC to estimate quantal contents because EPCs are 
evoked at a constant membrane potential, thus the driving force is constant and the 
magnitude of the EPCs is directly proportional to the quantal content.  
In the previous Chapter, I evaluated the change in EPP and MEPP characteristics with 
pesticide components and their metabolites, either singly or in combination, and their 





omethoate and cyclohexanol produced greater effects at a substancially lower concentration 
at both cellular and functional levels compared with their respective parent compounds 
dimethoate and cyclohexanone.  In addition to the anticholinesterase effects I observed with 
omethoate, I detected significant effects with cyclohexanol including prolongation of EPP 
decay, changes in the excitability of nerve, and synergistic effects in combination with 
omethoate on both EPPs and muscle contractions.  In order to understand better the 
mechanisms underlying these combined effects of omethoate and cyclohexanol, I turned my 
attention to the effects of these compounds on the underlying endplate currents.  
First, however I asked whether these compounds have any effects on passive membrane 
properties of the muscle fibres. Changes in excitability (action potential threshold and 
current required to produce an action potential) of the muscle fibre along with the passive 
membrane properties (input resistance and capacitance) would give rise to a plausible 
explanation for some of the observed EPP and tension record characteristics described in the 
previous chapter.  Secondly, I asked whether EPC in the presence of omethoate or 
cyclohexanol (either singly or in combination) have similar physiological characteristics to 
those I observed for EPPs. Thirdly, I sought to measure neurotransmitter release (quantal 
content) from presynaptic terminals in omethoate and cyclohexanol-treated preparations. For 
this I used both direct and variance methods of quantal analysis (See General Introduction). 
Lastly, I have also attempted to explain the unexpected effects of cyclohexanol, including 
possible effects on presynaptic currents and ACh transport into synaptic vesicles.    
4.2 Methods 
The following methods are specific to this chapter. For general methods and chemicals, refer 
to Chapter 2.  
Base line recordings for all the experiments were carried out in Hepes MPS at room 
temperature unless otherwise stated on specific occasions. The majority of my experiments 
were carried out using intercostal nerve-trangularis sterni (TS) muscle preparations, however 
in some occations tibial nerve, FDB muscle preparations were also used (quantal analysis 
using the Variance method). 
4.2.1 Input resistance measurements 
Microelectrodes (Harvard apparatus / glass capillary tube, GC150F-15, 1.5 O.D. * 0.86 I.D.) 





Flaming / Brown micropipette puller. Recording electrodes were back filled with 4 – 5M 
potassium acetate solution and had microelectrode tip resistance of 30 – 50 MΩ. Current 
passing electrodes were back filled with 3M KCl solution and had microelectrode tip 
resistance of 5 – 10 MΩ. Single muscle fibres were identified with the use of upright 
microscope (Axioskop 2, 40X-W/0.75 numerical aperture water-immersion objective; Zeiss, 
Oberkochen, Germany). Voltage and current microelectrodes were mounted (Sutter 
instruments MP285 electric micromanipulators) and tips were separated 50 – 100 µM apart 
on impalement of muscle fibres at the endplate.  Voltage recording were obtained using a 
HS2A X 0.1H head stage connected to Axoclamp 2B amplifier while step currents were 
delivered to a HS2A X  1H head stage connected to the same amplifier. Signals were further 
amplified using Neurolog NL106 AC/DC amplifiers, low pass filtered at 3KHz (NL92) and 
then passed through a Humbug filter to eliminate 50 Hz main interference.  Then they were 
digitized (20KHz) in to a personal computer (DELL., USA) via Digidata 1322A (Axon 
instrument, USA) interface.  The cells were depolarized or hyperpolarized to a -70mV by 
passing constant current to standardize the measurement. In some instances, they were 
hyperpolarized to -90mV where none of the fast, voltage-sensitive Na channels in the muscle 
membrane are inactivated and the rate of rise of the action potential is maximal (Grampp et 
al., 1972; Harris and Marshall, 1973). A series of 100ms square wave current pulses were 
passed in 10nA steps to the muscle fibre via the current electrode and corresponding voltage 
displacement was recorded using Clampex software (pClamp 9 software; Axon instrument, 
USA).  The input resistance was calculated as the slope of the current-voltage (I-V) plot 
using the Clampfit program (pClamp9 software, Axon Instruments), in the region where the 
response were linear. Recordings with evidence of activation or inactivation of outward and 
inward rectifying potassium channels at large depolarization or hyperpolarization were 
excluded.   
4.2.1.1 Technical challenges with input resistance measurements 
Activation and inhibition of inwardly rectifying potassium channels influenced responses to 
step current injection, resulting in a non-linear relationship between current and voltage (Fig 
4.1 A,B). Another notable complication was a ragged response to depolarising current 
injection, perhaps partly due to asynchronous activation of delayed rectifying potassium 
currents. This was usually as a result of poor current-passing electrode characteristics. This 
also became problematic when I measure the action potential threshold (fig 4.1 C). This 






4.2.1.2 Sampling protocol for Input resistance measurements and time constant 
Base line recordings for input resistance measurements were made from 10 fibres 
(trangularis sterni muscle preparations) followed by adding respective drugs in to the bath to 
achieve the targeted drug concentration. Samples were incubated for 20 minutes to achieve 
equilibrium followed by further measurements of input resistance in 15 fibres, to evaluate 
the effects of treatment.  
4.2.2 Action potential threshold and amount of current required to produce an action 
potential 
Action potential threshold was defined as the voltage at the (Vt) inflexion/saddle point of the 
rising phase of the endplate potential - action potential complex, at the time T1 when the rate 
of the rise increased significantly to produce an overshoot of the action potential. The 
threshold current required to trigger an action potential in response to step currents, was 
recorded. (see inset fig 4.6A).  
4.2.3 EPC recording (Indirect stimulation) using two electrode voltage clamp (TEVC) 
Intercostal nerve, trangularis sterni muscle preparations were pre-treated with µ-CTX GIIIB 
to block muscle action potentials. Nerve – muscle preparations were then mounted in a 
Sylgard lined Petri dish / recording chamber which contained Hepes MPS at room 
temperature. Thin-walled glass microelectrodes (Harvard apparatus / glass capillary tube, 
GC150TF-10, 1.5mm O.D. X 1.17mm I.D.) for intracellular recordings were pulled using 
P87 Flaming / Brown micropipette puller and back filled with either 4 - 5M potassium 
acetate (KAc) (voltage electrode; tip resistance 5 - 15ΩM) or 3M potassium chloride (KCl) 
(current electrode; tip resistance 1 - 5ΩM).  Low impedance recording and current electrodes 
were crucial in achieving adequate voltage clamp as this helped to reduce noise and 
improved the voltage clamp frequency response. The intercostal nerve was positioned in 
suction electrode and connected PG 4000A digital stimulator (Cygnus technology, Inc., 
USA) for the simulation, which was driven by PClamp software via digidata 1322A 
interface. Single muscle fibres were impaled with both voltage and current electrodes at 
either side of an endplate with the separation of 50 – 100 µM. Accurate impalement was 
assisted by observing the tip through an upright microscope (Axioskop 2, 40X-W/0.75 
numerical aperture water-immersion objective; Zeiss, Oberkochen, Germany).  Voltage 





amplifier while feedback currents were applied using a HS-2A X1H head stage connected to 
an Axoclamp 2B amplifier.  A holding potential of -70mV was applied and maintained in 
voltage clamp mode. The gain of the voltage clamp amplifier was adjusted at every 
recording in an effort to achieve faithful clamp with a target of <10% escape from the 
unclamped voltage response, while preventing signal oscillation. The level of the MPS 
solution was also reduced to minimize the electrode – bath capacitive coupling, along with 
the shielding of the water-immersion optical lens above the meniscus with aluminium foil. 
Recordings were carried out at the room temperature (20 – 25 ºC) and bath temperature was 
monitored using digital thermostat. Recorded signals were also amplified using Neurolog 
NL106 AC/DC amplifiers, low pass filtered at 3 KHz (NL92) and then passed through a 
Humbug to eliminate 50 Hz interference.  Then they were digitized in to a personal computer 
via Digidata 1322A interface. Data acquisition and analysis was carried out using P Clamp 
software (pClamp 9 software; Axon instrument, USA). When analysing, recordings were 
filtered using Butterworth filters (Clampfit).  
4.2.3.1 Technical challenges with two electrode voltage clamp  
The primary challenge of the TEVC technique is to achieve effective voltage control, 
minimising voltage escape to less than 5 – 10% of the unclamped EPP response (fig 4.2).  At 
room temperatures (18 - 20°C), I was able to achieve fairly reliable voltage clamp according 
to this criterion. However, when the bath temperature exceeded more than about 20°C, for 
example during the summer months, I experienced several difficulties. Those included 
generation of substantially larger endplate currents with control conditions (Hepes MPS) 
compared to cooler days (18 - 20°C) (Stiles et al., 1999). As a consequence of the large 
endplate currents, achieving adequate voltage control became quite challenging. Base line 
noise level also became considerably higher with the increase gain settings required to 
voltage clamp amplifier  (fig 4.3). Therefore in some experiments, I cooled the bathing 
medium to less than 20°C. Mostly, I attempted to maintain good voltage control by adjusting 
the feedback gain without adding any oscillations to recordings.  
4.2.3.2 Sampling protocol for two electrode voltage clamp measurements 
Baseline recording of EPCs and MEPCs were made from 3 – 5 muscle fibres (µ-CTX pre-
treated intercostal nerve / trangularis sterni nerve-muscle preparations) using the following 
protocol. First, MEPCs were recorded for 60sec. Then from the same fibre, EPCs at different 





added to the bath to achieve the targeted drug concentration. Further recordings from 10 – 15 
fibres were then carried out using the same protocol as above.  
4.2.4 Quantal analysis  
4.2.4.1 EPP responses 
In addition to the EPC analysis, I re examined EPP records I made from FDB. Quantal 
content measurements of were made using WinWCP software. Trains of 30 EPP recordings 
from each fibre were used for calculating quantal content using Variance method. Estimates 
from Direct method of quantal analysis (where it was possible to estimate the mean MEPPs 
amplitude) were used to compare the variance method values.  
EPP recordings are subject to non-linear summation when the quantal content is relatively 
high (McLachlan and Martin, 1981). The McLachlan - Martin equation corrects EPP 
amplitude using the equation V’ = V/ (1-f.V/E) equation (V’ = corrected amplitude, V= 
recorded amplitude, f=”fudge” (correction) factor, E = difference between the resting 
membrane potential and the reversal potential for the action of ACh at its receptor).   
The correction is incorporated in to WinWCP and I applied it with a reversal potential of -
10mV and f factor of 0.3. This gave a good empirical agreement with the direct, variance and 
failures method when quantal content was reduced in MPS contained low Ca2+ / high Mg2+ 
(R Brown PhD thesis).  
4.2.4.2 EPC responses 
I also measured quantal content from EPC recordings in TS preparations using the Direct 
Method of quantal analysis. Both amplitude and the area under curve (total charge) of 
spontaneous MEPC and evoked EPC analysed using Clampfit (pClamp software 9, Axon 
instrument, USA). If the decay time constant (τ) of MEPC recording differed from EPC 
recordings, then total charge was utilised. Otherwise, the ratio of the amplitude 
measurements was used to determine the quantal content. Endplate currents are not subjected 
to non-linear summation due to constant membrane voltage; therefore correction of EPC 







4.2.5 Focal extracellular recording / nerve terminal currents 
Preliminary nerve terminal current recordings were obtained from TS nerve muscle 
preparation during a visit to Rutgers New Jersey Medical School, USA with the help of Dr. 
V. Patel and Prof. J. McArdle.  Focal macropatch electrodes were pulled and back filled with 
Hepes MPS. The preparation was pre-treated with TRITC-α-bungarotoxin (30nM) to block 
muscle contraction and facilitate identification of the endplate under a fluorescence 
microscope (Patel et al., 2014). The patch electrode was manipulated above the identified 
NMJ and trains of 100 stimuli delivered at 1Hz using via stimulation of the intercostal nerve. 
Nerve terminal currents were recorded via Axoclamp 2B amplifier and analysed using 





















Fig 4.1: Sample traces showing different voltage responses to current injection. A: 
inactivation of inward rectifying potassium channels produces substantial amount of 
hyperpolarization (t2) resulting in a non-linear current – voltage relationship (T1 and T2 are 
two sampling points for current – voltage relationship), B; graph showing the current-voltage 
relationship for the traces in A at different time points, i.e, T1 & T2.  C; Poor current passing 
electrode characteristics resulted in sluggish action potentials with large step currents, with 
poor demarcation of threshold and action potential. In Traces A & C, lower panel indicate 













Fig 4.2: Voltage clamp circuitry and characteristics of the endplate currents. A: 
Diagrammatic illustration of the differences in circuitry in recording of voltage response to 
direct injection of current and two electrode current recording (Two electrode voltage clamp) 
(S indicate the stimulation), B; Voltage response to a step current injection (lower traces 
represent the injected current and upper traces represent the resulting voltage) C; analysis of 
the endplate currents (Top trace demonstrate the voltage escape and bottom trace 
demonstrate the current. The time of the stimulation was displayed by the stimulus artefact 
appear at the beginning of the both traces. The measured parameters of the current include; 
peak amplitude, latency (time between the stimulus and the beginning of the response) and 
rise time. Decay time was analysed as Tau (Ʈ), i.e. the time for the EPC amplitude to decay 
37% of its original value or T90, time for the EPC amplitude to decay 90% of its original 






















Fig 4.3: Effectiveness of two electrode voltage clamp. A: TECV trace at 18°C (voltage 
escape is less than 10% from the original value), B; TECV trace at 25°C (note that the 
substantial production of current compared to trace A. Superimposed traces in B indicate the 
clamping of the voltage with different gain settings. Note the unclamp mode (current clamp) 
with red colour active trace and the amount of reduction in voltage escape with higher gain 
settings in voltage clamp mode. C; TECV trace at 25°C (voltage clamp is 10 – 15 % from 
the original value), D; TECV trace at 25°C (voltage clamp is less than 10 % from the 
original value – but note the oscillation of the currents caused by a high gain settings of the 
feedback amplifier. It was not possible using the phase lag control on the Axoclamp B 
amplifier to compensate for this without further loss of voltage control), E; effective voltage 
clamp recording MEPC at 18°C. Note the two vertical panels indicate the switching between 
current clamp and voltage clamp mode. Scale bars on trace D represent all the traces from A 

















4.3.1 Neither pesticide nor metabolic breakdown products changes the passive 
membrane properties of the muscle fibre. 
The primary objective of this set of experiments was to examine whether any of the pesticide 
ingredients or their metabolites either singly or in combination alters the passive membrane 
properties of the muscle fibres. Change in passive membrane properties would affect the 
magnitude of the endplate potential and would also change the time course of the response of 
membrane potential after DC current injection.  
The data revealed that neither pesticide nor their metabolites change the input resistance of 
the muscle fibre (MPS: 0.31±0.09MΩ, dimethoate; 0.23±0.04 MΩ, cyclohexanone; 
0.33±0.09 MΩ, omethoate; 0.30±0.11 MΩ, cyclohexanol; 0.29±0.05 MΩ, omethoate + 
cyclohexanol; 0.32±0.09 MΩ, DOCC; 0.29±0.06 MΩ, mean ± SEM, P > 0.05, ANOVA, “F 
= 0.5”, n = 3 muscles per each treatment group) (fig 4.4). Assuming muscle fibre diameter 
was relatively constant for all the experiments, I concluded that none of these treatments 
changed the specific membrane resistance (i.e. the general leakiness of the muscle fibre 
membrane).   
Next, I measured the time constant of the voltage response by calculating the 84% of the 
time taken to produce steady state voltage response after injecting step current. As discussed 
in Chapter 1, membrane time constant is a product of input resistance and input capacitance 
of the muscle fibres. This determines the time it takes membrane potential to change in 
response to a step injection of current. The results showed that none of the treatments altered 
the time constant. Taken together with the Rin measurements, this  supports that there were 
no effect of the components on the membrane capacitance either (Ʈ) MPS: 4.79±0.64ms, 
dimethoate; 5.21±0.56 ms, cyclohexanone; 4.45±0.77 ms, omethoate; 5.09±0.96 ms, 
cyclohexanol; 4.48±0.57 ms, omethoate + cyclohexanol; 4.25±0.54 ms, DOCC; 4.96±0.55 
ms, mean ± SEM, P > 0.05, ANOVA, “F = 1.33”) (fig 4.5). 
Next I examined the action potential threshold for each of the treatments. I wanted to 
establish whether these treatments had any direct effects on action potential initiation in the 
muscle fibres. If any of the treatments elevated the action potential threshold, then the 
probability of producing muscle action potential would become reduced, perhaps thereby 
contributing to overall failure of neuromuscular transmission. However, the data did not 





52.19±2.32mV, dimethoate; -53.23±2.11 mV, cyclohexanone; -51.24±1.69 mV, omethoate; -
51.36±1.87 mV, cyclohexanol; -49.69±5.18 mV, omethoate + cyclohexanol; -51.14±2.53 
mV, DOCC; -50.96±1.36 mV, mean ± SEM, P > 0.05, ANOVA, “F= 0.9”) (fig 4.6B). I also 
measured the currents required to produce an action potential with these treatments. Similar 
to measurements of the action potential threshold, none of the treatments treatments 
produced any changes in the magnitude of the current required to produce an action potential 
(MPS: 51.70±8.64nA, dimethoate; 65.88±3.11 nA, cyclohexanone; 53.85±5.67 nA, 
omethoate; 55.58±16.72 nA, cyclohexanol; 51.79±10.85 nA, omethoate + cyclohexanol; 
51.25±18.49 nA, DOCC; 61.02±12.65 mV, mean ± SEM, P > 0.05, ANOVA, “F = 0.1”) (fig 
4.6C). 
Therefore, from the data obtained it appears that pesticide components and their metabolites 
do not alter either the passive membrane properties or the voltage gated ion channels that 




















Fig 4.4: Input resistance of the muscle fibre. A: traces displaying production of voltage 
differences as a result of direct step currents injected to muscle fibre, B; current – voltage 
relationship in response to hyperpolarizing current injected (input resistance was measured 
as a slope function of current – voltage plot), Each point represent the voltage response to a 
step current in control condition. C; comparison of input resistance measurements under 
different treatments. Each bar represents mean  ± SEM (n = 3 muscles per each treatment 











Fig 4.5: Membrane time constant (Ʈ) with different treatments. A: measurement of 
membrane time constant with using voltage response produced to constant current (note that 
the 84% of the ΔVm represented by Ʈ), B; bar chart showing differences in Ʈ with pesticide 
components and its metabolites. Each bar represents mean  ± SEM (n = 5 muscles per each 




















Fig 4.6: Comparison of the action potential threshold and currents with different 
treatments. A: Traces showing generation of action potential and amount of current required 
(highlighted area is to display the action potential threshold level), B; different threshold 
values of action potential with pesticide components and its metabolites, C; the current 
requirement to produce action potentials with different treatments. Vt and Tt are the voltage 
and time at the inflexion points decides the threshold of the action potential (see page 153). 
















4.3.2 Omethoate prolonged EPCs 
In this set of experiments I aimed to understand how omethoate and cyclohexanol, either 
singly or in combination, act on synaptic currents.  
Data from TEVC recordings showed that omethoate produced significant prolongation of 
synaptic current decay time for both MEPC and EPC (Fig 4.7, 4.8, 4.9). Surprisingly, 
however cyclohexanol did not increase the decay time constant (MEPC - Hepes MPS: 
0.95±0.18ms, omethoate; 2.48±0.95ms, cyclohexanol: 0.68±0.40ms, omethoate + 
cyclohexanol; 1.94±0.25ms, mean ± SEM, P < 0.05, ANOVA, “F15.76”) (Fig 4.7, 4.8, 4.9). 
Peak amplitudes of the treated preparations were not significantly different compared to 
control (Hepes MPS: -2.47±0.74nA, omethoate; -2.50±0.39nA, cyclohexanol: -2.43±0.30nA, 
omethoate + cyclohexanol; -2.19±0.87nA, mean ± SEM, P > 0.05, ANOVA, “F = 0.02”) (fig 
4.9). 
 Analysis of the EPC showed no difference in peak amplitude with treatments either singly 
or in combination (Hepes MPS: -268.06±127.18nA, omethoate; -247.13±70.73nA, 
cyclohexanol: -320.24±58.74nA, omethoate + cyclohexanol; -273.42±98.41nA, mean ± 
SEM, P > 0.05, ANOVA, “F = 0.3”) (fig 4.10). However, the half decay time of the EPCs 
with different treatments showed significant prolongation with omethoate and combination 
of omethoate and cyclohexanol treated preparations (Hepes MPS: 0.69±0.07mS, omethoate; 
6.38±72.35mS, cyclohexanol: 0.83±0.05mS, omethoate + cyclohexanol; 4.53±0.78mS, mean 
± SEM, P < 0.05, ANOVA, “F = 18.45”)(fig 4.10). However the normalized area (unit 
integrative charge) measurements showed different patern of increment compared to half 
decay time increament. This is also showen in Fig. 4.11 comparing consecutive traces of 
single experiment for each treatment, demonstrating different decay kinetics in these 
preparations. Interestingly, when I attempted to fit exponential curves to the EPCs 
recordings, those in Hepes MPS showed single exponential decay, consistent with classical 
AChR kinetics (Kordas, 1972). However, both omethoate and cyclohexanol treated 
preparations required double exponential fits to their EPC decay time. Moreover, the 
combination of omethoate and cyclohexanol treated preparation EPCs sometimes required 
more than two exponentials to  fits to their decay time, suggesting decay time function of 
those treatments together are complex and independent from one another (fig 4.12).   
The last EPC in response to train of high frequency (50Hz) repetitive stimulation revealed a 
significant prolongation of the decay time with combination of omethoate and cyclohexanol 





pronounced effects of combination of omethoate and cyclohexanol in repetitive high 


























Fig 4.7: Comparison of MEPC traces with different treatments. A-a: Hepes MPS, B-b; 
cyclohexanol (5mM), C-c; omethoate (100µM), D-d; omethoate and cyclohexanol. A – D 
traces represent the MEPC over 10s time period while a – d represent single MEPC in each 
treatment. Note that the decrease MEPC amplitude in cyclohexanol treated preparations 
while, increase decay time in omethoate treated preparations. (Average MEPC trace was 
shown in the boxes).  A – D traces represent a slower time base and show the distribution of 


















Fig 4.8: Comparison of the example EPC traces with different treatments. A: Hepes 
MPS, B; omethoate (Note the increase yet complex decay phase in omethoate treated 
preparations), C; cyclohexanol, D; omethoate and cyclohexanol (interestingly, combination 
of two metabolites produced more prolonged decay phase than that of omethoate alone. 
However cyclohexanol alone did not prolong the decay phase, suggesting more complex 










Fig 4.9: Quantitative analysis of MEPC parameters with different treatments. 
Statistically significant increase in decay time constant was observed in omethoate treated 
preparation. Each bar represents mean  ± SEM [n (No of muscles):  Hepes MPS = 11, 
omethoate = 3, cyclohexanol = 5, omethoate and cyclohexanol = 3] (p < 0.05, ANOVA, 
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Fig 4.10: Qualitative analysis of EPC parameters with different treatments. Similar to 
MEPC, omethoate treated preparation shows an increase in half decay time. However, 
comparison of normalized area (unit integrative charge) (area/peak amplitude) measurements 
showed different pattern of increase compared to half decay time increment. Each bar 
represents mean  ± SEM [n (No of muscles):  Hepes MPS = 11, omethoate = 3, cyclohexanol 
= 5, omethoate and cyclohexanol = 3] (p < 0.05, ANOVA, Bonferroni post test-
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Fig 4.11: Traces (EPC) comparing time course of the treatments (10 consecutive traces 
from single experiment for each treatment). Sampling of EPCs were carried in every 8 – 
10 minutes. A: EPCs of cyclohexanol treated preparations, B; EPCs of omethoate treated 
preparations, C; EPCs of cyclohexanol and omethoate treated preparations. Downward arrow 
indicates the progression of time. Note that the cyclohexanol treatment does not increase the 
decay time of EPC, in the contrary omethoate treatement increase the time course 
substancially. There is also some evidence of desensitization in omethoate treated 










Fig 4.12: Exponential decay time fit with different treatments. A: Hepes MPS, B; 
omethoate, C; cyclohexanol, D; omethoate and cyclohexanol. Traces in B and D panels 
clearly demonstrate the multiple exponential fit to decay time. Trace C also shows slight 













Fig 4.13: Decay time of last EPC on 50Hz repetitive stimulation. A: Hepes MPS traces, 
B; omethoate traces, C; cyclohexanol traces, D; omethoate and cyclohexanol traces, E; 
qualitative analysis of half decay time of last EPC of trains of stimuli with different 
treatments.  Note the increase in half decay time when combination of omethoate and 
cyclohexanol were added to the preparation. Each bar represents mean  ± SEM [n (No of 
muscles):  Hepes MPS = 11, omethoate = 3, cyclohexanol = 5, omethoate and cyclohexanol 















4.3.3 Pesticide metabolites modulate transmitter release from the presynaptic terminal 
Since I observed complex post synaptic responses with high frequency repetitive stimulation 
with both EPP (Chapter 3) and EPC (fig 4.13), I also asked whether there might be 
presynaptic effects of pesticide components and their metabolites. First I evaluated the 
quantal content (amount of transmitter released during evoked responses) during trains of 
stimuli. I initially used EPP recordings from FDB muscle fibres treated with pesticide 
ingredients, either singly or in combination. Unfortunately, I could not quantify the data 
obtained in response to 50Hz stimuli because of complex nature of the response (see Chapter 
3). I therefore analysed 10Hz trains (this frequency is also close to the human respiratory 
muscle firing frequency). From the data (fig 4.14) I observed a slight reduction in quantal 
content in the presence of dimethoate, omethoate and cyclohexanol compared with Hepes 
MPS. However, the most surprising result was a significant reduction of quantal content 
when all the components of poisoned plasma were combined (Hepes MPS: 63.09±19.25 
quanta, dimethoate: 25.92±7.62 quanta, omethoate: 30±7.62 quanta, cyclohexanone: 
47.51±10.72 quanta, cyclohexanol: 20.86±4.25 quanta, omethoate and cyclohexanol 
13.96±7.61 quanta, dimethoate + omethoate + cyclohexanone + cyclohexanol: 8.09±2.8 
quanta, mean ± SEM, P < 0.05, ANOVA, “F = 9.96”).  
The main disadvantage of using the EPP to calculate quantal content is the effect of non-
linear summation, due to the changing driving force on EPP amplitude. Despite correction 
for non-linear summation (McLachlan and Martin, 1981), misleading values for quantal 
content (both over and under estimates) may still be obtained when comparing the 
pharmacological effects of different drug levels. It is therefore best practice to estimate 
quantal content from endplate currents obtained at a fixed membrane potential, when the 
driving force is always constant (assuming no significant escape from voltage control). 
Therefore, I further analysed the quantal content in the presence of omethoate and 
cyclohexanol either singly or in combination using the direct method of dividing EPC 
amplitude by MEPC amplitude.  
Under these conditions, I did not see a statistically significant change in quantal content with 
any of the treatments either singly or in combination (fig 4.15) MPS: 101.19±25.47 quanta, 
omethoate; 103.31±19.62 quanta, cyclohexanol; 125.29±13.68 quanta, omethoate and 
cyclohexanol; 121.42±6.01 quanta, mean ± SEM, P > 0.05, ANOVA, “F = 1.64”). Increase 






Fig 4.14: Comparison of quantal content estimated using EPPs with different 
combinations of the pesticide components in FDB preparations. CH-one, CH-ol, DOCC 
represent cyclohexanone, cyclohexanol and dimethoate, omethoate, cyclohexanone and 
cyclohexanol respectively. Each bar represents mean  ± SEM [n (No of muscles):  Hepes 
MPS = 18, dimethoate = 3, omethoate = 3, cyclohexanone = 3, cyclohexanol = 3, omethoate 
and cyclohexanol = 3, DOCC = 3] (p < 0.05, ANOVA, Bonferroni post test-treatements 
were compared with Hepes MPS). (Estimates were carried out using variance method of 


















































Fig 4.15: Comparison of quantal content estimated using EPCs with pesticide 
metabolites in TS preparations.  Each bar represents mean  ± SEM [n (No of muscles):  
Hepes MPS = 11, omethoate = 3, cyclohexanol = 5, omethoate and cyclohexanol = 3] (p > 












































4.3.4 Cyclohexanol has complex effects on presynaptic terminals. 
The slight reduction in MEPC amplitude along with slight increase in quantal content (EPC 
recordings) that I observed in the presence of cyclohexanol suggested to me that this 
component could be modulating transmitter release from presynaptic terminals. Therefore I 
examined more closely whether cyclohexanol reduces the quantal size (amount of transmitter 
in a single vesicle). One possible mechanism behind a reduced quantal size would be through 
depletion of the ACh content of synaptic vesicles, perhaps mediated by inhibition of 
transport into vesicles. This has previously observed in pharmacological inhibition of ACh 
vesicular transport using vesamicol (Prior et al., 1992), which is a derivative of cyclohexanol 
(Fig 4.16). In order to test this hypothesis, I recorded MEPCs in the presence of 
cyclohexanol immediately after indirect nerve stimulation (10Hz, for 1minute) in order to 
detect the stimulation effects (Searl et al., 1991). Qualitative analysis of the traces showed 
that reduction in MEPC amplitude with cyclohexanol after intermittent indirect stimulation 
(fig 4.17). This observation merits further investigations.  
Finally, to test for a direct effects of cyclohexanol on presynaptic currents, I made 
preliminary observations using focal current recordings (these experiments were carried out 
in Rutgers University – Newark, USA in Prof. J.J. McArdle’s lab). Qualitative data 
suggested there is a change in focal current waveform with cyclohexanol treated preparations 













Fig 4.16: Comparison of the structure of cyclohexanol and vesamicol. Note that the 
vesamicol is a derivative of cyclohexanol, both structures contain functional hydroxyl group 








































Fig 4.17: Vesicular depletion protocol with 5mM cyclohexanol. Note the reduction in 
MEPC amplitude after each cycle of acute stimulation. (Traces are from a single experiment 













Fig 4.18: comparison of nerve terminal current traces with Hepes MPS and 5mM 
cyclohexanol treated preparations. A: Hepes MPS, B; 5mM Cyclohexanol. Note the 








































As I have shown in Chapter 3, pesticide ingredients and their metabolic breakdown products 
have multiple effects on neuromuscular synaptic transmission. Therefore, the primary 
objective of this chapter was to carry out a more detailed and rigorous investigation of the 
mechanisms behind these alterations. As I have discussed in previous Chapters (1 & 3), the 
characteristic features of intermediate syndrome following organophosphorus pesticide 
poisoning in humans is the prolonged muscle weakness leading to muscle paralysis. 
However, I showed in Chapter 3 that acute exposure to pesticide ingredients and their 
metabolites led to prolonged nerve-evoked muscle contractions. Therefore, I felt it necessary 
to explore the possible mechanisms which affect the functional unit of muscle contraction 
and how this might contribute to muscle paralysis. At a cellular level, motor units comprise 
two main components, namely muscle fibres and the motor nerve terminals that innervate 
them. Therefore, I sought to examine first whether pesticide ingredients or their metabolic 
breakdown products change the passive membrane properties of the muscle fibres including 
input resistance, time constant and action potential threshold. I then turned my attention to 
properties of postsynaptic endplate currents, recorded under voltage clamp.  
Technical challenges faced during this part of study may have affected the quality of my 
observed results. These include, damage of the muscle fibres and quality of the TEVC. Low 
resistance recording and current passing electrodes tend to damage the muscle fibre when 
impaled, producing an inadequate seal between the electrode tip and the muscle fibre 
membrane, thereby allowing leakage of the ion in and out of the membrane. This could have 
affected the measurements input resistance and the time constant, as well as magnitude and 
stability of endplate currents. Another potential caveat is that inadequate voltage clamp 
affects the amplitude of the synaptic current (low gain of the amplitude with larger escape of 
membrane voltage).  On the other hand, minimum voltage escapes (higher gain of the 
amplifier) can lead to oscillations to the recorded current traces, which affect the time course 
of the waveform. Furthermore, the bathing medium temperature also affected the TEVC 
efficiency. Even though I replaced the bath solution often, heat generated from the 
surrounding equipment, including the microscope light source increased the bath medium 
temperature quickly. Therefore, in future using a perfusion system of chilled bathing 
medium may yield more reliable data.  
Notwithstanding the reservations noted above, I did not see any alterations in the passive 
membrane properties of the muscle fibre with any of the pesticide ingredients or metabolites, 





to effects at the neuromuscular junction alone. Thus, I moved on to examine neuromuscular 
transmission in more detail by examining both post synaptic and presynaptic mechanisms, 
including neurotransmitter release upon evoked stimulation. I observed that metabolic 
breakdown products of the pesticide ingredients have additive or synergestic effects on the 
properties of the neuromuscular junction. Of interest, a preliminary recording in 
cyclohexanol treated preparations appears to show similar effects to vesamicol on 
neuromuscular transmission. These observations need further detailed examination in order 
to validate my findings.  
4.4.1 Passive membrane properties are unaffected by the pesticide ingredients or their 
metabolic breakdown products. 
In addition to the anticholinesterase effects displayed by the dimethoate and omethoate I 
hypothesised that cyclohexanone and cyclohexanol might change the passive membrane 
properties, which could result in modifications of synaptic potentials. I tested this hypothesis 
by examining input resistance and membrane time constant of the muscle fibres. The 
reduced excitability of axons in the presence of cyclohexanol suggested that perhaps this 
compound might have a general effect on reducing membrane resistance, producing 
“leakier” muscle fibres. However I did not observe any change in input resistance or 
membrane time constant with any of the treatments. I also hypothesized that muscle 
paralysis in intermediate syndrome could be due to reduced capacity to initiate action 
potentials. I examined this possibility by measuring at action potential threshold. However, 
neither threshold stimulating current nor thresholds potential were changed in the presence 
of pesticide ingredients or their metabolic breakdown products. Previously it was reported 
that some anticholinesterases change input resistance of muscle fibres (Kelly and Ferry, 
1994), while others do not (Blaber, 1972). However, I could find no reports or evidence of 
solvent or its metabolites action on passive membrane properties. Therefore I concluded that 
the synaptic potential changes I observed are due to combinatorial effects of 
anticholinesterase activity and more direct action of all these ingredients on neuromuscular 
function.  
4.4.2 Pesticide metabolites produce complex effects on the post synaptic NMJ 
In order to understand the more complex effects of pesticide metabolites, described in the 
previous chapter, I set out to examine EPC characteristics with these compounds. The 





the number of channels (nicotinic ACh receptors) being activated. Furthermore, the time 
course of the endplate current depends on the time course of the conductance change caused 
by each quantum of ACh in addition to the time course of the release of quanta (Gage and 
Armstrong, 1968). Omethoate produced slow but relatively similar peak amplitude MEPC 
compared to Hepes MPS, while cyclohexanol produced fast, but relatively smaller size 
MEPC compared to those recorded in Hepes MPS. However, EPC characteristics differ from 
MEPC in cyclohexanol, which produced larger responses compared to Hepes MPS. 
Omethoate produced slow EPC requiring a double exponential fit to the decay time. This 
suggests that the time course of the conductance change has two different components 
consistent with direct action of omethoate on receptors, changing their gating kinetics.  
Cyclohexanol also had similar effects on the requirements for exponential fit, its decay time 
also needing a double exponential fit, although cyclohexanol did not prolong the overall time 
course of the decay. It has been shown that anticholinesterases have concentration-dependent 
effects on the MEPC/EPC.  Neostigmine, physostigmine and edrophonium at a concentration 
less than 10µM produced increases in EPC amplitude; while higher concentrations depressed 
the increment of EPC amplitude (Albuquerque et al., 1988). My results showing increased 
decay with omethoate confirming previous reports of anticholinesterase action on EPC decay 
(Takeuchi and Takeuchi, 1959; Gage and Armstrong, 1968; Kordas, 1972; Kordas et al., 
1975). It was observed previously that the nicotinic non-competitive antagonist meproadifen 
interacts with the closed ionic channel of the ACh receptor in its resting and activated but 
non-conducting state, and only slightly affects the open conformation of the ionic channel 
(Maleque et al., 1982). There is also a possible mode of action of pyridostigmine 
independent of AChE inhibition (Pascuzzo et al., 1984). These authors speculated that 
pyridostimine blocks AChR thus producing non-conducting intermediates and changes in the 
conductance properties of the activated channels. This observation was confirmed by the 
direct action of pyridostigmine on the receptor complex (Akaike et al., 1984). They showed 
that pyridostigmine reduced channel conductance with unaltered channel life time. They also 
indicate that a higher concentration, of the drug (200µM) induced irregular waves of bursting 
activity during the initial phase of the application and, subsequently, significantly reduced 
the frequency of channel opening, thus indicating the pyridostigmine reacts with the ACh 
receptor, and both alone or in combination with ACh, induced an altered, desensitized 
species of the nicotinic AChR-ion channel complex. Moreover it was reported that 
physotigmine interact directly with AChR and blocks its open conformation (Kuba et al., 
1974; Albuquerque et al., 1984; Albuquerque et al., 1985). It is also observed that higher 





channel complex thus altering the gating kinetics and subsequently blocking the ACh 
receptor (Fiekers, 1985). Neostigmine and pyridostigmine act mainly as partial agonists, 
while physotigmine is mostly an inhibitor of the channel in the activated receptor 
conformation. These drugs bind to ACh recognition sites and to sites at the ionic channel as 
non-competitive blockers of the AChR.  
Several studies have showed responses to conformational changes of AChR with 
anticholinesterase drugs. These include decreased channel conductance and prolonged 
channel life time (Akaike et al., 1984; Albuquerque et al., 1984; Pascuzzo et al., 1984). Also 
it is reported that direct interaction of physostigmine with nAChR blocks the ionic channel in 
its open conformation with a concomitant decrease of conductance and open time of the 
channel activation, while VX (nerve gas) only showed the shortening of open time with 
unaltered conductance (Albuquerque et al., 1985; Shaw et al., 1985).   
These observations of receptor gating modulations with different anticholinesterase might 
contribute to the explanation of observed double exponential decay with omethoate in my 
experiments. However, there are few reports on the action of cyclohexanol with nAChR, 
except Aguayo and Albuquerque (1986), who demonstrated a double exponential decay 
function with 1-phenyl-4-piperidino-cyclohexanol treated preparations. Some reports suggest 
the cyclohexanol analogue vesamicol possess anticholinesterase activity on frog NMJ (Van 
der Kloot, 1986). However, cyclohexanol did not produced significant prolongation of 
MEPC/EPC decay in my experiments. Nevertheless further experiments such as ACh 
iontophoresis in isolated single muscle fibres and patch clamp recordings of single channels 
are needed to understand the action of cyclohexanol on the nAChR.   
4.4.3 Modulation of transmitter release from presynaptic terminal is complex in the 
presence of pesticide components 
 When quantal content was calculated from EPPs I observed a reduction in omethoate and 
cyclohexanol treated preparations, either singly or in combination. But, quantal content was 
unaffected when I use EPCs for the calculations. Non-linear summation effects on the EPPs, 
might have affected the final calculations of quantal content. Moreover, the experiments in 
which the recorded EPPs were carried out using tibial nerve / FDB muscle preparations, 
while my EPC experiments were carried out on intercostal nerve / triangularis sterni muscle. 
Intriguingly, this observation was opposite to the effects observed in the EPP driven 





presynaptic terminals in the presence of these compounds (pesticide parent and metabolic 
compounds). 
Effects of anticholinesterases on evoked transmitter release have also been reported 
previously. Some studies have reported that evoked transmitter release with 
anticholinesterases shows a reduction in quantal content (Straughan, 1960; Potter, 1970; 
Laskowski and Dettbarn, 1975), while others reported there is no effect on quantal content 
(Blaber and Christ, 1967; Ferry and Marshall, 1971; Blaber, 1972). 
Quantal content (m) is determined by the number of quanta (n) released from the presynaptic 
terminal and the probability (p) of release of the quanta (m=np). Several factors including 
empty vesicles in the presynaptic terminal or changes in presynaptic currents could affect the 
probability of release thereby changing the quantal content in the presence of pesticide 
components. Another plausible hypothesis could be feedback mechanism from the 
accumulated ACh at synaptic cleft (due to anticholinesterase activity) exerted on the 
presynaptic terminal in order to minimise the amount of quanta release. It has been suggested 
that presynaptic nicotinic AChRs act as auto-receptors (Meir et al., 1999). This role was 
suggested by the evidence shown on effects of pharmacological modulation of these 
receptors at mammalian NMJ, showing these receptors have the ability to modulate 
transmitter release from the nerve terminal (Wessler et al., 1986; Wessler et al., 1992). 
Furthermore, some previous studies have also shown a reduction in quantal content with 
anticholinesterase treatment (Straughan, 1960; Potter, 1970; Laskowski and Dettbarn, 1975). 
Provan (1991) has shown the opposing effects on probability of transmitter release with 
different AChE inhibitors. They observed increase in m with increase p in tetrahydro-
aminoacridine (an anticholinesterase drug prescribed for patients with Alzheimer disease), 
while physostigmine showed a decrease in m with a decrease in p. However neostigmine 
caused an increase m with unchanged p, suggesting different mechanism of action for 
changes in quantal content with different anticholinesterases. Even though there is some 
evidence for anticholinesterase effects on neurotransmitter release, lack of information 
regarding the solvent and their metabolites action on transmitter release makes it more 








4.4.4 Cyclohexanol may exert vesamicol-like effects 
In addition to the anticholinesterase (dimethoate and omethoate) effects on NMJ 
transmission, the pesticide solvent (cyclohexanone) metabolite, cyclohexanol may have 
another, effect on neuromuscular transmission, reminiscent of the effects of vesamicol. (-)-
Vesamicol is a reversible, non-competitive inhibitor of the transport of ACh into synaptic 
vesicles (Whitton et al., 1986).  Searl et al (1991) showed that (-)-vesamicol has stimulation-
dependent effects on reducing MEPC mean amplitude and changes in the distribution of 
MEPC amplitude due to inhibition of vesicular filling with ACh. Similarly, my preliminary 
experiments with cyclohexanol also produced stimulation sensititve reductions in MEPC 
amplitude. This vesamicol-like effect requires further investigation.  
Examination of nerve terminal currents with cyclohexanol also showed a change in the 
characteristics of waveform compared to Hepes MPS. Previous reports on vesamicol action 
on perineural recordings also showed a inhibitory effects on nodal Na+ -channels (fig 4.19) 
(Pemberton et al., 1992).  Furthermore Naves & Van der Kloot (1996) reported that 
vesamicol action is more pronounced in the presence of anticholinesterase. Since I have seen 
more potent effects on modulation of NMJ synaptic transmission with the combination of 
omethoate and cyclohexanol together, the mechanism of action of cyclohexanol may be 
similar to that of vesamicol. Further detailed examination such as perineural recordings of 
presynaptic ion currents and detailed observation of pre stimulation and post stimulation 













Fig 4.19: Representative examples of nerve terminal cuurent waveforms recorded from 
a single impalement in the absence (a,b) and presence (c,d) of 100µM (-)-vesamicol. 
“Figure shows the first (a,c) and last (b,d) waveforms from a 6s period of 50Hz nerve 
stimulation. The numbers in (b), (c) and (d) give the amplitude of the two negative-going 
components of the waveform as a percentage of their amplitude in (a).” Figure and legends 












































Chapter 5: Use of an ex-vivo organ culture assay as a model of intermediate syndrome 

















In the previous two chapters, I characterized and explored the mechanisms by which 
pesticide components and their metabolites act on NMJ after acute exposure in-vitro. 
However, I did not see any neuromuscular transmission block and / or muscle paralysis in 
experiments utilising the pesticide components even after in vitro nerve-muscle preparations 
were treated with combinations of pesticide and its metabolites (Chapter 3 & 4) at  
concentrations similar to those present in IMS patients and the minipig model (Eddleston et 
al., 2012). This is puzzling but it suggests, perhaps, that in order for IMS to develop either 
other constituents of pesticide-poisoned plasma are required, or perhaps longer exposure to 
the components I investigated thus far is needed. Therefore, in this chapter I studied the 
effects of longer exposure to pesticide components and their metabolites in an attempt to 
mimic the conditions in which IMS develop. For this, I exploited the advantages of a 
relatively novel ex-vivo organ culture assay (Di Stefano et al., 2014; Brown et al., 2015). 
This comprised an isolated nerve-muscle preparation from FDB and lumbrical muscles 
maintained for up to 48 hrs in oxygenated MPS. These preparations undergo Wallerian 
degeneration of motor terminals and axons over this period, but the rate of this can be 
modified genetically and by administration of various compounds (Di Stefano et al., 2014; 
Brown et al., 2015).  
Wallerian degeneration is a process which taken place after nerve injury, which the distal 
part of the axon, separated from the neuron’s cell body, degenerates. This process occurs in 
both peripheral nervous system and central nervous system. It was first described by 
Augustus Waller in 1850, following severance of hypoglossal and glossopharyngeal nerves 
in frogs, cutting off the distal axons from their cell bodies. Since then, Wallerian 
degeneration has been studied in many aspects including neurodegenerative disorders in 
humans (Coleman and Freeman, 2010; Conforti et al., 2014). The discovery of Wlds 
(Wallerian-degeneration slow) spontaneous mutant mice has benefitted our understanding of 
the mechanisms of Wallerian degeneration (Lunn et al., 1989; Conforti et al., 2014).   It has 
also shown that there is a delay in synaptic degeneration about tenfold following axonal 
injury in homozygous Wlds young adult mice (Gillingwater and Ribchester, 2003). This 
finding enables Wlds mice to be used as a test bed for studying the mechanisms of Wallerian 
degeneration (Gillingwater et al., 2002). 
Wallerian degeneration is also associated with organophosphorus toxicity. 





that occurs weeks to months after exposure of certain OP compounds (Abou-Donia, 2003). 
Wohlsein et al (2012) have also shown that spontaneous degenerative 
polienecephalomyelopathy in parathion intoxicated feeder pigs is associated with Wallerian 
degeneration of ventral rootlets and neurogenic muscle atrophy of limb muscles which is 
more similar to pathological features seen in equine and human motor neuron disease. In 
contrast Kawabuchi et al (1991) have shown non Wallerian type axonal degeneration of the 
neuromuscular synapse after single exposure to a sub-lethal dose of OP in-vivo. Even though 
IMS is a delayed muscle paralysis, availability of reports on morphological examination of 
neuromuscular junction during the morbidity is rare. 
Since around 2000, mice transgenic for yellow fluorescent protein (YFP), (a variant of the 
jellyfish green fluorescent protein (GFP) in motor nerves have become available (Feng et al., 
2000), labelling both nerve terminal and axons. These were subsequently cross bred with 
Wlds mice to yield double mutations with fluorescent axons and motor terminals that were 
also protected by Wlds expression, and this has become more valuable resource for the 
studying morphological evidence of the degenerative process (Beirowski et al., 2004; 
Beirowski et al., 2005; Wong et al., 2009). These mice were originally generated using a 
modified thy 1 gene to promote expression of YFP (Caroni, 1997; Feng et al., 2000; 
Lichtman and Sanes, 2003).  
Previous research in our laboratory has shown that the time course of synaptic degeneration 
in vivo is delayed in WldS mice (Ribchester et al., 1995; Gillingwater et al., 2002; Bridge et 
al., 2009; Wong et al., 2009; Brown et al., 2015). These studies used thy1.2 YFP16 Wlds 
mice and demonstrated that homozygous Wlds mice have a longer time course of synaptic 
degeneration compared to heterozygous mice or wild type mice (fig 5.1, 5.2).  Recently our 
lab has developed an organotypic explant assay (ex-vivo), using homozygous thy1.2 YFP16 
Wlds mice to test for modulators of synaptic degeneration (Di Stefano et al., 2014; Brown et 
al., 2015). This novel organ culture system was established using tibial nerve - FDB muscle 
preparations and demonstrated the difference of the Wlds phenotype from wild-type 24-48hrs 
after overnight incubation at 32°C (Brown et al., 2015). This organ-culture system allows us 
not only to test the modulators of synaptic degeneration, but also to evaluate the effects and 
mechanisms of long term exposure to different compounds active on neuromuscular 
transmission, thus identifying and screening for efficacy of potential novel treatments.   
Therefore, the aims of my experiments in this chapter were first to explore the effects of 24hr 





this might reproduce effects of pesticide ingestion that give rise to IMS in humans. Next I 
utilize a paradigm for activity dependence test for these components on NMJ transmission. 
Finally, I asked whether synaptic degeneration might be triggered or enhanced by the 
extended exposure to pesticide ingredients and their metabolites.  
My results suggest that the isolated ex-vivo Wlds mouse nerve-muscle preparation may 























Fig 5.1: Motor nerve terminals are protected from Wallerian degeneration in Wlds 
mice. Conventional confocal microscopic images of distal tibial nerve axons (A–C) and 
neuromuscular junctions in deep lumbrical muscles (DL; D–F) three days after 
ipsilateral section of the sciatic nerve. Axons and nerve terminals are labelled via transgenic 
expression of YFP. Postsynaptic acetylcholine receptors were labelled with TRITC-α-
bungarotoxin to visualize motor endplates. Axons and motor nerve terminals degenerate 
rapidly in wild-type (+/+; A,D). Axons are protected in Wlds heterozygotes (B,E), which 
express about half the level of mutant protein compared with homozygotes, but motor nerve 
terminals are not. Both axons and nerve terminals are protected in Wlds homozygotes (C,F). 
The time course of synaptic degeneration (G) was measured by scoring the percentage of all 
endplates in whole mounts of DL muscles (about 250 fibres per muscle) that were ‘vacant’: 
that is, with no overlying YFP-positive terminal (as in D,E). Each point represents mean data 
from up to four lumbrical muscles from three to four mice (total number of axotomized 
lumbrical muscles examined D—33; E—56; F—29). Calibration bar: 50 µm. (Fig and 


























Fig 5.2: Time course of synapse withdrawal in 2-month-old Wlds mice. A, morphological 
data showing the time course of nerve terminal withdrawal in 2-month-old 
Wlds (homozygous) mice FDB muscles following axotomy. B, electrophysiological 
measurements of the time course of nerve terminal loss in 2-month-old Wlds mice FDB 
muscles following axotomy. C, morphological analysis of the incidence of endplate partial 
occupancy in 2-month-old Wlds mice FDB muscles following axotomy. D, 
electrophysiological analysis of the incidence of failures in response to nerve stimulation in 
2-month-old Wlds mice FDB muscle fibres following axotomy. For all panels, ▴ and ▾ 
represent data points from individual muscles and ○ indicates the mean value calculated at 





















5.2 Materials and methods 
The following methods are specific to this chapter. For general methods and chemicals, refer 
to Chapter 2.  
Base line recordings for all the experiments were carried out in bicarbonate buffered MPS at 
room temperature unless otherwise stated on specific occasions. 
5.2.1 Animals  
In these experiments I primarily used C57 Wlds mice. In some of the experiments I also used 
homozygous thy1.2 YFP16 Wlds mice (Wlds mice cross bred to double homozygous thy 1.2 
YFP 16 (commercially available line from Jackson laboratories) (Feng et al., 2000; Wong et 
al., 2009). The genotyping of these mice was carried out routinely for YFP expression by 
checking for fluorescent axons in ear punches (removed upon weaning), under a 
fluorescence microscope. All the Wlds mice used in this chapter were aged between 6 to 8 
weeks in order to avoid the age dependent decline in Wlds phenotypic characteristics 
(Gillingwater et al., 2002).   
5.2.2 Ex-vivo organ culture assay 
The rational for the approach in this Chapter is that axons and motor nerve terminal 
degenerate very slowly in Wlds mice after axotomy in-vivo (Gillingwater and Ribchester, 
2001) The phenotype is partially reproduced in ex-vivo, when muscles are cultured over 
night at 32° (Di Stefano et al., 2014; Brown et al., 2015). 
Bicarbonate buffered Mammalian Physiological saline (MPS: 120mM NaCl, 5mM KCl, 
2mM CaCl2, 1mM MgCl2, 0.4mM NaHCO3, 5.6mM Glucose) was prepared at room 
temperature and equilibrated with continuous bubbling of medical gas (5% CO2 and 95% O2) 
in order to set its pH value with in physiological range (7.2 – 7.4). Mice (Wlds or 
thy1.2YFP16:WldS) were sacrificed and amputated hind limbs were pinned in a Sylgard-
lined Petri dish containing MPS, for dissection. The tibial nerve along with the FDB and 
deep lumbrical muscles attached together were dissected. The nerve-muscle preparation was 
then pinned on dental wax (Polyscienses Europe, Inc., Germany) through muscle proximal 
and distal tendons. The preparation was then transferred to a sterile 30ml universal tube 
containing MPS ± drug treatment for overnight incubation. The tube was placed in a water 





mixture) and bubbled for 24hrs, prior to commencing both physiological and morphological 
analysis. The whole apparatus was covered in aluminium foil in order to prevent evaporation 
of liquid and damage by the direct sunlight. After 24 hrs, preparations were transferred to 
freshly prepared MPS ± drug treatment before commencing further analysis. Physiological 
analysis was carried out in two steps: first scoring the number of innervated muscle fibres, 
followed by acute intense stimulation for one hour.Scoring of the muscle fibres was then 
repeated after stimulation to ascertain any use-dependent deterioration of synaptic function 
with or without drug treatment.  
5.2.2.1 Sampling protocol for scoring innervated muscle fibres 
Scoring of innervated muscle fibres were performed (ex-vivo organ culture assay FDB nerve 
muscle preparation) prior to µ-CTX pre-treatment. Estimate of innervated muscle fibres were 
calculated from 10 – 20 randomly selected muscle fibres. Innervated muscle fibres were 
defined as those giving rise to spontaneous MEPP and evoked responses (EPP ± action 
potential). These were subcategorized as a) fully functional / innervated muscle fibres 
(presence of MEPP and EPP ± action potential) and b) partially functional / paralysed 
muscle fibres (spontaneous MEPP only). Denervated muscle fibres were defined as those 
producing neither MEPP nor evoked response (EPP ± action potential) upon stimulation. 
This categorization represents a low stringency test for effects of pesticide ingredients and 
their metabolites on neuromuscular transmission and function.  
The preparations were then subjected to acute stimulation for one hour, followed by the 
previous step of scoring for innervated fibres (20). The protocol adopted for acute 
stimulation comprised trains of four stimuli at 2Hz frequency, repeated every 10 seconds for 
one hour.  
5.2.3 Fluorescence microscope measurements  
Visualization of the nerve terminals and motor endplates was accomplished based on the 
YFP fluorescence of axons and TRITC α-bungarotoxin labelling of all junctional receptors. 
Both 10X and 20X objectives of the fluorescence microscope were used to visualise the 
NMJs. Images were captured using a Hamamatsu Orca-ER camera coupled to an Apple Mac 
G5 computer, and processed using Openlab software (Improvision, UK). NMJs were 
classified as fully occupied, partially occupied or vacant, depending on the extent of 
occupancy of TRITC- α-bungarotoxin labelled endplates by the overlying YFP labelled 





considered a denervated muscle fibre (method for semiquantitative analysing of synaptic 
degeneration).  
5.3 Results 
5.3.1 24hrs exposure of pesticide and its metabolites reduced the number of innervated 
muscle fibres. 
The primary objective of this set of experiments was to identify whether protracted exposure 
to pesticide ingredients and their metabolites in different combinations affects the functional 
capacity of neuromuscular junctions. Reduction in the number of functional muscle fibres 
would also produce muscle paralysis; so my attempt was to examine whether the ex-vivo 
preparation mimicked IMS in any fashion. 
The data revealed that the percentage of responsive muscle fibres (giving rise to  MEPP or 
EPP ±AP) after 24hrs incubation with DOCC (dimethoate1mM, omethoate 100µM, 
cyclohexanone 1mM, cyclohexanol 5mM) was significantly reduced compared to incubation 
in MPS alone (MPS: 100 ± 0%, dimethoate + cyclohexanone; 93.33  ± 7.63%, omethoate + 
cyclohexanol; 80  ± 8.66%, omethoate + cyclohexanone + cyclohexanol; 80 ± 18.02%, 
dimethoate, omethoate, cyclohexanol; 76.66 ± 7.63%, DOCC; 77 ± 5.70%, mean ± SD, P < 
0.05, ANOVA, “F = 17.84”) (fig 5.3, 5.4). Combinations of dimethoate and cyclohexanone 
preparations acted similar to control MPS, showing no significant reduction in responsive 
muscle fibres after 24hrs exposure to the treatments. However, all the other combinations of 
pesticide ingredients and their metabolites showed a significant reduction in responsive 
muscle fibres compared to control MPS.  
To characterize the effects in more detail responsive muscle fibres were sub categorised, 
depending on their ability to produce evoked responses upon stimulation. The data showed 
that there was a significant increase in fibres showing only spontaneous MEPPs in the 
presence of DOCC and dimethoate + omethoate + cyclohexanol treated preparation. 
Percentages were compared with bicarbonate MPS was: MPS: 8.75 ± 2.31%, dimethoate + 
cyclohexanone; 12  ± 15.71%, omethoate + cyclohexanol; 11.66 ± 2.88%, omethoate + 
cyclohexanone + cyclohexanol; 21.66 ± 2.88%, dimethoate, omethoate, cyclohexanol; 
56.66± 18.92%, DOCC; 39 ± 21.33%, mean ± SD, P < 0.05, ANOVA, “F = 8.64” (Fig 5.5). 
Reduction of evoked responses in preparations treated with dimethoate + omethoate + 





does not have considerable effects on evoked transmission. Collectively, the data also show 
that prolonged exposure to DOCC had a strong effect on evoked transmission.  
These data support the suggestion that muscle fibre paralysis due to inability to produce an 
evoked synaptic response might contribute to IMS. Since the pesticide ingredients alone did 
not affect the responsive muscle fibres, the data suggest that the most important components 
to affect muscle fibre innervation are the pesticide metabolites, i.e. omethoate and 
cyclohexanol. Collectively, these data support the hypothesis that longer term exposure to 






















Fig 5.3: Example traces of action potential / EPP with different treatments. A: 
Bicarbonate MPS, B; dimethoate (1mM) and cyclohexanone (1mM), C; omethoate (100µM) 
and cyclohexanol (5mM), D; DOCC. Note that the prolonged decay time with combination 
































Fig 5.4: Percentage of responsive muscle fibres (MEPP ± EPP/AP). Note that the 
reduction in responsive muscle fibres when omethoate and cyclohexanol combined together. 
However, long term exposure of pesticide ingredients does not reduce the responsive muscle 
fibres. Each bar represents mean  ± SEM [n (No of muscles): MPS = 17, dimethoate + 
cycloxexanone = 3, omethoate + cyclohexanol = 3, omethoate + cyclohexanone + 
cyclohexanol = 3, dimethoate + omethoate + cyclohexanol = 3, DOCC = 3] (p < 0.05, 














































































Fig 5.5: Percentage of responsive muscle fibres expressing either MEPP ± EPP/AP or 
MEPP only. Note the significant increase in MEPP only responsive fibres with DOCC and 
dimethoate + omethoate + cyclohexanol treated preparations, showing that these components 
possibly affect evoked transmission. Each bar represents mean ± SEM [n (No of muscles): 
MPS = 17, dimethoate + cycloxexanone = 3, omethoate + cyclohexanol = 3, omethoate + 
cyclohexanone + cyclohexanol = 3, dimethoate + omethoate + cyclohexanol = 3, DOCC = 3] 











































































5.3.2 Acute stimulation after long term exposure of pesticide ingredients and their 
metabolites enhances loss of transmission.  
Next I explored whether the failure of NMJ synaptic transmission after 24hr exposure to 
pesticide components and their metabolites might be further exacerbated by activity. In 
normal healthy individuals, the most active muscle groups at rest are the respiratory muscles 
(due to continuous breathing) and neck muscles (to balance the body posture). In pesticide 
poisoned patients, due to cardiorespiratory shock (hypoxemia and hypotension) even higher 
demand are placed upon the respiratory muscles during the acute cholinergic episode. 
Therefore I hypothesised that increasing activity along with the prolonged exposure to 
pesticide ingredients and their metabolites might also be a contributing factor for muscle 
paralysis present in IMS. To test this I stimulated the nerve-muscle preparations after 
overnight culture with treatment, using trains of four stimuli (TOF) (2Hz) every 10 seconds 
for one hour. I then reassayed the amount of functional innervation. 
The data revealed that preparations treated with DOCC produced a significant reduction in 
responsive fibres after one hour of acute stimulation (table 5.1, fig 5.6). Interestingly, 
however, none of the other treatments produced additional use-dependent block.   
These data suggests that there is apparently activity dependent modulation of synaptic 















Fig 5.6: Percentage or responsive muscle fibres (MEPP ± EPP/AP) in before and after 
acute stimulation. Note that the reduction in responsive muscle fibres upon acute 
stimulation with combination of dimethoate, omethoate, cyclohexanol and DOCC treated 
preparations compared to rest of the treatment groups.  Each bar represents mean  ± SEM (n 
= 3 muscles per each treatment group) (p < 0.05, Two-way, repeated measures, ANOVA, 













































































Table 5.1: Summary of statistical analysis of effects on acute stimulation with pesticide 
ingredients and their metabiolites. Statistical test; twoway analysis of variance. Post test; 

























Before Stimulation vs After Stimulation 
Row Factor Before Stimulation After Stimulation Difference 95% CI of diff. 
Control 100 100 0 -5.840 to 5.840 
Dimethoate + Cyclohexanone 93.33 83.33 -10 -24.30 to 4.304 
Omethoate + Cyclohexanol 80 71.67 -8.333 -22.64 to 5.971 
Ometh+CH-one+CH-ol 83.33 80 -3.333 -17.64 to 10.97 
Dimeth +Ometh+CH-ol 76 60 -16 -30.30 to -1.696 
DOCC 77 57 -20 -34.30 to -5.696 
  
Row Factor Difference t P value Summary 
Control 0 0 P > 0.05 ns 
Dimethoate + Cyclohexanone -10 1.915 P > 0.05 ns 
Ometh+CH-ol -8.333 1.596 P > 0.05 ns 
Ometh+CH-one+CH-ol -3.333 0.6383 P > 0.05 ns 
Dimeth +Ometh+CH-ol -16 3.064 P < 0.05 * 





5.3.3 Long term exposure to pesticide and metabolites causes synaptic degeneration 
Finally I asked whether DOCC might have caused paralysis in the overnight cultures by 
enhancing synaptic degeneration.  
Lumbrical muscles from YFP16 Wlds mice were counterstained with TRITC-α-
bungarotoxin, to label post synaptic ACh receptors after 24 hour exposure to DOCC. These 
muscles showed signs of enhanced Wallerian degeneration (fig 5.7). Control muscles 
showed no signs of degeneration. Subjective and semi-quantitative analysis (number of 
vacant endplates) of the treated preparation showed increased synaptic degeneration with the 
combination of omethoate and cyclohexanol and with the DOCC treated-preparations 
compared to control MPS (table 5.2). However, these observations need further investigation 
to clarify whether the observed synaptic degeneration in combination of omethoate and 



















Table 5.2: Semi quantitative analysis (number of vacant endplates) of synaptic 
degeneration, after 24hrs exposure of pesticide ingredients and their metabiolites in 
nervemuscle preparations. Note that the enhanced degeneration with pesticide metabolites 
(omethoate and cyclohexanol) and DOCC treated preparations. “+” sign indicate the amount 



























Control MPS + 
Dimethoate and cyclohexanone + 





















Fig 5.7: Motor nerve terminal undergoes degeneration after long term exposure to 
DOCC. Fluorescence microscopic images of neuromuscular junctions in deep lumbrical 
muscles after 24 hrs exposure to either bicarbonate buffered MPS alone (A) or DOCC (B). 
Axons and nerve terminals are labelled via transgenic expression of YFP (green). 
Postsynaptic acetylcholine receptors were labelled with TRITC-α-bungarotoxin (red) to 
visualize motor endplates. Note that intramuscular axons are intact and all the endplates in 
control (A) samples are occupied with an overlying, YFP-positive terminal, while almost all 
the axons in the DOCC treated preparation (B) are fragmented and the endplates are vacant  




















The primary aim of this Chapter was to establish and study the effects on neuromuscular 
transmission of longer term exposure (24 ± 1 Hrs) to the concentrations of pesticide and 
metabolites found in poisoned plasma. My objective was to establish whether an ex-vivo 
preparation, developed in our laboratory, could be used to emulate the IMS of human 
pesticide-poisoned patients.  Furthermore, I wanted to test whether there was an activity 
dependent modulation of synaptic transmission in the presence of pesticide components and 
to investigate any other evidence for synaptic degeneration with longer exposure to these 
compounds. 
I observed that direct exposure for 24hrs to pesticide and metabolites produced a significant 
reduction in innervated muscle fibres (presence of either spontaneous or evoked 
transmission). More surprisingly, among those innervated muscle fibres, there were a 
significant proportion of paralysed muscle fibres (spontaneous transmission only). These 
data may therefore provide some insight towards the muscle paralysis present in human 
pesticide poisoned patients. Furthermore I also observed activity-dependent modulation of 
synaptic transmission in preparations treated with pesticide and their metabolites (DOCC). 
This suggests that increased activity in affected muscle groups might contributed to the 
muscle paralysis observed in patients with IMS. Finally, there was some evidence of 
synaptic degeneration after long term exposure (24 ± 1 Hrs) to high concentration of DOCC 
suggesting involvement of several mechanisms, not all of which are apparent in human IMS.  
Further refinement of the experimental protocol may be necessary to simulate IMS. In 
human pesticide poisoned patients (and minipigs model of OP pesticide toxicity), when the 
toxins are ingested these compounds first undergo absorption from the gut and intestinal 
epithelium. Next, these parent compounds undergo metabolic conversion. Some of these 
compounds (both parent and metabolites) are excreted via urine. Therefore, it takes time 
(approximately about 3 – 5 hrs) to accumulate these compounds in the plasma and tissue. 
However, in the experiments described in Chapters 3 & 4, I introduced the active compounds 
immediately into the bathing medium, rather than gradually and producing change in the 
relative concentrations of the compounds over time. Therefore, in future the experiments in 
the present chapter could be further refined by introduction of these compounds gradually 
into the nerve muscle preparation (such as use of perfusion system over the 24hrs time 
period) which might help us to understand the time course of this muscle paralysis. 
Moreover, I have used an acute stimulation protocol to evaluate the role of activity on use-





continuous bursts during the 24hrs period. This would more accurately simulate the pattern 
of respiration or attempted muscle use in-vivo. Finally, ex-vivo preparations of respiratory 
related muscle such as phrenic nerve - diaphragm or intercostal nerve - trangularis sterni 
muscle might be more appropriate for exploring the mechanisms of this respiratory muscle 
paralysis in human patients. 
However, in principle this ex-vivo culture system could be used as an efficient and 
inexpensive screening tool to test for possible treatments for NMJ synaptic transmission 
failure in IMS. For example, it will be possible to test for protective effects of blocking the 
post synaptic receptors using nicotinic receptor antagonist (eg; rocuronium) along with the 
DOCC, and to examine whether reduction in repetitive activity will rescue the NMJ 
transmission in the long run. This proposal is based on the partial success that has been 
observed already in minipigs pre-treated with rocuronium (Eddleston, personal 
communication / unpublished) and a clinical trial underway in Sri Lanka using rocuronium 
as a potential prophylactic agent against onset of IMS.  
5.4.1 Long term (24 ± 1 hrs) exposure of pesticide ingredients and their metabolites has 
greater effects on NMJ synaptic transmission 
Despite the observed effects on NMJ synaptic transmission including increasing in decay 
time of synaptic potentials and currents, after acute exposure of pesticide and metabolites 
either singly or in combination, as I described in my previous results chapters (Chapter 3 & 
4), I did not observe NMJ synaptic transmission block as described in intermediate syndrome 
patients, except when I applied pesticide poisoned plasma from pigs. Therefore, I 
hypothesised that in order to produce muscle paralysis / NMJ synaptic transmission block, 
longer exposure to these compounds would be required. I tested this hypothesis by 
examining NMJ synaptic function after long term exposure of those compounds using ex-
vivo culture assay. The observation of reduction in responsive muscle fibres suggests the 
mechanisms might be involved in muscle paralysis intermediate syndrome patients. 
Reduction in muscle fibres able to produce evoked responses suggests possible involvement 
of many mechanisms (excitation, release, action and excitation-secretion coupling). Since it 
was still possible to observe MEPPs, this shows that spontaneous transmission is still intact. 
Therefore, I suggest that mechanisms involved in evoked transmission such as excitation of 
the presynaptic terminal or secretion of ACh from presynaptic terminals are affected; thus 
preventing EPPs / APs which normally lead to muscle action potentials and muscle 





membrane properties were not affected by short term exposure to these components. 
Therefore, this suggests that further examination of NMJ synaptic transmission is needed to 
locate the failure point of excitation and secretion mechanisms of NMJ synaptic 
transmission.  
Involvement of activity dependent modulation in synaptic transmission has been studied for 
many decades. It has been shown that fast and slow muscle NMJs display marked plasticity 
by being able to adapt important release characteristics to the impulse patterns imposed on 
them (Reid et al., 2003). Furthermore, some studies have also reported that remarkable 
plasticity and adaptive responses to the chronic absence of AChE, which has direct 
consequence of the functioning of the neuromuscular junction (Girard et al., 2005). 
Therefore I wanted to examine how activity along with the pesticide its metabolites modulate 
the synaptic plasticity.  My experiments showed that acutely increased activity is harmful to 
the NMJ synaptic transmission in the presence of DOCC, producing further reduction of 
innervated muscle fibres compared to preparations wtih unstimulated muscle fibres but 
exposed to DOCC.  
Finally, the data also suggested that DOCC induced synaptic degeneration. However, further 
quantitative analysis of the effect is required to clarify where enhanced degeneration 
explains the physiological findings. Although there is no direct evidence on synaptic 
degeneration on IMS patients or animal models of OP poisoning, there are few reports of 
limited muscle necrosis in both cases. Human IMS patients have shown myopathic changes 
(both muscle biopsies and post mortem samples) including focal necrosis of the muscles (De 
Reuck and Willems, 1975; De Wilde et al., 1991; John et al., 2003); however, they did not 
report any abnormalities in peripheral nerves (De Wilde et al., 1991). Similarly, animal 
studies of OP pesticide toxicity also have reported increase muscle necrosis after exposure to 
OP agents including pesticide and nerve gases (Salpeter et al., 1979; Hughes et al., 1991)). 
These previous observations suggest that morphological changes in cellular architecture of 
NMJ may occur in IMS. Furthermore, it has also been shown previously, that OPIDN 
involves Wallerian degeneration (Abou-Donia, 2003).  
Collectively, from the data and the previous reports, I suggest that the involvement of 
synaptic degeneration in IMS along with the activity dependent transmission block with 
longer term exposure of pesticide ingredient and its metabolites might be a plausible 





may turn out to be a useful model for studying IMS, with the potential to screen and identify 






















































The data presented in this thesis may have an important bearing on the treatment of the 
delayed synaptic transmission failure at the neuromuscular junction in organophosphorus 
pesticide poisoning. 
Though IMS has been documented for decades, the underling mechanism is still unclear. The 
hypothesized mechanism of action for IMS includes: overstimulation of nicotinic 
acetylcholine receptors (nAChRs); down regulation of post synaptic nAChRs; and nAChR 
conformational changes with prolonged depolarization (Senanayake and Karalliedde, 1987; 
De Bleecker, 1995). Developing a better understanding of this delayed neuromuscular 
transmission with OP pesticide poisoning may benefit patients by discovering effective 
treatment and therefore saving many lives in the future. 
Effects of AChE inhibition on neuromuscular transmission had been studied in both 
functional and cellular aspect since mid-20th century (Brown et al., 1936; Brown, 1937; 
Eccles and O'Connor W, 1941; Fatt and Katz, 1951; Del Castillo and Katz, 1954; 
Senanayake and Karalliedde, 1987). However, experimental evidence on mechanisms of 
delayed, muscle paralysis or neuromuscular transmission failure due to AChE inhibition is 
rare. The components of OP pesticide include active ingredients (OP compound), solvent 
(organic) and a surfactant. Moreover, when ingested these components undergo metabolism, 
mainly in the gastric epithelium and liver. Even though anticholinesterase activity on 
synaptic transmission at NMJ is well documented, the effects of solvents on synaptic 
transmission at the NMJ were yet to have been explored.  
A previous study involving intensive care of a minipig model of OP poisoning has suggested 
that both anticholinesterase and solvent may be necessary for the development of the 
neuromuscular transmission failure (Eddleston et al., 2012). Therefore, I hypothesised that 
pesticide toxicity is not entirely due to acetylcholinesterase inhibition, but to combinatorial 
effects of both OP and the solvent present in the pesticide.  Hence, the aim of my project was 
first to investigate whether the acute syndrome is caused only by the anticholinesterase 
effects of pesticide at the neuromuscular junction or whether metabolic conversion of the 
parent compounds has more potent, additive toxic effects at the NMJ. I focused on one 
particular pesticide; Dimethoate Ec. Secondly, I investigated mechanisms involved in 
possible neuromuscular transmission failure with pesticide ingredients and their metabolites. 
Finally, to model the neuromuscular transmission failure in IMS and to verify whether it 
might be due to the persistent combined effects of metabolites of pesticide ingredients 





pesticide ingredients and their metabolites on isolated nerve-muscle preparations maintained 
for 24 hrs ex vivo.  
In Chapter 3, I provided evidence for effects of synaptic transmission at NMJ with 
components of pesticide either alone or in combination. Intracellular endplate potential 
recordings from nerve-muscle preparations treated with minipig plasma obtained from pigs 
treated with either commercial pesticide, dimethoate alone, or saline showed increase in 
decay time of the EPP with pesticide plasma or dimethoate plasma compared to saline 
plasma or Hepes MPS. Preparations treated with neostigmine as a positive control showed 
decay times of both MEPPs and EPPs that, as expected, were significantly increased 
compared to Hepes MPS (Blaber and Christ, 1967; Katz and Miledi, 1973; Kordas, 1977; 
Miledi et al., 1984). However, the decay time facilitation comparing minipig pesticide 
plasma or dimethoate plasma was not statistically different. Interestingly, the latency for 
prolongation of the decay time with plasma (pesticide or dimethoate) was longer compared 
to neostigmine. This suggests complex mechanisms may underly the response to plasma, 
such as: a) anticholinesterase activity present in plasma may have been lower than expected, 
b) some of the molecules of anticholinesterases may be bound to other molecules in the 
plasma, inactivating them or slowly releasing. Interestingly, pesticide treated plasma also 
produced a significant increase in MEPP frequency compared to the other treatment groups 
suggesting increase in spontaneous release activity of neurotransmitter from presynaptic 
terminals. Changes in MEPP frequency with AChE inhibition had been observed previously 
including increase (Blaber and Christ, 1967; Laskowski and Dettbarn, 1975; Bois et al., 
1980) and decrease (Duncan and Publicover, 1979) of spontaneous activity. However, 
neither dimethoate plasma nor neostigmine produced such an increase in MEPP frequency 
suggesting this may be an effect of both anticholinesterase and solvent/metabolite present in 
the pesticide plasma. More importantly, reversible evoked synaptic transmission block was 
observed with pesticide plasma treated samples, suggesting complexity of the evoked 
transmission with the presence of both anticholinesterase and solvent. There were previous 
observations of either depolarizing block (Nastuk and Alexander, 1954; Katz and Thesleff, 
1957a; Blaber and Christ, 1967) or irreversible transmission block (Laskowski and Dettbarn, 
1979), however neither the positive control (neostigmine) nor dimethoate plasma produced 
synaptic transmission block suggesting the observed transmission block with pesticide 
plasma is a consequence of multiple effects including, effect of AChE inhibition and 





Treatment of nerve muscle preparation with pure ingredients of pesticide components and 
their metabolites showed greater effects with metabolites of pesticide compared to its parent 
components. It has been widely accepted that thiophosphorus OP compounds need bio-
activation inside the body to become more potent (Foxenberg et al., 2007; Eddleston and 
Clark, 2010). The cumulative dose response of pesticide ingredients indicated increased 
potency of drug action with metabolite (omethoate) compared to its parent (dimethoate) 
compound. More interestingly, the solvent metabolite cyclohexanol also showed more 
pronounced effects on synaptic transmission at NMJ compared to its parent component 
cyclohexanone.  
Synergistic / additive effects on prolongation of synaptic transmission were observed when 
omethoate and cyclohexanol (metabolites) were combined.  This was a significant finding as 
concentration of omethoate (100µM) used in these experiment produced > 99% AChE block, 
suggesting cyclohexanol contributed to the synaptic transmission prolongation by a 
mechanism other than AChE inhibition. The synergistic effects were supported by the 
functional assay of synaptic transmission at NMJ: muscle contraction. High frequency 
tetanic contraction with omethoate and cyclohexanol produced sustained after contraction 
with prolonged relaxation compared to rest of the treatments.  
Furthermore, high frequency repetitive stimulation revealed short term synaptic transmission 
depression with some evidence suggesting desensitization when preparations were treated 
with combination of all parent components and metabolites (DOCC). These findings 
suggested involvement of activity in producing synaptic transmission impairment in the 
presence of these components. Increase activity dependent synaptic transmission 
modification has been studied previously (Dorlochter et al., 1991; Fahim, 1997); however 
the use-dependent transmission impairment at NMJ with pesticide components is yet to be 
fully explained.   
Importantly, I did not observe a neuromuscular transmission block with a combination of 
dimethoate, omethoate, cyclohexanone and cyclohexanol (DOCC) in vitro (both intracellular 
recordings and muscle contraction), similar to reversible evoked transmission block noted 
with the pesticide plasma experiments. However, Eddleston et al (2012) have reported 
transmission block in minipigs either with treatment of pesticide or combination of 
dimethoate and cyclohexanone. This suggests that in order to develop synaptic transmission 





(e.g. either additional metabolites, or prolonged action of these components and continuous 
activity at NMJ).   
In Chapter 4, I examined the possible mechanisms of actions in relation to the synaptic 
transmission failure at the NMJ. First I measured the effects on passive membrane properties 
with pesticide components either alone or in combination. Some early reports have shown 
that changes in input resistance of the muscle fibres with AChE inhibition (Kelly and Ferry, 
1994), however my results did not show any alterations in any passive membrane properties 
with anticholinesterase alone, similar to Blaber et al (1972), or in combination with solvent. 
This suggests that these compounds do not produce leakier muscle fibres.  
Having excluded the possible alterations in passive membrane properties, I then measured 
characteristics of the underlying currents affected by omethoate and cyclohexanol, either 
alone or in combination. Omethoate produced prolongation of the decay time, consistent 
with the evidence for anticholinesterase activity (Takeuchi and Takeuchi, 1959; Gage and 
Armstrong, 1968; Kordas, 1972; Kordas et al., 1975). Interestingly, omethoate induced an 
EPC decay time that required a double exponential fit, suggesting two mechanisms of 
actions for the prolongation of decay. Previous reports of effects of anticholinesterase 
activity on EPCs also showed evidence for complex mechanisms, perhaps consistent with a 
direct action of these compounds on the nAChR, changing the gating kinetics of the channels 
(Kordas, 1972; Kuba et al., 1974; Kordas et al., 1975; Akaike et al., 1984; Albuquerque et 
al., 1984; Albuquerque et al., 1985). Furthermore, some reports provided evidence for direct 
blocking of the ACh receptor with neostigmine (Fiekers, 1985). This raises the possibility 
that omethoate might also have direct effects on the AChRs, which might be responsible for 
blocking the channel complex. Even though cyclohexanol did not prolong EPC decay 
substantially, it also conferred a double exponential decay suggesting a complex mechanism 
of action. Among the few documented pieces of evidence available on effects of 
cyclohexanol on synaptic transmission at NMJ, it was shown that double exponential decay 
function in EPC with 1-phenyl-4-piperidino-cyclohexanol treated preparation. Furthermore, 
the cyclohexanol derivative vesamicol also possesses anticholinesterase activity at frog NMJ 
(Van der Kloot, 1986). Remarkably, in the presence of both omethoate and cyclohexanol 
more than two exponentials were required to fit the EPC decay. This intriguing result further 
suggests that complex, independent effects of these compounds on AChRs. This could 
perhaps be investigated by performing ACh iontophoresis using isolated single muscle fibres 





from single channels in order to measure the direct effects of these compounds on the AChR 
gating.   
Having examined the possible post synaptic effects, I then examined the presynaptic 
characteristics with these components. First I estimated the influence on transmitter release 
from presynaptic terminals in the presence of pesticide components. Estimates of quantal 
content using EPPs suggested a significant reduction in transmitter release with the 
combination of metabolites or all four components together. Studies have reported 
alterations in transmitter release with AChE inhibition showing reduction in quantal content 
(Straughan, 1960; Potter, 1970; Laskowski and Dettbarn, 1975), while others reported there 
is no effect on evoked transmitter release (Blaber and Christ, 1967; Ferry and Marshall, 
1971; Blaber, 1972). However, the use of EPPs to estimate quantal content has 
disadvantages as the amplitude of the EPPs can vary due to the change in driving force and 
non-linear summation. Therefore, as a more robust test I used EPCs to estimate quantal 
content. I obtained results with treatments that were not statistically different from the 
control. Hence, further experiments are needed to determine whether the effects of 
cyclohexanol on quantal content in FDB are a consequence of differences in the properties of 
motor nerve terminals of FDB compared with TS, or some other consequence of 
experimental recording conditions. 
The observed reduction in MEPC amplitude with cyclohexanol treated preparations drew my 
attention towards whether these preparations behave as vesamicol, a non-competitive 
inhibitor of the transport of ACh into synaptic vesicles (Whitton et al., 1986). My 
observation of stimulation dependent reduction in MEPC amplitude demonstrated 
vesamicol-like effects (Searl et al., 1991) with cyclohexanol. Previous reports of vesamicol 
action on perineural recordings also showed inhibitory effects on nodal Na+ -channels 
(Pemberton et al., 1992). The preliminary data from nerve terminal currents recorded with 
cyclohexanol treated preparations also showed some evidence of alterations. However, 
further experiments are required to confirm these findings, such as perineural recordings and 
evaluation of pre and post stimulation MEPP distribution in cyclohexanol treated 
preparations.  
In Chapters 3 &4, I have tried to understand and explain the effects of acute exposure of 
pesticide compounds on synaptic transmission, thereby exposing the mechanisms involved. 
However, IMS is a delayed syndrome. In my third results chapter I have tried to model the 





exploring any similarities and mode of action to IMS in an ex-vivo model.  24hrs of chronic 
exposure to DOCC produced a significant reduction in innervated muscle fibres. Among 
these innervated muscle fibres, a significant proportion were paralysed, as they did not 
produce evoked responses. EPPs recordings obtained following high frequency repetitive 
stimulation in the presence of DOCC also showed short term synaptic depression within the 
cycle and desensitization in consecutive cycles (Chapter 3), demonstrating possible activity 
dependent effects on synaptic transmission. Therefore, I wanted to explore the effects of 
acute stimulation after chronic exposure to pesticide components. The data showed an 
activity-dependent reduction in innervated muscle fibres in DOCC treated preparations. 
Although activity-dependent modulation of synaptic transmission at NMJ is quiet debatable 
(Dorlochter et al., 1991; Fahim, 1997), the data I obtained suggest that increasing activity in 
the presence of DOCC is detrimental to reliable transmission.   
The relatively small reduction I observed in innervated muscle fibres with both chronic 
exposure and upon acute activation in the presence of DOCC raises the question whether 
these findings are of significance for functional aspect of muscle contraction. For instance, 
ALS patients show muscle weakness after they have lost about 60% of the functional motor 
units (Krarup, 2011). In my experiments, I found that 60% of the fibres are still innervated 
after chronic exposure to DOCC, suggesting muscles should still be competent to contract. 
However, ALS is a progressive degenerative disorder and compensatory mechanisms such as 
collateral sprouting and muscle fibre hypertrophy contribute to the normal muscle 
contraction during early stages of the disease until they start showing clinical symptoms. In 
patients acutely poisoned with pesticide, there is only very limited time to activate 
compensatory mechanisms for reliable synaptic transmission in the event of loss of 
innervated muscle fibres. Therefore, acute loss of up to 40% loss of transmitting NMJs might 
plausibly explain the underlying signs and symptoms of IMS.  
There was some evidence for synaptic degeneration in DOCC treated preparations, 
suggesting involvement of more complex mechanism in the presence of these compounds. 
There are some evidence on involvement of myopathy in IMS patients (De Reuck and 
Willems, 1975; De Wilde et al., 1991; John et al., 2003). Furthermore, experimental study of 
sarin exposure in mice also showed degeneration responses with collateral sprouting 2- 3 
days after in-vivo treatment (Kawabuchi et al., 1989; Kawabuchi et al., 1991). However, on 
the other hand, intensive care minipigs model of OP toxicity does not provide sufficient 
evidence for possible degeneration effects after 12hrs from poisoning (Eddleston & Harris, 





degeneration effects along with the neurophysiological evaluation (in-vivo and in-vitro) in 
pesticide toxicity using an animal model, such as intensive care mouse model of OP toxicity 
(Dissanayake, MSc thesis 2010). Lack of evidence on neuropathic changes during the course 
of IMS in humans does not exclude the possible degenerative effects cause by these pesticide 
components. Future use of the techniques such as microendoscopy (Brown et al, 2014) in 
IMS patients may be able to detect any evidence of degeneration.  
Future experiments should be directed along two main paths. First, further understanding of 
the additive or synergistic actions of omethoate and cyclohexanol, and how they may 
contribute to development of IMS. Second, is to develop therapeutic regime that can be 
utilized to prevent development of IMS and to enhance the recovery of patients from the 
respiratory paralysis, thereby reducing the probability of IMS related morbidities and 
mortalities.  
In order to understand how omethoate and cyclohexanol augment the development of IMS, 
first it may be necessary to understand whether and how these components change the gating 
kinetics of AChRs. This could be attempted using patch clamp recording from single 
channels. Furthermore, it will be useful to know whether these components stimulate 
desensitization of the AChRs. This could be tested using ACh ionophoresis in the presence 
of the treatments. Changes in AChRs density could also be tested in the presence of these 
components in order to test the possibility of receptor internalization in IMS. Moreover, in 
order to identify the presynaptic alterations, changes in presynaptic ionic currents in the 
presence of these components could be evaluated using perineural recordings. Quantal 
analysis under low Ca2+ extracellular medium along with the treatment could help in 
identifying the role of extracellular Ca2+. Furthermore in order to understand, whether there 
is any feedback regulation of transmitter release by presynaptic AChRs in the presence of 
these components, AChRs antagonists could be used to block these receptors.  
Finally, the ex-vivo assay described in Chapter 4 could be used to test for both protective and 
therapeutic treatments for IMS. Protective mechanisms such as blocking of AChRs in order 
to prevent over stimulation could be tested using nAChRs antagonists. Since there is some 
evidence of protective action of neuromuscular blocking agents in data obtained from the pig 
model of OP toxicity, it may be possible to using this ex-vivo assay to identify any 
therapeutic window for commencement of treatment and understanding the underlying 
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